Structure-based mechanism of hydratase-aldolases in the Type I aldolase superfamily and structures of tautomerase superfamily members by LeVieux, Jake Allen
  
 
 
 
 
 
 
 
Copyright 
by 
Jake Allen LeVieux 
2017 
 
 
 
 
 
 
 
 
 
 
 
  
The Dissertation Committee for Jake Allen LeVieux certifies that this is the approved 
version of the following dissertation: 
 
 
 
Structure-Based Mechanism of Hydratase-Aldolases  
in the Type I Aldolase Superfamily and Structures of 
Tautomerase Superfamily Members 
 
 
 
 
 
 
 
 
 
 
Committee: 
 
Christian P. Whitman, Supervisor 
Walter L. Fast 
David W. Hoffman 
Sean M. Kerwin 
Yan (Jessie) Zhang 
  
Structure-Based Mechanism of Hydratase-Aldolases  
in the Type I Aldolase Superfamily and Structures 
of Tautomerase Superfamily Members 
 
by 
 
Jake Allen LeVieux, B.S. 
 
 
Dissertation 
Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 
Doctor of Philosophy 
 
 
The University of Texas at Austin 
May 2017 
Dedication 
 
            To my family in San Diego. To my Mom and Dad, who have been faithful in 
every phase of my life. You have been a model of integrity, respect, and authenticity, 
and for that I am forever thankful. Everything I do, including the work in this 
dissertation, is possible because of your care. To my brothers, Trevor and Lucas. You 
have changed me more than I think you know. I can see myself in both of you and this 
gives me a sense of self-compassion and confidence because it reminds me I am not 
ever alone. To my nephew, Jude, who has helped me understand human instinct at 
seven years old. To my grandmother, Baba, who has been so present throughout my 
life, and is a true example of strength and poise. To my aunt Cheri and my cousins 
Megan, Michelle, and Emily. To the families of John and Lyn Allen, and Jim and 
Peggy Allen. To my grandfather Rex Allen, who lives in us all.  
            To my local family in Austin — my grandparents Larry and Nana, my uncle Ted, 
my aunt Amanda, and cousins Kayla, Niki, and Hannah. Your support has been constant 
throughout my highs and lows during graduate school. The smiles we share make me feel 
at home. The weekly family dinners (or brunches) are precious to me, and I am a better 
person because of them. To Elizabeth and Larry Wilson and their daughters Helen (bff) 
and Margaret. To the family of James and Ryann LeVieux, who make the best of every 
moment. Plus, their iPad was used to remotely collect crystal diffraction data on a manly 
beach camping trip. To the aunts, uncles, and cousins that I have connected with at 
cousin’s camp and family reunions.  
 
 v 
Acknowledgements 
 
 The work in this dissertation is supported by the National Institutes of Health        
Grant GM-41239 (CPW) and the Robert A. Welch Foundation. I thank my advisor, Dr. 
Christian Whitman, for his guidance during my time as a graduate student. Because of 
you, I have enjoyed such freedom in my pursuit of discovery in science that has been 
exhilarating. Simultaneously, you have also kept me (as best you can) out of the weeds of 
interesting, but irrelevant science. I thank Dr. Tyler Stack for introducing me to Dr. 
Whitman, his dedication in managing our lab, and for the intellectual and personal 
conversations we have had. It was nice to have someone that would go to seminar with 
me. I think Dr. William Johnson Jr. for his jokes, good spirit, and wizardry in chemistry. I 
thank Kaci Erwin, the vicious athlete, for letting me borrow (take) enzymes and for 
playing Christmas music in lab. I thank Dr. Bert-Jan Baas for his mentorship over the 
past few years. I felt so alive discussing Fused 4-OT and its bizarre asymmetry. We 
stumbled upon a configuration I wondered might be possible when browsing the 
symmetry of protein homomultimers in a Biochemistry textbook. I thank Emily Lancaster 
for her clear communication and unifying spirit in our lab. I thank Dr. Jamison 
Huddleston for sharing his expertise and for giving me an additional opportunity to 
determine protein structures. I thank Samuel Guimarães for our conversations and for 
giving me a plasmid encoding an enzyme studied in his lab — that is trust. I thank Ingrid 
Johnson for her help with purification of PhdJ mutants.  
 vi 
 I thank Dr. Jessie Zhang and her lab members for their perspective in the world of 
crystallography. The weekly lab meetings were a pleasure. I thank Dr. Wenzong Li, for 
showing me the ropes in crystallography from crystal screening to MAD phasing and 
refinement. I thank Dr. Wupeng Yan for his technical advice when I struggle with 
structure determination. I thank Brenda Medellin for our discussions and for her 
positivity and courage. I thank Wendy Matthews for being exceptionally authentic and 
making sure I have all I need in lab. I thank Dr. Art Monzingo for his earnest support and 
advice in all areas related to crystallography. 
            I thank Dr. Ben Liu and the members of his lab for their positive influence in my 
education. I thank Dr. Mark Ruszczycky for his wit and honest feedback. I thank Dr. Hak 
Jong Kim his efforts in the study of AprD4 — a remarkable enzyme. I thank Dr. Reid 
McCarty (deceased) for initiating the AprD4 project with me. I thank Dr. Sean Kerwin 
and Dr. Kenneth Johnson for the worthwhile experiences in their laboratories during my 
rotations. I thank Dr. Walter Fast for his wisdom in my qualifying exam, my committee 
meetings, and in this period as I prepare for my defense.  
 I thank all of the professors that I have assisted in teaching including Dr. David 
Hoffman, Dr. Jeffery Barrick, Dr. Gail Grabner, Dr. Jon Robertus, and Dr. Adrian 
Keatinge-Clay. I believe I am a more balanced scientist because of the diverse material I 
was exposed to in their courses. I might have learned a thing or two about teaching, as 
well. 
 
  
 vii 
Structure-Based Mechanism of Hydratase-Aldolases  
in the Type I Aldolase Superfamily and Structures 
of Tautomerase Superfamily Members 
 
 
 
Jake Allen LeVieux, Ph.D. 
The University of Texas at Austin, 2017 
 
Supervisor:  Christian P. Whitman 
 
Polycyclic Aromatic Hydrocarbons (PAHs) are composed of multiple benzene-
like rings and their bacterial catabolism has potential utility for bioremediation. In the 
breakdown of each ring, oxygenation is followed by ring cleavage and side chain 
removal, the latter of which is catalyzed by hydratase-aldolases. These enzymes belong to 
the N-acetylneuraminate lyase (NAL) subgroup of the Type I aldolase superfamily. NahE 
and PhdJ are hydratase-aldolases that process benzylidenepyruvate compounds in PAH 
degradative pathways from Pseudomonas putida G7 and Mycobacterium vanbaalenii 
PYR-1, respectively. Crystal structures of these enzymes in liganded and unliganded 
states are reported here and reveal new details about their catalytic mechanisms. 
Stabilization of the developing hydroxide anion during hydration could involve the amide 
nitrogen of Asn-157 (NahE numbering), conserved in hydratase-aldolases, but not other 
NAL subgroup members. For NahE, Tyr-155 might act as the general base for addition, 
 viii 
but the identity of the base is less certain for PhdJ. The crystal structure of PhdG reveals a 
carbinolamine intermediate hydrogen bonding to Tyr-152, consistent with the 
participation of the residue in Schiff base formation.  
In addition, this dissertation describes structures within the tautomerase 
superfamily (TSF). The enzymes reported are from 4-oxalocrotonate tautomerase (4-OT), 
cis-3-chloroacrylic acid dehalogenase (cis-CaaD), and malonate semialdehyde 
decarboxylase (MSAD) subgroups. 4-OT catalyzes the ketonization of 2-
hydroxymuconate (2-HM) in the meta-fission pathway. cis-CaaD and MSAD 
respectively catalyze dehalogenation and decarboxylation reactions in the catabolic 1,3-
dichloropropene pathway, respectively. TSF members have a catalytic Pro-1 and share a 
common β-α-β fold. TSF members designated Ps01740, Pt0534, and Fused 4-OT have 
sequence similarity with the cis-CaaD and 4-OT subgroups and may provide insight into 
gene duplication and fusion events in the TSF. These enzymes have tautomerase activity 
and low or absent cis-CaaD activity. Liganded and unliganded structures suggest a 
structural basis for their activation. The trimeric structure of Fused 4-OT is unusual in 
that one monomer is inverted relative to the others. Mechanisms for 2-HM 
tautomerization are proposed based on a 2-HM-bound structure and kinetic parameters of 
mutants. Crystal structures for the MSAD homologues BP4401 and YusQ were obtained, 
and provide clues about their activities. 
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Chapter 1: The Roles of the Hydratase-Aldolases in the Degradation of 
Polycyclic Aromatic Hydrocarbons 
 
1.1 BIOREMEDIATION OF POLYCYCLIC AROMATIC HYDROCARBONS 
 
1.1.1 Properties, Sources, and Toxicity of Polycyclic Aromatic Hydrocarbons 
 
Polycyclic aromatic hydrocarbons (PAHs) are multi-ring structures with 
conjugated  systems. Low molecular weight (LMW) PAHs, such as naphthalene or 
phenanthrene, are made of three or fewer rings, but high molecular weight (HMW) PAHs 
contain four or more rings making them less soluble (Wild & Jones, 1995) and resistant 
to degradation (Kuśmierz et al., 2016). 
 
 
Figure 1-1 Representative PAHs.  
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PAHs are generated naturally and anthropologically in a process often involving 
heat, high pressure, and the lack of oxygen (Douben, 2003). Anthropogenic production of 
PAHs occurs through combustion of fossil fuels or wood, pyrolysis (coal distillation), and 
oil leakage. Natural sources include forest fires, volcanos, and petroleum seeps (European 
Commission, 2002). LMW PAHs can also be produced biologically — naphthalene has 
been shown to be produced in Magnolia flowers (Azuma et al., 1996), and in an 
endophytic fungus (Daisy et al., 2002). 
Sixteen PAHs have been targeted by the EPA as priority pollutants and are the 
focus of environmental research (Ranc et al., 2016). Dihydrodiol epoxides such as (+)-
benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide (Figure 1-2A) are vulnerable to attack by 
exocyclic amines of purine bases (Figure 1-2B), and are associated with inactivation of 
tumor suppressor genes and activation of proto-oncongenes (Yeh et al., 1995, Hecht, 
1999).  
                                                       
Figure 1-2 Modification of DNA by dihydrodiol epoxide benzo[a]pyrene. 
A) (+)-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide. B) NMR solution structure of N
6
-
amino modification of deoxyadenosine by the structure shown in A (PDB entry 1DXA).  
A 
B 
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1.1.2 Bioremediation of PAHs 
 
 
 For almost a century, bacteria have been known to degrade PAHs, either 
cometabolically or as a sole carbon source (Peng et al., 2008). Tausson and coworkers 
isolated three bacterial strains that degraded phenanthrene, anthracene, and other PAHs 
(Tausson, 1928). It was later discovered that bacteria responsible for the degradation of 
LMW PAHs are ubiquitous (Sisler & Zobell, 1947, Davies & Evans, 1964).  The report 
of a bacterium that could degrade fluoranthene and pyrene (Heitkamp & Cerniglia, 1988) 
was the first example of microbial degradation of HMW PAHs (four or more rings, 
Section 1.3).  
 Bacterial bioremediation is used for removing PAHs and has aided in the clean-up 
of large oil spills (Atlas & Hazen, 2011). Relatively few organisms are capable of 
degrading HMW PAHs, such as benzo[a]pyrene in comparison to the number of 
organisms able to degrade LMW PAHs. The large number of organisms able to degrade 
LMW PAHs sharply contrast with the relatively small number able to degrade HMW 
PAHs such as benzo[a]pyrene. This discrepancy in the ability of microbes to break down 
different size PAHs, in conjunction with the low water solubility of HMW PAHs, causes 
these compounds to persis in the environment at a higher rate than LMW PAHs (Boldrin 
et al., 1993, Tiehm, 1994, Juhasz & Naidu, 2000). An understanding of degradation 
pathways could help engineer microbes with improved catabolic abilities. 
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1.2 NAHE, A HYDRATASE-ALDOLASE IN THE UPPER PATHWAY OF NAPHTHALENE 
DEGRADATION IN PSEUDOMONAS PUTIDA G7 
 
 Napthalene degradation in P. putida G7 is the most extensively studied PAH 
catabolic pathway and involves operons for the upper and lower pathways on the NAH7 
plasmid. In the upper pathway, trans-o-hydroxybenzylidenepyruvate (HBP) hydratase-
aldolase (NahE) catalyzes a hydration reaction followed by a retro-aldol reaction. 
Previous studies of NahE suggest that both steps of the reaction are enzyme-catalyzed, 
and that the o-hydroxyl of the aromatic substrate is important for binding and HBP 
turnover. 
 
  
Scheme 1-1 NahE conversion of HBP to salicyaldehyde and pyruvate. 
 
1.2.1 Pseudomonas putida G7 and the NAH7 Plasmid  
 
Study of naphthalene degradation has a long history, and has recently focused on 
a salicylate-induced pathway encoded in a transmissible NAH7 plasmid from 
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Pseudomonas putida G7. Discoveries in this pathway began before DNA sequencing was 
developed. Bacterial growth on naphthalene-mineral salts was described in 1928, and 
intermediates including 1,2-dihydrodihydroxynaphthalene and salicylic acid were 
isolated in the 1940s and 1950s (Davies & Evans, 1964). The NAH7 plasmid contains 
operons for the upper pathway (Figure 1-3, conversion of naphthalene to salicylate) and 
lower pathway (conversion of salicylate to pyruvate and acetaldehyde), which were likely 
obtained through horizontal gene transfer (Sota et al., 2006). Expression of both lower 
and upper pathway enzymes are induced in the presence of salicylate by NahR, a positive 
regulator (Chauhan et al., 2008). 
 
 
 
Figure 1-3 Operon for the upper naphthalene degradation pathway on the NAH7 
plasmid. 
 
Although the pathway for naphthalene degradation is established, NAH7 gene 
products may facilitate the degradation of large PAHs as well. Anthracene and 
phenanthrene degradation products such as naphthoic acid were detected from 
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Pseudomonas fluoresecens 5R, which contained a plasmid similar to NAH7 (Menn et al., 
1993). These intermediates suggest the known enzymes from the NAH7 plasmid tolerate 
larger substrates for degrading three-ring PAHs.  
 
1.2.2 The Upper Pathway for Naphthalene Degradation in P. putida G7 
 
 
Initial dihydroxylation of naphthalene (Scheme 1-2) is facilitated by a ring-
hydroxylating oxygenase (RHO) system comprised of four gene products 
NahAaAbAcAd. Electrons from NADH are initially transferred to an iron-sulfur 
flavoprotein NahAa. This protein reduces NahAb, a Rieske ferredoxin, which finally 
transfers electrons to the Rieske center of naphthalene dioxygenase NahAcAd. The 
protein is of α3β3 composition, where each α subunit contains a Rieske [2Fe-2S] center 
and a mononuclear iron (Karlsson et al., 2003). Electron access to mononuclear iron is 
gated by a conserved aspartate to initiate side-on binding of O2 to Fe
2+
 to form 
naphthalene cis-dihydrodiol. 
Conversion of naphthalene 1,2-cis-dihydrodiol to 1,2-dihydroxynaphthalene is 
catalyzed by a NAD
+
-dependent dehydrogenase NahB (Eaton & Chapman, 1992). This 
protein is likely nonspecific, because several homologues oxidize cis-dihydrodiols with 
one to three rings including napththalene, anthracene, phenanthrene, and biphenyl (Patel 
& Gibson, 1976), though none were found to process trans-dihydrodiols.  
While meta-cleavage of 1,2-dihydroxylnaphthalene was apparent in 1965 (Evans 
et al., 1965), identification and functional assignment of the enzymes involved in the 
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currently accepted pathway (Scheme 1-2) wasn’t established until the enzymes were 
expressed heterologously in the 1990s (Eaton & Chapman, 1992). This report showed 
that 2-hydroxychromene-2-carboxylate (HCCA) was the initial product of ring cleavage 
by the dioxygenase NahC and that isomerization, assisted by NahD, occurred to form 
trans-o-hydroxybenzylidenepyruvate (HBP). Although HCCA is the observed product, a 
monocyclic species may be released from NahC prior to cyclization (Patel & Barnsley, 
1980). Based on reactions catalyzed by extradiol dioxygenases, a quinone methide might 
be the first product by NahC prior to cyclization to HCCA (Vaillancourt et al., 2006, 
Bugg & Ramaswamy, 2008). HCCA isomerizes to HBP, the substrate for HBP 
hydratase-aldolase (NahE), non-enzymatically, or with the assistance of HCCA 
isomerase (NahD). NahE converts HBP to salicylaldehyde and pyruvate. 
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Scheme 1-2 Degradation of naphthalene by Pseudomonas putida G7 NAH7 plasmid. 
 
The nonenzymatic isomerization of HCCA to HBP reaches an equilibrium 
mixture of 55% HCCA and 45% HBP in five hours (Eaton & Chapman, 1992). The 
interconversion is accelerated by NahD, a member of the glutathione transferase 
superfamily that uses tightly bound reduced glutathione (KD of 5 nM) as a cofactor 
(Thompson et al., 2007). Glutathione is proposed to attack the benzylic carbon for 
rotation around C-3 or C-4 of HBP or HCCA. During conversion of HCCA to HBP 
(forward direction in the pathway), attack could occur before or after ring opening of 
HCCA (Scheme 1-3). 
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Scheme 1-3 Proposed mechanism for NahD-catalyzed isomerization of HCCA to HBP. 
 
 
The final enzyme in the upper pathway is salicyaldehyde dehydrogenase (NahF) 
which oxidizes salicylaldehyde to salicylate using NAD
+ 
(Eaton & Chapman, 1992). 
Salicylic acid, the end product of the upper pathway, undergoes a decarboxylation 
reaction catalyzed by salicylate hydroxylase (NahG) encoded in the operon for the lower 
pathway. The remaining reactions of the lower pathway resemble meta fission pathways 
such as those for toluene and xylene, where enzymes are encoded on the TOL plasmid in 
Pseudomonas putida mt-2 (Yen & Gunsalus, 1982). Degradation of catechol to 
acetaldehyde and pyruvate in the NAH7 and TOL degradative pathways are identical, 
and the plasmids likely originated from a single ancestral sequence (Harayama et al., 
1987).   
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1.2.3 The Hydratase-Aldolase (NahE) 
 
Hydratase-aldolases are understudied compared to other PAH degradative 
enzymes and other type I aldolases (Section 1.4). NahE is the most thoroughly 
characterized hydratase-aldolase involved in PAH degradation. For that reason it is the 
starting point for the work presented here. NahE forms a Schiff base with 4-phenyl-3,4-
unsaturated α-keto acids, prefers o- and m- hydroxyl groups, and facilitates both 
hydration and retro-aldol cleavage without tautomerization using the o-hydroxyl group. A 
mechanism consistent with prior research of NahE is shown in Scheme 1-4. Lys-183 is 
conserved in the N-acetylneuraminate lyase subgroup (Section 1.4) and forms a Schiff 
base with HBP at C-2, consistent with the mechanisms for the enzymes which process α-
keto acids within the subgroup. Water is then activated for addition at C-4 of HBP, with 
subsequent rearrangement to form the enamine. The enamine abstracts a proton from an 
active site group. Deprotonation of the C-4 hydroxyl allows for heterolytic cleavage of 
the intermediate and the formation of a pyruvoyl enamine, which tautomerizes to form 
the pyruvate Schiff base adduct. A conserved tyrosine (Tyr-155) in the N-
acetyleneuroaminate Lyase subgroup (Section 1.4) is likely involved in Schiff Base 
formation and retro-aldol catalysis. Salicylaldehyde is also produced and the pyruvate 
imine is hydrolyzed to release pyruvate and the lysine. 
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Scheme 1-4 Proposed catalytic cycle for NahE using HBP to produce salicylaldehyde 
(sal) and pyruvate. 
 
Further support for this mechanism comes from the work on a NahE homologue 
from Pseudomonas vesicularis DSM 6383. This homologue is inactivated by either HBP, 
salicylaldehyde, or pyruvate in the presence of NaBH4 (Kuhm et al., 1993), suggesting 
that it is a type 1 aldolase (Section 1.4) where a lysine residue forms a Schiff base with α-
keto acid and aldehyde moieties. Reduction of the Schiff base produces an amino acid 
adduct, which cannot be hydrolyzed. The same homologue was shown to be inhibited by 
salicylaldehyde (product) with an IC50 of 15-20 µM without NaBH4 (Kuhm et al., 1993).  
The o-hydroxyl group of HBP has also been shown to be important for NahE 
activity. With the exception of trans-m-hydroxybenzylidenepyruvate (m-HBP, Figure 1-
 12 
4B), HBP analogues without o-hydroxyl substituents are processed at less than 2% of the 
rate compared to HBP (Eaton, 2000). The relative rates for trans-benzylidenepyruvate 
(BP) and trans-o-carboxybenzylidenepyruvate (CBP, Figure 1-4A) were 0.52% and 
1.4% of that for HBP, respectively (Eaton, 2000). Consistent with this finding, 
conversion of BP by an NahE homologue from Pseudomonas vesicularis DSM 6383 
showed a rate of 1% that of HBP (Kuhm et al., 1993). However, trans-
dihydroxybenzylidenepyruvate compounds with o-hydroxyl groups were processed 
efficiently. Crude extracts from P. versivularis BN6, P. putida KT2442 NAH7, and 
Pseudomonas NCIB 10535, all processed HBP, 2,4-dihydroxybenzylidenepyruvate, and 
2,6-dihydroxybenzylidenepyruvate (Figure 1-4C,D) at similar rates. Based on these 
results, the conclusion is that hydroxyl groups at the ortho or meta positions of 
benzylidenepyruvate are important for binding and turnover.  
 
 
 
Figure 1-4 Structures of A) HBP: R=OH, BP: R=H, CBP: R=COO
-
 B) m-HBP C) 2,6-
dihydroxybenzylidenepyruvate D) 2,4-dihydroxybenzylidenepyruvate. 
 
The activation energy for hydration of a quinone methide intermediate could 
hypothetically be lower than for the HBP Schiff base (Scheme 1-5A). Precedence for a 
quinone methide intermediate comes from the 4-hydroxycinnamate decarboxylase-
A B C D 
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catalyzed reaction (Ferrara et al., 2011). In this reaction, the 4-hydroxycinnamate 
rearranges to form the quinone methide (Scheme 1-5B), allowing decarboxylation and 
the reformation of the 4-hydroxyl group (Hashidoko & Tahara, 1998). However, the 
NahE-catalyzed conversion of trans-p-hydroxybenzylidenepyruvate (p-HBP) had 1% 
relative activity of wild-type, where m-HBP, an isomer that cannot form a quinone 
methide was processed at 75% of the wild-type rate (Eaton, 2000). These results suggest 
that a mechanism involving the aromatic ring is not operative.  
 
 
Scheme 1-5 A) Hydration of HBP via a ortho-quinone methide intermediate. B) 
Decarboxylation of 4-hydroxycinnamate via a para-quinone methide. 
 
 
In the reverse direction, NahE catalyzes aldol condensation reactions. In these 
reactions, pyruvate is the only donor known, but various aldehydes are accepted. The 
condensation reaction gives some insight about substrate preference in the forward 
direction. Over 30 aldehydes have been identified as substrates for NahE (Eaton, 2000). 
A 
B 
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The different rates for these substrates indicate that a nitro group at the para position 
accelerates the reaction in a Pseudomonas fluorescens N3 homologue (96% sequence 
identity). This suggests electron withdrawing subsitutents accelerate the reaction (Sello & 
Di Gennaro, 2013), as expected since the withdrawing group increases electrophilicity at 
the benzyl carbon, which is the target for nucleophilic attack by the pyruvate enamine. 
More than one methylene between the aldehyde and aromatic ring such as 3-
phenylpropionaldehyde (Figure 1-5B) slows down the reaction, unless the extra carbon is 
part of an α,β-unsaturated system, such as the C-2 carbon in cinnamaldehyde (Figure 1-
5C). The hydroxyl group in salicylaldehyde (Figure 1-5A) increased the rate 2-fold over 
that of benzaldehyde (Ferrara et al., 2011). The observations suggest that NahE tolerates 
a wide variety of substrates in the reverse direction. Additionally, the preference for the 
o-hydroxyl group is observed for both the forward and reverse directions. 
 
 
Figure 1-5 Structures of A) salicyaldehyde: R=OH, benzaldehyde: R=H B) 3-
phenylpropionaldehyde C) cinnamaldehyde. 
 
The extent to which NahE participates in the dehydration step of the condensation 
reaction is covered in the literature (Eaton, 2000). This contributes to our understanding 
of the reaction in the forward direction. The reactions of 3-hydroxybenzaldehyde and 4-
hydroxybenzaldehyde with pyruvate give products that have trans coupling constant by 
A B C 
 15 
1
H NMR spectroscopy (Eaton, 2000). This observation indicates that dehydration is 
enzyme-catalyzed. However, there is the possibility that dehydration occurs quickly so 
that an intermediate does not accumulate. This possibility could be ruled out by the 
results of an experiment following the condensation of pyridine-2-carboxaldehyde and 
pyruvate. When catalyzed by NahE, an olefin is produced (Scheme 1-6A), whereas 2-
keto-3-deoxy-6-phosphogalactonate aldolase (KDGA, Scheme 1-6B, Section 1.4.5) 
produces (R)-4-hyrdoxy-2-keto-4-(2ʹ-pyridyl)butyrate (Henderson et al., 1998). In 
another experiment, mass spectral results show that 1-hydroxy-2-naphthaldehyde, a 
phenanthrene intermediate, is processed by NahE to form a condensation product that is 
not dehydrated (Scheme 1-6C). The sum of these results suggests the 4-hydroxy 
intermediate in the reaction with the pyridine and naphthyl aldehyde is stable in solution, 
and implies dehydration is enzyme-catalyzed when using other aldehydes as substrates.  
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Scheme 1-6 Evidence for stability of 4-hydroxy intermediates and NahE-catalyzed 
dehydration in condensation reactions. 
Reactions of pyridine-2-carboxaldehyde and pyruvate catalyzed by A) NahE and B) 
KDGA, revealing dehydration is catalyzed with NahE, but not with KDGA. C) The 
reaction of 1-hydroxy-2-naphthaldehyde with pyruvate suggests dehydration is not 
obligatory in NahE catalysis, and that the intermediate is stable. 
 
1.3 PAH METABOLIC NETWORK IN MYCOBACTERIUM VANBAALENII PYR-1 
 
  
 M. vanbaalenii PYR-1 completely oxidizes more than ten PAHs including the 
potent carcinogen benzo[a]pyrene using enzymes genomically-encoded in large clusters. 
Degradation of each ring of the PAH occurs in a sequential manner using the same series 
of reactions (often catalyzed by different enzymes). The enzymes used in this PAH 
metabolic network are often nonspecific and redundant in function. Phenanthrene 
degradation is a focus in this dissertation because it is more complex than napthalene 
A 
B 
C 
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degradation (Section 1.2) and the enzymes involved in its degradation are poorly 
characterized. 
1.3.1 PAHs Degraded and Gene Clustering 
 
 M. vanbaalenii PYR-1 is a Gram positive non-pathogenic bacteria that degrades a 
variety of compounds with varying efficiencies (Heitkamp et al., 1988). The strain was 
initially isolated from Redfish Bay near Port Aransas, Texas and found to mineralize 
pyrene (Heitkamp & Cerniglia, 1988, Heitkamp et al., 1988). In addition, M. vanbaalenii 
PYR-1 degraded naphthalene, 2-methylnaphthalene, biphenyl, anthracene, 
phenenanthrene, fluoranthene, 3-methylcholanthrene, benzo[a]pyrene, 1-nitropyrene, and 
6-nitrochrysene (Figure 1-6, Heitkamp et al., 1988, Heitkamp & Cerniglia, 1989, Kelley 
& Cerniglia, 1995, Moody et al., 2002, Kweon et al., 2011). When grown in a mixture of 
PAHs, M. vanbaalenii PYR-1 preferred phenanthrene (Kelley & Cerniglia, 1995, 
MacLeod & Daugulis, 2003). 
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Figure 1-6 PAHs mineralized by Mycobacterium vanbaalenii PYR-1. 
 
 The circular genome of M. vanbaalenii PYR-1 is 6.5 Mb and contains a unique 
arrangement of genes within two large clusters of 150 kb and 31 kb (Habe & Omori, 
2003, Kim et al., 2008). PAH-degrading genes are scattered throughout these clusters in 
an atypical mosaic structure (where groups of genes that have different evolutionary 
origins). Just over half of the genes, found in three genomic islands in the 150 kb cluster, 
were found to have high sequence similarity with nocardioform actinomycetes like 
Terrobacter and Nocarioides (Kweon et al., 2011).  The 31 kb region is separated from 
the first by over 2 Mb (Kim et al., 2008). The pattern of gene gain and loss when 27 
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Mycobacterium genomes were compared suggested that PAH degradative ability was 
acquired from a common ancestor and was dispensable as genus members became 
pathogenic and host-dependent (Kweon et al., 2015). Mycobacterium vanbaalenii PYR-1 
is related to Mycobacterium tuberculosis, which killed 1.2 million HIV-negative people 
worldwide in 2010 (WHO, 2011), mostly in developing countries.  
1.3.2 Enzymes of the PAH Metabolic Network 
 
 Breakdown of the individual rings of a PAH by M. vanbaalenii PYR-1 is 
accomplished sequentially by gene products that are mostly uncharacterized. Each cycle 
of ring-cleavage and side chain removal (Scheme 1-7) is reminiscent of the upper 
pathway for naphthalene degradation (Section 1.2). In fact, M. vanbaalenii PYR-1 
degrades naphthalene to salicylate, in a pathway that is identical to that in Pseudomonas 
putida G7 (Kelley et al., 1990), except the β-ketoadipate pathway involving ortho 
cleavage is used in place of the meta fission pathway. Although many enzymes from 
Mycobacterium vanbaalenii PYR-1 have not been characterized, their functions have 
been inferred from sequence analysis. 
 The degradation of each individual ring is performed by a collection of diverse 
enzymes (Scheme 1-7, adapted from Kweon et al., 2011). Ring-hydroxylating 
oxygenases (RHOs) are nonheme iron enzymes composed of α and β subunits, and 
require the electron transfer components ferredoxin and ferredoxin reductase. They are 
members of the Rieske oxygenase family and use oxygen and NADH to form a cis-
dihydrodiol (Kweon et al., 2010). Next, Dihydrodiol dehydrogenases use NAD
+
 to 
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oxidize dihydodiols to form dihydroxyl PAHs. Degradation rounds can diverge at this 
juncture, where ring-cleavage dioxygenases may facilitate ortho or meta cleavage of 
PAHs which have o-hydroxyl or carboxylate groups. After ring cleavage, the hydratase-
aldolases act on the intermediate to remove the side chain. The aldehyde on the aromatic 
ring is often oxidized to a carboxylic acid by an aldehyde dehydrogenase using NAD
+
. A 
decarboxylase might act on the aromatic acid before the next cycle begins. 
 
 
 
 
 
Scheme 1-7 General cycle for the degradation of a single ring of a PAH. 
  
 Central metabolic processes such as glycolysis and the Krebs cycle are important 
for integrating metabolic networks. The same concept is found in M. vanbaalenii PYR-1, 
because all degradative pathways converge at the monocyclic metabolite phthalate, the 
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hub of the metabolic network. Degradation products proceed through β-ketoadipate 
pathway (Kweon et al., 2011, Stingley et al., 2004), where ortho cleavage occurs and the 
final products are succinyl-CoA and acetyl-CoA. The central aromatic process is loosely 
regulated in comparison to the tightly regulated upper pathways (Kweon et al., 2014).  
The funneling of PAH metabolites into one single pathway (the β-ketoadipate pathway) 
for monocyclic aromatic hydrocarbon degradation simplifies the network and regulation 
system.  
  In the course of these reactions, o-quinones are generated by oxidation of PAH 
catechols. These quinones modify cell components and generate reactive oxygen species. 
M. vanbaalenii PYR-1 detoxifies o-quinones by converting them to catechols using 
quinone reductase and NAD(P)H (Kim et al., 2003). Methyltraneferases modify Non-K 
and non-Bay PAH catechols (Figure 1-7) of anthracene, fluoranthene, and 
benzo[a]pyrene for excretion (Kelley et al., 1993, Moody et al., 2001, Moody et al., 
2004).  
 
Figure 1-7 Bay and K regions of several PAHs. 
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 Though o-quinone PAHs are often biologically conjugated by glutathione (Bolton 
et al., 2000), M. vanbaalenii PYR-1 might uses mycothiol as a substitute for glutathione. 
This subsititution is evident in M. tuberculosis, where mycothiol biosynthesis is 
obligatory (Sareen, et al., 2003) and to which glutathione is directly toxic (Dayaram, et 
al., 2006). A glutathione S-transferase enzyme (Mvan_5043) was identified in M. 
vanbaalenii PYR-1 and proposed to be involved in detoxification (Kim et al., 2008). 
However, the protein could be an isomerase, like the glutathione S-transferase NahD 
(18.8% sequence ID) which participates in naphthalene degradation (Section 1.2). The 
transferase and isomerase activity both require glutathione, and it is unknown if 
mycothiol could substitute for the substrate/cofactor in Mvan_5043 from M. vanbaalenii 
PYR-1. 
 
1.3.3 Redundancy and Pleiotropy of Enzymes in M. vanbaalenii PYR-1 
  
 The number of each type of enzyme in the PAH degradative network in M. 
vanbaalenii PYR-1 varies. When the M. vanbaalenii PYR-1 proteome was analyzed in 
after exposure to 7 aromatic compounds (Kweon et al., 2011), commonly upregulated 
proteins included 10 ring-hydroxylating oxygenases (RHOs), 20 cytochrome P450s 
(CYPs), 10 other monooxygenases, two epoxide hydrolases, two dihydrodiol 
dehydrogenases, five ring-cleavage dioxygenases, five hydratase-aldolases, five 
hydrolases, and only one decarboxylase. 
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 Many RHOs in M. vanbaalenii PYR-1 have overlapping specificities. For 
example, in vivo experiments with recombinant PdoA2B2, NidA3B3, and NidAB show 
that each can oxidize phenanthrene at the 3,4 position, at varying efficiencies (Kweon et 
al., 2014). There are a number of reasons M. vanbaalenii PYR-1 might produce 
redundant enzymes for a particular activity. Redundancy may exist so that a particular 
activity can be modulated incrementally by varying expression of isozymes with different 
kinetic parameters, so that expression is not a binary on/off switch. This effect would also 
prevent a lag while the necessary enzyme is produced. Redundancy could also exist as an 
evolutionary strategy to increase the number of compounds degraded by M. vanbaalenii 
PYR-1, by “tweaking” active sites to accommodate new substrates. 
  In addition to the redundancy of enzymes that catalyze a single reaction, many 
enzymes from M. vanbaalenii PYR-1 are nonspecific, which is considered pleiotropy. 
For example, NidA3B3 was shown to process six different PAHs, including both LMW 
and HMW species (Kim et al., 2006). Pleiotropy is also observed in the RHO 
components; all RHOs in M. vanbaalenii PYR-1 share the same ferredoxin and 
ferredoxin reductase enzymes encoded by phtAcAd (Kim et al., 2007). Furthermore, a 
single decarboxylase was detected when M. vanbaalenii PYR-1 was incubated with 
various PAHs. Although it seems wasteful for M. vanbaalenii PYR-1 to express multiple 
nonspecific enzymes, some metabolites may only be processed by one nonspecific 
enzyme, and the ability of that particular enzyme to catalyze other reactions may not be 
harmful for the bacteria. 
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1.3.4 Phenanthrene Catabolism in M. vanbaalenii PYR-1 
 
In the presence of phenanthrene, heterologous expression of a 37-kb region 
(cloned from the larger 150 kb cluster of PAH catabolism genes into a fosmid) of the M. 
vanbaalenii PYR-1 genome in the presence of phenanthrene generated phenanthrene cis-
3,4-dihydrodiol. In the presence of 1-hydroxy-2-naphthoic acid, the culture produced 
trans-o-carboxybenzylidenepyruvate (CBP), o-carboxybenzaldehyde (CBA), and 
phthalic acid (Stingley et al., 2004). A catabolic pathway was proposed (Scheme 1-8) 
using enzymes encoded in the fosmid (including those shown in Figure 1-8). Other data 
show that addition to hydroxylation at the 3 and 4 positions, phenanthrene is oxidized to 
cis-dihydrodiols at the 1,2- and 9,10- positions, the latter of which is an alternative 
degradation route (Kim et al., 2005). The numbering system for phenanthrene is shown in 
Scheme 1-8.  
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Scheme 1-8 Phenanthrene catabolic pathway via 3,4-dihydroxyphenanthrene. 
 
Stingley et al. propose the 3,4-dihydroxyphenanthrene ring-cleavage product is 
processed by an isomerase that is missing from the cloned 37-kb region to form a 3,4-
unsaturated α-keto acid that is converted by the phdG gene product, annotated as a 
hydratase-aldolase. Pyruvate and 1-hydroxy-2-naphthaldehyde are produced, and the 
latter is then oxidized by an NAD
+
-dependent aldehyde dehydrogenase to form 1-
hydroxy-2-naphthoate. ortho cleavage of this compound by PhdI forms CBP. The cis (Z) 
isomer of CBP is the reasonable first product of the dioxygenase, but deuterium exchange 
at C-3 did not occur in D2O during the reaction with PhdI. Thus, the cis to trans 
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conversion was proposed to be part of the catalytic mechanism (Adachi et al., 1999). The 
ring-cleavage product CBP is then processed by trans-o-carboxybenzylidenepyruvate 
hydratase-aldolase (PhdJ), to form CBA and pyruvate. An aldehyde dehydrogenase 
converts CBA to phthalate, which is degraded via the β-ketoadipate pathway and the 
Krebs cycle. 
 
1.3.5 The Hydratase-Aldolases PhdJ and PhdG 
 
 
 Five hydratase-aldolases are proposed to be involved in PAH metabolism and 
vary significantly in terms of expression levels in the presence of 7 different PAHs 
(Kweon et al., 2011). Hydratase-aldolase genes phdJ and phdG, proposed to be involved 
in phenanthrene catabolism (Section 1.3.4), are located in the same operon (Figure 1-8, 
Stingley et al., 2004). The presence of pyrene increased the expression of PhdJ and PhdG 
about two-fold. Although both enzymes were not upregulated when M. vanbaalenii PYR-
1 was incubated with fluoranthene, the expression levels of putative hydratase-aldolases 
Mvan_0558 and Mvan_2387 increased (Kweon et al., 2007, Kim et al., 2008).   
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Figure 1-8 Genomic context of PhdJ and PhdG. 
 
  Sequence analysis identified PhdJ as a N-acetylneuraminate lyase (NAL) 
subgroup member in the Class I aldolase superfamily (Section 1.4). PhdJ from 
Nocardioides KP7 was isolated and shown to function as a hydratase-aldolase (Iwabuchi 
& Harayama, 1998). Conversion of CBP to CBA and pyruvate by purified PhdJ (see 
Scheme 1-8 for structures) was ~95% complete at equilibrium. The kcat and KM values 
were 13 s
-1
 and 50 µM (kcat/KM = 2.6  10
5
 M
-1
s
-1
), respectively. The enzyme doesn’t 
accept trans-o-hydroxycinnamate, BP, or trans-o-methoxybenzylidenepyruvate (Figure 
1-4) as substrates. Surprisingly, the incubation of PhdJ with pyruvate (20 µM) and 
NaBH4 did not inhibit the enzyme, as would be expected for type I aldolases (see the 
next section).  
 
 
 
Unknown function 
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1.4 THE N-ACETYLNEURAMINATE LYASE SUB-FAMILY OF TYPE I ALDOLASES 
 
1.4.1 Type I Aldolases 
 
 Class I aldolase superfamily members share the (α/β)8, or triose phosphate 
isomerase (TIM) barrel motif and catalyze aldol reactions using α-keto acids as electron 
donors and aldehydes as electron acceptors via Schiff base intermediates (Scheme 1-9). 
Schiff base formation and hydrolysis with a conserved lysine and substrate is facilitated 
by a conserved glutamate, tyrosine, or histidine on β-strand 5 next to the conserved lysine 
on β-strand 6 (Choi et al., 2006). The superfamily includes the glycolytic enzyme 
aldolase, transaldolase, and members of the N-acetylneuraminate lyase (NAL) subgroup.  
 
 
Scheme 1-9 Aldol mechanism for Class I Aldolases. 
 
1.4.2 The N-Acetylneuraminate Lyase (NAL) Subgroup 
 
 The NAL subgroup of type I aldolase enzymes participate in diverse reactions 
including those in PAH catabolism (Sections 1.4.3-1.4.6). Like all type I aldolases, 
members of the NAL subgroup have a conserved lysine residue that participates in 
covalent catalysis. During reactions catalyzed by enzymes of the NAL subgroup, a Schiff 
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base is generated using the ε-amine group of a conserved lysine on β-strand 6 and the 2-
oxo group of substrate. A conserved tyrosine is on the adjacent strand, β-strand 5, and is 
the general acid/base that mediates Schiff base formation. Enzymes in the NAL subgroup 
are identified by their inactivation by pyruvate and other α-keto acid substrates in the 
presence of sodium borohydride or sodium cyanoborohydride. This reduces Schiff base 
moiety to produce an amino acid, and tethers the substrate or ligand to the conserved 
lysine.  
 Enzymes in the NAL subgroup are tetrameric, where each subunit is composed of 
an (α/β)8 barrel and three C-terminal α-helices (Figure 1-9A,C). Members of the NAL 
subroup have “tight” and “weak” interfaces between monomers. Most NAL subgroup 
members orient the three C-terminal helices near the weak interface (parallel to the sheets 
of the β-barrel, Figure 1-9A), with the exception of plant DHDPS, where the helices 
point in the direction normal to the plane of the tetramer (Atkinson et al., 2012). The tight 
interface is formed by a tryptophan or tyrosine located in the loop between β-strand 4 and 
α-helix 4 that extends deep into an adjacent subunit. In the available structures, the 
hydrophobic side chain of Trp or Tyr breaches various loops near the N-terminal region 
of the β-barrel and forms a hydrogen bond with the side chain of serine or threonine in 
the neighboring subunit positioned as the second X in a conserved GXXGE motif. The 
motif, arranged in two overlapping type I β-turns, is placed between β-strand 2 and α-
helix 2 (Figure 1-9B,C), where the backbone amides interact via hydrogen bonds with 
the C-1 carboxylate group of an imine adduct of pyruvate (Figure 1-9D), for example. 
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The conserved lysine, tyrosine (at β-strand 5), and GXXGE motif constitute the primary 
residues that are conserved throughout the NAL subgroup. 
 
 
Figure 1-9 The crystal structure of E. coli NAL (2.2 Å resolution, PDB entry 1NAL).  
A) Tetrameric structure with surface representation. B) Intersubunit interaction in the 
tight interface showing Tyr-137, Lys-165, GXXGE motif (yellow) and Tyr110ʹ (salmon). 
C) (α/β)8 of NAL (lime green) showing three C-terminal helices (dark blue). D) Active 
site of E. coli NAL (light teal) where Lys-165 is covalently attached to pyruvate (1.7 Å 
resolution, PDB entry 2WNN). 
A B 
C D 
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1.4.3 N-Acetylneuraminate Lyase 
 
 N-Acetylneuramintate lyase (NAL) converts the 9 carbon sugar N-
acetylneuraminic acid, or sialic acid, to N-acetyl-D-mannosamine and pyruvate. Sialic 
acid is toxic to E. coli, and detection of the amino sugar by the bacterium is followed by 
induction of NAL. The kinetic mechanism is Uni-Bi ordered sequential, where sialic acid 
binds and is processed, to form acetyl-D-mannosamine and pyruvate. Acetyl-D-
mannosamine leaves prior to pyruvate. NAL has the conserved lysine, tyrosine, and 
GXXGE motif, but the enzyme also has different active site residues closer to the 
entrance of the active site cavity to accommodate the hydrophilic substrate during the 
reaction.  
 The crystal structure of the E. coli NAL with the pyruvoyl adduct shows that the 
C-1 carboxylate of pyruvate interacts with backbone amides of Ser-47 and Thr-48 of the 
GXXGE motif as well the hydroxyl group of Tyr-137 (Figure 1-9D) (Barbosa et al., 
2000). The side chains of Tyr-110ʹ (prime indicates adjacent NAL monomer), Ser-47, 
and Tyr-137 hydrogen bonds and link the adjacent monomer to the C-1 carboxylate 
group of pyruvate. Although the interactions of Tyr-110ʹ and Ser-47 suggest that Tyr-
110ʹ stabilizes the catalytic Tyr-137 hydroxyl group, its hydrophobic property seems to 
be more important. The Y110A variant shows a 40-fold drop in kcat/KM and the Y110F 
variant did not affect activity significantly (Daniels et al., 2014). The bulk and 
hydrophobicity of this residue is shown to be more important in other NAL subgroup 
members as well. The conserved lysine, tyrosine, and GXXGE motif are considered the 
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primary residues that are conserved in all NAL subgroup members, and all other residues 
that contribute to binding and catalysis are specific to individual enzymes in the subgroup 
and are designated secondary residues. 
 Crystallographic and kinetic experiments suggest that a proton is transferred from 
the hydroxyl group at C-4 of sialic acid to Tyr-137 (Scheme 1-10), a residue shown to be 
critical for activity, with the assistance of the hydroxyl group of Thr-167 (Barbosa et al., 
2000, Daniels et al., 2014). Thr-167 is not conserved in DHDPS, KDGDH, NahE, or 
PhdJ, but is present in KDGA. QM/MM simulations suggest deprotonation is rate-
determining as the activation barrier is mostly due to C-C bond formation (Daniels et al., 
2014). Modeling of Schiff base intermediates in the active site of NAL indicated direct 
substrate-assisted catalysis where Tyr-137 is deprotonated by the C-1 carboxylate of the 
pyruvoyl adduct in preparation for retro-aldol cleavage (Smith et al., 1999). However, 
QM/MM simulations suggest that a Tyr-137 phenoxide is stable and does not need to be 
protonated in a substrate-assisted manner (Daniels et al., 2014).  
 
Scheme 1-10 Mechanism for NAL-catalyzed conversion of N-acetyneuraminate (sialic 
acid) to acetyl-D-mannosamine and pyruvate.  
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 The backbone carbonyl of Gly-188 may also contribute to catalysis. In a structure 
of the Haemophilus influenza homologue, Gly-188 is closer than Thr-166 (H. influenza 
numbering) to a C-4 gem-diol of a sialic acid analogue bound to NAL (Figure 1-10, all 
residues shown are conserved in the E. coli enzyme, Barbosa et al., 2000). This 
interaction might allow stabilization of the partial negative charge on the C-4 oxygen of 
substrate that develops during deprotonation. 
 
 
Figure 1-10 The crystal structure of Haemophilus influenza NAL (1.6 Å resolution, PDB 
entry 1F7B) liganded with the C-4 gem-diol of substrate analogue N-acetyl-
4-oxoneuraminate.  
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1.4.4 Dihydrodipicolinate Synthase 
 
 Dihydrodipicolinate synthase (DHDPS) catalyzes the condensation of the gem-
diol form of (S)-aspartate-β-semialdehyde and pyruvate to form (S)-4-hydroxy-2,3,4,5-
tetrahydro-(2S)-dipicolinic acid and participates in the meso-diaminopimelate pathway 
for lysine biosynthesis (Scheme 1-11, Blickling et al., 1997, Dobson et al., 2008, Dobson 
et al., 2009). After the pyruvoyl Schiff base is formed, presumably with the assistance of 
Tyr-133, tautomerization allows the formation of an enamine. After binding of (S)-
aspartate semialdehyde hydrate (the reaction is Bi-Uni), dehydration occurs using Tyr-
133, while the geminal hydroxyl group interacts with the backbone carbonyl of Gly-186. 
The protonated aldehyde is susceptible to attack by C-3 of the enamine adduct. The aldol 
reaction gives a 7-carbon adduct, which undergoes cyclization via attack of the α-amine. 
Rearrangement to form the imine in the ring leads to elimination of Lys-161. After the 
product, (S)-4-hydroxy-2,3,4,5-tetrahydro-(2S)-dipicoolinic acid, leaves the active site, 
dehydration occurs and dihydrodipicolinate is formed.  
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Scheme 1-11 DHDPS-catalyzed condensation of pyruvate and (S)-aspartate 
semialdehyde hydrate. 
 
Like NAL, a triad of residues in DHDPS links the catalytic tyrosine (Tyr-133) to 
the GXXGE motif in the neighboring subunit. For the E. coli homologue, these residues 
are Tyr-133, Thr-44, and Tyr-107ʹ (Figure 2-11). As for NAL, the second residue of the 
GXXGE motif in DHDPS is critical (Laber et al., 1992), and the hydroxyl group of Tyr-
107ʹ is less important. However, in contrast with NAL, the hydroxyl group of Tyr-107ʹ in 
DHDPS is significant as the relative activity of the Y107F mutant is 17% of the wild-type 
activity. The decrease indicates that the hydroxyl group plays a role in catalysis, as 
opposed to solely strengthening the tight interface through hydrophobic intreactions, as 
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shown for NAL (Griffin et al.). The size of Tyr-107ʹ preserves the tetrameric state and 
activity of DHDPS. The Y107W mutant is mostly monomer and tetramer and the kcat 
decreases 20-fold (Pearce et al., 2008). Tyr-107 is necessary for tetramerization and may 
protect the active site from solvent or provide structural stability that is critical for 
activity. 
While the carboxylate of pyruvate is stabilized by the GXXGE motif, Arg-138 
forms an important electrostatic interaction with the carboxylate of (S)-aspartate-β-
semialdehyde hydrate. This residue is critical for catalysis, as a more than 100-fold 
reduction in kcat was observed for R138A and R138H variants relative to the wild-type 
activity (Dobson et al. 2005).  
 
Figure 1-11 The crystal structure of the E. coli dihydrodipicolinate synthase covalently 
bound with condensation product of pyruvate and succinate (2.3 Å 
resolution, PDB entry 4EOU).  
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1.4.5 D-2-Keto-3-deoxygluconate Aldolase 
 
D-2-Keto-3-deoxygluconate Aldolase (KDGA) from the thermophilic Archaea 
Sulfolobus solfataricus has a half-life of 2.5 hours at 100°C and participates in a variant 
of the Entner-Doudoroff glucose catabolic pathway. The enzyme is promiscuous, and can 
convert either D-2-keto-3-deoxygluconate or D-2-keto-3-deoxygalactonate to D-
glyceraldehyde and pyruvate using Tyr-155, Lys-130, and Thr-157 as catalytic residues 
(Theodossis et al., 2004, Scheme 1-12).  
 
 
Scheme 1-12 The KDGA-catalyzed conversion of D-2-keto-3-deoxygluconate or D-2-
keto-3-deoxygalactonate to D-glyceraldehyde and pyruvate. 
 
Crystal structures reveal space to accommodate and stabilize the C-5 and C-6 
hydroxyl groups of substrate at different positions in the active sites, explaining the lack 
of specificity for KDGA (Theodossis et al., 2004). The backbone carbonyl of Gly-179 
participates in C-C bond cleavage. It is conserved in NAL and DHDPS, but its role in 
assisting Tyr-130 (KDGA numbering) in the deprotonation of the C-4 hydroxyl group of 
its substrate is likely substituted by Thr-157. 
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Figure 1-12 Active site of the KDGA showing D-2-keto-3-deoxygluconate covalently 
bound at Lys-155 (2.1 Å resolution, PDB entry 1W3N). 
1.4.6 Keto-deoxy-D-galactarate Dehydratase 
  
Keto-deoxy-D-galactarate dehydratase (KDGDH) from Agrobacterium fabrum 
catalyzes the dehydration and decarboxylation of keto-deoxy-D-galactarate, or 3-deoxy-
L-threo-2-hexulosarate, forming α-ketoglutaric semialdehyde and CO2 (Scheme 1-13). 
The enzyme is a tetramer and participates in the catabolism of D-galactouronate, one of 
the major components of pectin. Unlike all other subgroup members, the enzyme does 
not have a serine or threonine at the second X of the GXXGE motif, which interacts with 
the conserved tyrosine.  
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The crystal structure of KDGDH labeled with 2-oxoadipate, a 3,4-dideoxy 
analogue, reveals that Arg-142 replaces Ser/Thr in the GXXGE motif, which stabilizes 
Tyr-140 (Figure 1-13). The tyrosine that typically links Ser/Thr with a neighboring 
monomer is present at position 113, but is positioned several residues N-terminal to the 
usual location. The lack of the triad typically present in tetrameric KDGDH is consistent 
with the findings for DHDPS and NAL where the hydrophobic property of the tyrosine is 
more important for maintaining the tetrameric state and retaining enzyme activity than is 
hydrogen bonding using the Tyr-Ser/Thr-Tyr triad. 
 
 
Figure 1-13 Active site of the KDGDH covalentely bound with 2-oxoadipic acid (1.9 Å 
resolution, PDB entry 1EC8). 
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The proposed mechanism for decarboxylation of keto-deoxy-D-galactarate is 
shown in Scheme 1-13 (Jeffcoat et al., 1969, Taberman et al., 2014). After Schiff base 
formation with Lys-166 and substrate, dehydration begins with deprotonation at C-3 and 
formation of an enamine using Tyr-140, which is shown to be nearby C-3 in the crystal 
structure (Figure 1-13). An α,β-unsaturated imine is then formed concurrently with 
dehydration. Protonation of the leaving hydroxyl group is likely facilitated by the side 
chain of Ser-211 and backbone carbonyl of Gly-191 (conserved in NAL, DHDPS, and 
KDGA) via a water molecule, due to proximity in the crystal structure and the 30-fold 
reduction in specific activity of the S211A variant. The adduct is then poised for 
decarboxylation, where electrons flow from the anionic carboxylate to the imino nitrogen 
of Lys-166 with release of CO2. The resulting dienol tautomerizes twice, forming an 
aldehyde and iminium. This adduct is then hydrolyzed and released as 2-oxo-glutaric 
semialdehyde.  
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Scheme 1-13 Proposed mechanism for KDGDH. 
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Chapter 2: The Hydratase-Adolase Homologues NahE, PhdJ, and PhdG 
 
2.1 INTRODUCTION 
 
Sequence analysis shows that NahE, PhdJ, and PhdG have Lys-183, Tyr-155, and 
the GXXGE motif, which are conserved in all other NAL subgroup members. Studies of 
these enzymes suggest that Tyr-155 is involved in Schiff base formation between the 
lysine and substrate and the subsequent aldol reaction. However, the other residues that 
contribute to these steps and those that activate water in the hydration are unknown. 
Additionally, residues that provide selectivity for NahE and PhdJ have not been 
identified. Kinetic and crystallographic studies allowed us to identify secondary active 
site residues that are unique to hydratase-aldolases. Based on the positions in liganded 
and unliganded structures of NahE and PhdJ, we are able to propose roles for each 
residue in binding and catalysis for these enzymes. The proposed activity for PhdG in the 
phenanthrene catabolic pathway could not be confirmed in our hands. However, we 
showed activity with other substrates including HBP, and determined crystal structures. 
These structures were compared with those of NahE and PhdJ.  
2.2 EXPERIMENTAL PROCEDURES 
 
  Materials. Chemicals, biochemicals, buffers, and solvents were purchased from 
Sigma-Aldrich Chemical Co. (St. Louis, MO), Fisher Scientific Inc. (Hampton, NH), or 
EMD Millipore, Inc. (Billerica, MA). The Phenyl-Sepharose 6 Fast Flow, DEAE Fast 
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Flow, and Superdex 200 resins used for protein purification was obtained from GE 
Healthcare Life Sciences (Boston, MA). The HisPur Ni-NTA resin was obtained from 
ThermoFisher Scientific (Waltham, MA). The Econo-Column
®
 chromatography columns 
were obtained from Bio-Rad (Hercules, CA). The Amicon stirred cell concentrators and 
the ultrafiltration membranes (10000 and 30000 Da, MW cutoff) were purchased from 
EMD Millipore Inc. Oligonucleotide primers were obtained from Sigma-Aldrich.  
  Crystallography. Crystallization experiments were carried out in the 
Macromolecular Crystallography Facility in the Institute for Cellular and Molecular 
Biology (ICMB) at the University of Texas at Austin. Various crystallization conditions 
were screened using the Phoenix crystallization robot made by Art Robbins Instruments 
(Sunnyvale, CA). Four crystallization screening kits (JCSG+, PEGs, Protein Complex, 
and Classics Suites) were obtained from Qiagen (Venlo, Netherlands).  Each kit contains 
96 conditions that were screened in three ratios of protein to reservoir solution volume 
(1:2, 1:1, and 2:1). Conditions that yielded crystals were optimized in 24-well sitting 
drop plates using 500 µL reservoir wells of varying pH and precipitant concentrations. 
Crystallization was performed using sitting drop vapor diffusion. Crystallization and 
crystal soaking were carried out at room temperature. Reflections in all datasets were 
indexed, integrated, and scaled in HKL2000 (Otwinowski & Minor, 1997). Reciprocal-
space refinement was performed using Phenix Refine (Afonine et al., 2012) and the 
structures were refined in real-space using COOT (Emsley et al., 2010). Waters were 
added before the final refinement. Final models were evaluated by Molprobity (Chen et 
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al., 2010). All figures were prepared with PyMol (The PyMOL Molecular Graphics 
System, Version 1.8 Schrödinger, LLC.) and Adobe Illustrator CS4.  
  General Methods. The PCR amplification of DNA sequences was conducted in a 
GeneAmp 2700 thermocycler made by Applied Biosystems (Waltham, MA).  Techniques 
for restriction enzyme digestion, ligation, transformation, and other standard molecular 
biology manipulations were based on methods described elsewhere (Sambrook, 1989). 
DNA sequencing was performed in the DNA Core Facility in the ICMB.  Electrospray 
ionization mass spectrometry (ESI-MS) was carried out on an LCQ electrospray ion-trap 
mass spectrometer made by Thermo Scientific (Waltham, MA). Steady-state kinetic 
assays were conducted on an Agilent 8453 diode-array spectrophotometer at 22 °C.  Non-
linear regression data analysis was performed using Mathmatica (Wolfram Research, 
Inc.).  Protein concentrations were determined by the Waddell method (Waddell, 1956). 
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was carried out 
on denaturing gels containing 12% polyacrylamide.
  
Nuclear magnetic resonance (NMR) 
spectra were recorded on a Varian INOVA-500 or a Varian DirectDrive 600 MHz 
spectrometer. NMR signals were analyzed using the software program SpinWorks 3.1.6.  
The sequence alignments and secondary information were visualized using ESPript 
version 3.0. 
2.2.1 Preparation of NahE, PhdJ, and PhdG 
 
  Bacterial Strains and Plasmids. The plasmid designated pRE701 (carrying the 
nahE gene) was a gift from Dr. Richard Eaton. The Mycobacterium vanbaalenii PYR-1 
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genomic DNA was a gift from Dr. Carl Cerniglia (National Center for Toxicological 
Research, US Food and Drug Administration, Jefferson, AR). Escherichia coli 
ArcticExpress cells were obtained from Agilent Technologies (Santa Clara, CA).   
  Construction of the NahE Expression Vector. NahE was amplified using the PCR 
with 5'- TAGTAGTAGCATATGTTGAATAAAG -3' and 5'- 
GATGATGATCTCGAGTCATTATTATTTACTGTATTTAGCGTG -3', as the forward 
and reverse primers, respectively. The primers contained the XhoI and NdeI restriction 
sites (underlined). The PCR product and the pET24 vector were treated with the 
appropriate restriction enzymes, ligated, and processed to construct an expression vector 
for NahE. Three mutations (D265G, S275T, and P299S) were introduced using the 
QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara) 
following the manufacturer's instructions. These changes corrected mutations that had 
been introduced during the PCR.  
  Construction of the PhdJ Expression Vector. The gene, phdJ (Mvan_0469) was 
amplified from the M. vanbaalenii PYR-1 genomic DNA using the PCR with 5'-
CGAGAGAGCATATGGTGCACGT-3' and 5'-TCCTCAGGATCCGTGGTTCGAGAC-
3' as forward and reverse primers, respectively. The primers contained NdeI and BamHI 
restriction sites (underlined). The PCR product and the pET24 vector were treated with 
the appropriate restriction enzymes, ligated, and processed to construct an expression 
vector for PhdJ. The PCR introduced two mutations, which were corrected (K44T, and 
G335Stop) using the QuikChange Site-Directed Mutagenesis Kit (Agilent Technologies) 
following the manufacturer's instructions. The plasmid containing the phdJ gene was 
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transformed into E. coli Arctic Express cells (Agilent Technologies) following the 
manufacture’s transformation protocol.  The ATG start codon was positioned 
immediately before the GUG start codon found for phdJ M. vanbaalenii PYR-1, so the 
expressed protein had an additional residue, valine, on the N-terminus. 
  Construction of PhdG Expression Vector. The phdG gene was amplified from M. 
vanbaalenii PYR-1 genomic DNA using the PCR with 5ʹ-
CACGGCTCGGATCCACAACACG-3ʹ and 5ʹ-
CCGGCGTGAGCTCCTATGACGAGG-3ʹ as forward and reverse primers, respectively. 
The primers contained BamHI and SacI restriction sites (underlined), which were used 
for insertion into a pET24a vector. QuikChange mutagenesis was performed to correct 
several mutations including the start codon and Q325E. E. coli DH5α cells were used for 
plasmid replication. A sequence encoding a C-terminal His-tag and TEV cleavage site 
was also inserted using Gibson Assembly following the manufacturer's protocol (New 
England Biolabs, Ipswich, MA). When the sequenced DNA showed that no mutations 
were present in the gene, the plasmid was transformed into Arctic Express cells. 
 Expression and Purification of NahE. The pET vector construct (encoding nahE) 
was transformed into E. coli ArcticExpress cells and used to inoculate LB media (450 
mL) containing kanamycin (50 µg/mL), and gentimicin (20 µg/mL). After the cells had 
been shaken overnight at 37°C, 25 mL of the culture was used to inoculate each of 9 2-L 
Erlenmeyer flasks containing 500 mL M9 minimal media (Sambrook, 1989) with 0.4% 
glucose, kanamycin (50 µg/mL), and gentimicin (20 µg/mL). The cells were allowed to 
grow until the OD600 reached ~0.5 (~3 h). In one preparation, the flasks containing the 
 47 
cells were put on ice for 30 min, then β-D-thiogalactoside (IPTG) was added to make 
each 1 mM in IPTG. After growing for ~65 h at 15 °C, cells were harvested by 
centrifugation (20 min at 11300 rpm) and stored at -20 °C. In another preparation, NahE 
was expressed in LB media and induced overnight with IPTG (1 mM) at room 
temperature.  
  In a typical procedure, cells were thawed and suspended in 150 mL of 50 mM 
sodium phosphate (pH 7.0) containing protease inhibitors [0.5 mM phenylmethylsulfonyl 
fluoride (PMSF), 5 mM EDTA, 1.5 mg/mL lysozyme]. Cells were lysed by sonication 
using a W-385 ultrasonicator made by Heat Systems (15 min at 30% duty, 5 s cycles). 
Ground (NH4)2SO4 was added to the lysate to 30% saturation before centrifugation (30 
min at 39000 g). The supernatant was loaded onto a Phenyl Sepharose 6 (~55 mL, GE) 
column equilibrated in 50 mM sodium phosphate (pH 7.5) made up to 15% in 
(NH4)2SO4. After the column was washed (>1 column volume, CV), protein was eluted 
by using a gradient (~200 mL) of 50 mM sodium phosphate (pH 7.0) made 15% in 
(NH4)2SO4 to 50 mM sodium phosphate pH 7.0. The protein did not completely elute 
from the column as determined by the Bradford assay, so a 100 mL gradient was run 
from 50 mM sodium phosphate to de-ionized water, which resulted in complete elution. 
Fractions (150 drops) were collected and analyzed by SDS-PAGE for the appearance of a 
band around 35000 Da. Fractions were pooled based on the purity (assessed by SDS-
PAGE). The protein was exchanged into 50 mM sodium phosphate (pH 7.0) by dialysis 
overnight. 
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 The dialyzed protein was loaded on a DEAE anion exchange column (~30 mL) 
equilibrated in 50 mM sodium phosphate (pH 7.0). Protein was eluted using a gradient 
(~100 mL) to 50 mM sodium phosphate (pH 7.0) made 0.5 M NaCl. Fractions of eluent 
(~2 mL) were collected and analyzed by SDS-PAGE. Fractions were pooled based on 
purity (as assessed by SDS-PAGE) and dialyzed into 50 mM sodium phosphate (pH 7.0).  
 Protein used for crystallography was concentrated and further purified by gel 
filtration chromatography using an a HiLoad 16/60 Superdex (120 mL, GE) column 
connected to a fast protein liquid chromatography (FPLC) setup. The protein was eluted 
isocratically (1 mL/min) in 25 mM HEPES (pH 7.5) made 0.1 M in NaCl. Fractions (1.0 
mL) were collected, analyzed by SDS-PAGE, and pooled based on purity. The pooled 
fractions were concentrated and divided into small aliquots. These stocks were flash-
frozen with liquid nitrogen, then stored at -80 °C. Typically the yield for this procedure is 
~30 mg per L of culture or 3 mg per g of cells purified. The purity of NahE was 
determined to be >95% as assessed by SDS-PAGE and electrospray ionization mass 
spectroscopy (ESI-MS).  
 Preparation of SeMet-NahE. The L-selenomethionine (SeMet) derivative of NahE 
was expressed and purified similar to wild type enzyme with the following modifications. 
Cells were grown in M9 minimal media (Sambrook, 1989) with 0.2% glucose until the 
OD600 reached 0.5-1.0. To each flask were added lysine, phenylalanine, threonine (100 
mg each); isoleucine, leucine, and valine (50 mg each); and selenomethionine (60 mg). 
Additionally, IPTG (1 mM) was added prior to incubation (16 h) at room temperature. 
The remainder of the purification protocol for the derivative was identical to wild-type 
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except that dithiothreitol (5 mM) was added to all buffers to prevent oxidation of 
selenium. The size-exclusion chromatography step was included in the purification.  
 Preparation of K183A NahE. QuikChange Mutagenesis was performed to 
generate a plasmid encoding K183A NahE. Once the sequence was confirmed by DNA 
sequencing, the mutant was expressed and purified similar to wild-type and submitted for 
ESI-MS.   
 Expression and Purification of PhdJ, S278N PhdJ, and D282E PhdJ. The E. coli 
Arctic Express cells (containing the PhdJ expression vector) were used to inoculate a 
starter culture containing 50 mL LB media with kanamycin (50 µg/mL) and gentimicin 
(20 µg/mL). The cultures were grown at 37°C overnight. Subsequently, 4 2-L Erlenmeyer 
flasks containing 400 mL ZYM-5052 auto-induction media (Studier, 2005) and 
kanamycin (100 µg/mL) were inoculated with 25 mL starter culture (each) and grown 
until the OD600 reading was ~0.3 (~3 h). The cultures were then cooled to 12° C and 
shaken at 250 rpm for ~65 h. Cells were harvested by centrifugation at 11300 rpm for 20 
min and stored at -20 °C. The cell pellet mass for the 1.6 L culture was 25.5 g.  
 The cells were thawed and suspended in 50 mM sodium phosphate (pH 7.0, 80 
mL) containing protease inhibitors (1 mM PMSF, 5 mM EDTA, 1.5 mg/mL lysozyme).  
The cells were lysed by sonication using a W-385 ultrasonicator from Heat Systems (20 
min. at 30% duty, output level 6, at 5 s intervals). The lysate was centrifuged (30 min at 
12,000 rpm) and the pellet was discarded. 50 mM sodium phosphate buffer (pH 7.0, ~30 
mL) was added to the supernatant and the solution was centrifuged again (20 min at 
18,000 rpm). This supernatant was loaded onto a DEAE column (17 mL) equilibrated 
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with 50 mM sodium phosphate buffer (pH 7.0). The column was washed (>1 CV) with 
the same buffer. Protein was then eluted with a linear gradient (0-0.5 M NaCl in the 
sodium phosphate buffer, 85 mL). Fractions (1.4 mL) were pooled based on the presence 
of an SDS-PAGE band at ~35 kD and activity using substrate, ortho-
carboxybenzylidenepyruvate (CBP).  
 (NH4)2SO4 (30%) was added to the pooled fractions and stirred for 20 min on ice 
for ~20 min prior to centrifugation (20 min at 18,000 rpm). After storage of the 
supernatant overnight at 4 °C, (NH4)2SO4 (40%) was added. The colution was stirred for 
~20 min on ice before centrifugation (20 min at 18,000 rpm). The pellet was dissolved 
and dialyzed into 50 mM sodium phosphate (pH 7.0). For a typical preparation, the yield 
was 4.9 mg per L culture or 0.3 mg per g cells. An additional hydrophobic interaction 
column using Phenyl Sepharose column was employed when the purity was <95% as 
assessed by SDS-PAGE. The purity and identity of PhdJ was determined by SDS-PAGE 
and ESI-MS, respectively. The homogeneous protein was divided into small aliquots (50-
200 L), flash-frozen with liquid nitrogen, and then stored at -80°C.   
 Expression and Purification of PhdG. All culture media contained kanamycin (50 
µg/mL) and gentimicin (20 µg/mL). For expression of PhdG, LB media (7 mL) was 
inoculated with Arctic Express cells containing pET24a (encoding phdG). After the cells 
were grown 37 °C overnight with shaking, LB media (50 mL) was added, and the culture 
was incubated for 4 h. Culture (3 mL) was used to inoculate each of 12 2-L flasks 
containing 400 mL of ZYM-5052 media (Studier, 2005). The cultures were incubated for 
2.5 h with shaking at 37 °C until the OD600 reached 0.6. The culture was then incubated 
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with shaking at 12 °C for ~65 h prior to centrifugation (20 min at 8000 rpm). The cell 
pellet (95 grams) was stored at -80 C°.  
 Cells were thawed and suspended (by stirring) in 50 mM sodium phosphate (pH 
7.0, ~200 mL) containing EDTA (5 mM), PMSF (1 mM), and lysozyme (1 mg/mL). The 
cells were lysed by sonication using a W-385 ultrasonicator from Heat Systems (20 min. 
at 30% duty, output level 6, at 5 s intervals) prior to centrifugation of the lysate (20 min 
at 20,000 rpm). The pellet was discarded and the supernatant was then centrifuged again 
(30 min at 60,000 rpm), and loaded on a HisPur column (8 mL) equilibrated with 50 mM 
sodium phosphate (pH 7.0) made 300 mM in NaCl. The column was washed with the 
equilibration buffer (5 CV). To elute PhdG, a linear gradient (50 mL) was used from the 
equilibration buffer to 50 mM sodium phosphate (pH 7.0) containing 300 mM NaCl and 
200 mM imidazole. Fractions (~1.6 mL) were collected and analyzed by SDS-PAGE. 
Fractions that appeared to be most homogeneous were treated with TEV protease (600 
µL, 1.8 mg/mL, gift from Dr. Tyler Stack). The digested PhdG solution was then 
dialyzed into 25 mM HEPES (pH 7.5) containing 0.1 M NaCl (4 L, 6000 Da MW cutoff) 
and concentrated using an Amicon to 5.8 mg/mL.  
 Buffer-exchanged PhdG (5 mL) was injected onto a Hiload 16/60 Superdex (GE) 
size-exclusion column and eluted isocratically (1 mL/min) in 25 mM HEPES (pH 7.5) 
containing 0.1 M NaCl. Fractions (1.0 mL) were collected and analyzed by SDS-PAGE. 
Fractions were combined based on homogeneity (assessed by SDS-PAGE) and 
concentrated. Concentrated PhdG was divided into small aliquots (100 and 200 µL) and 
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flash frozen using liquid nitrogen prior to storage at -80 °C. The typical yield for PhdG 
was 24 mg per L culture or 1.2 mg per g of cell pellet.  
 
2.2.2 Synthesis 
 
 trans-o-Hydroxybenzylidenepyruvate (HBP). Salicaldehyde (1 g, 13 mmol) was 
added to ethyl triphenylphosphoranylidenepyruvate (5 g, 13 mmol, Ernest et al., 1978, 
Johnson et al., 1995) in anhydrous DMF with a catalytic amount of benzoic acid (50 mg) 
and was heated at 80°C for ~15 h (Scheme 2-1). Water was added (25 mL) prior to 
extraction with hexanes-ethyl acetate (2:1). Na2SO4 was added to the organic phase and 
the solution was run through a plug of silica. Silica chromatography using hexanes-ethyl 
acetate (4:1) was performed. Fractions were collected and evaporated to dryness. The 
residue was redissolved in H2O and made alkaline by adding NaOH (1 M) dropwise so as 
to not exceed pH 10. The solution was extracted with ethyl acetate to remove ethanol and 
remaining ethyl ester. The aqueous phase was then acidified to pH 2 and the product was 
isolated by extraction with ethyl acetate. The ethyl acetate layers were dried using 
anhydrous Na2SO4 and evaporated to dryness. The yield was 1 g (64%). HBP: 
1
H NMR 
(H2O, 600 MHz)  6.773 (1H, d, J = 16.44 Hz), 6.786 (1H, d, J = 7.56 Hz), 6.805 (1H, t, 
J = 7.86 Hz), 7.196 (1H, td, J = 7.77 Hz, 1.65 Hz), 7.469 (1H, dd, J = 7.86 Hz, 1.62 Hz), 
7.789 (1H, d, J = 16.50 Hz)]. 
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Scheme 2-1 Synthesis of HBP (R=OH) and CBP (R=CO2
-
), starting with salicylaldehyde 
(R=OH) or CBA (R=CO2
-
).  
 
 ortho-Carboxybenzylidenepyruvate (CBP). ortho-Carboxybenzaldehyde (CBA)  
methyl ester was synthesized by mixing o-carboxybenzaldehyde (1.5 g, 10 mM) and 
dimethyl sulfate (1.9 g, 15 mM) with ~2.5 equivalents K2CO3. The reaction was stirred at 
a gentle reflux in acetone (50 mL). The majority of the acetone is removed under reduced 
pressure. The residue is diluted with 100 mL ethanol and filtered to remove salts. The 
ethyl acetate is washed with water, dried (NaSO4), and the solvent is removed to give the 
methyl ester. Water was added and the methyl ester was extracted with hexanes-ethyl 
acetate (4:1). The organic phase was dried over anhydrous Na2SO4 and evaporated to 
dryness. A mixture of 2-carboxybenzaldehyde methyl ester (1 g, 13 mmol), ethyl 
triphenylphosphoranylidenepyruvate (5 g, 13 mmol, Ernest et al., 1978, Johnson et al., 
1995) and a catalytic amount of benzoic acid (50 mg) was heated in anhydrous DMF 
under argon at 80°C (~15 h) (Scheme 2-1). Water (25 mL) was added and the reaction 
mixture was extracted with hexanes-ethyl acetate (2:1). The organic layers were 
combined, dried over anhydrous Na2SO4, and run through a small silica plug. The 
compound was purified using flash chromatography (hexanes-ethyl acetate, 4:1). After 
removing the solvent under reduced pressure, CBP methyl ester was redissolved in H2O 
(~5 mL) and hydrolyzed by NaOH (1 M), dropwise so as to not exceed pH 10. The 
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solution was extracted with ethyl acetate. The aqueous phase was then rapidly acidified 
(pH 2) using 8.5% phosphoric acid. CBP was extracted using ethyl acetate, dried over 
anhydrous Na2SO4, and evaporated to dryness. The overall yield was ~1 g. CBP: 
1
H 
NMR (H2O, 600 MHz)  6.719 (1H, d, J = 16.28 Hz), 7.268-7.351 (3H, m), 7.620 (1H, d, 
16.34 Hz), 7.864 (1H, d, J = 16.34).   
 2-hydroxychromene-2-carboxylate (HCCA). HCCA was prepared by dissolving 
HBP in 100 mM dibasic sodium phosphate (200µL) and water (400 µL). NaOH (25 M) 
was added in 3 µL increments until the pH was above 5, then NaOH (1 M) was added in 
3 µL increments until the pH was 7. The solution was incubated overnight to form a 
mixture HBP and HCCA in equilibrium. The solution was loaded onto a G-15 sepharose 
column (~7 mL).  Fractions were collected on ice and fractions with an A255/A296 greater 
than 2.5 were pooled and determined to be adequately free of the trans isomer by 
1
H 
NMR spectroscopy. The fractions were flash frozen and stored at -20°C. HCCA: 
1
H 
NMR (H2O, 600 MHz)  5.764 (1H, d, J = 9.74 Hz), 6.658 (1H, d, J = 9.76 Hz), 6.821 
(1H, d, J = 8.07 Hz), 6.873 (1H, t, J = 7.309 Hz), 7.0943 (1H, d, J = 7.46 Hz), 7.128 (1H, 
t, J = 7.71 Hz). 
 Synthesis of trans-Benzylidenepyruvate (BP). BP was synthesized using a 
published procedure (Reimer, 1931). BP: 
1
H NMR (H2O, 600 MHz)  6.717 (1H, d, J = 
16.51 Hz), 7.285-7.351 (3H, m), 7.514 (1H, d, 16.51 Hz), 7.536-7.508 (2H, m).   
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2.2.3 Steady-State Kinetics  
 
 Determination of Extinction Coefficients for HBP, salicylaldehyde, HCCA, CBP, 
CBA, BP, trans-Cinnamaldehyde, and 2-oxo-6-phenyl-3,5-Hexadienoate. To determine 
the ε296 for HBP, 5.2 mg was dissolved in ethanol (10 mL). An aliquot (25 µL) of this 
stock was then added to 50 mM sodium phosphate (970 µL, pH 7.0). The ε296 for 
salicylaldehyde was determined by dissolving 6.0 mg in 50 mM sodium phosphate (3.00 
mL, pH 7.0). An aliquot (5 µL) of this solution was diluted in 50 mM sodium phosphate 
(995 µL, pH 7.0). The ε300 for CBP was determined by measuring the absorbance of CBP 
(81 µM) in 50 mM sodium phosphate (pH 7.0). To measure ε300 for CBA, 3.6 mg was 
dissolved in 1.00 mL sodium phosphate (pH 7.0). An aliquot (5 µL) was diluted into 50 
mM sodium phosphate (995 µL, pH 7.0). To measure ε300 for BP, 9.7 mg was dissolved 
in ethanol (1.0 mL). The stock was diluted 10-fold with ethanol, and an aliquot (5 µL) 
was added to 50 mM sodium phosphate (1.0 mL, pH 7.0). The ε340 for trans-
cinnamaldehyde was determined by adding trans-cinnamaldehyde (5 µL, 2.05 mg/mL) to 
50 mM sodium phosphate (980 µL, pH 7.0). To determine the ε340 2-oxo-6-phenyl-3,5-
hexadienoate, which was not isolated, pyruvate (5 µL, 325 mg/mL) and PhdG (20 µL, 8.4 
mg/mL) were then added to the solution with trans-cinnamaldehyde to force its complete 
conversion to 2-oxo-6-phenyl-3,5-hexadienoate. The reaction was assumed to be 
complete when the absorbance did not change significantly after a second addition of 
pyruvate (5 µL, 325 mg/mL). All measurements were performed at room temperature. 
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 Non-enzymatic Isomerization of HBP and HCCA. Isomerization was measured in 
50 mM sodium phosphate buffer (pH 7.0) by UV absorbance every min for 60 min. The 
extinction coefficients for HCCA at wavelengths of 255, 296, and 340 nm were 6800 M
-
1
cm
-1
, 2700 M
-1
cm
-1
, and 700 M
-1
cm
-1
 respectively. The extinction coefficients for HBP 
at wavelengths of 255, 296, and 340 nm were determined to be 4000 M
-1
cm
-1
, 11000 M
-
1
cm
-1
, and 7000 M
-1
cm
-1
 respectively. Non-enzymatic rates were calculated by dividing 
absorbance changes by the absorbance differences of the species. All measurements were 
carried out at room temperature. 
 Steady-State Kinetic Analysis of NahE with HBP. HBP (15.3 mg) was dissolved in 
ethanol (1.4 mL) and diluted to make separate stocks of 2.19, 1.56, 1.09, 0.728, 0.437, 
0.273, 0.168, 0.0397, 0.0546, 0.0728 mg/mL. NahE (6.5 mg/mL) in 50 mM sodium 
phosphate buffer (pH 7.0) was diluted to 23 µg/mL (0.63 µM) for use in the enzyme 
assays. Substrate stock (10 µL) was added to 50 mM sodium phosphate (985 µL, pH 7.0) 
in a 1 mL cuvette. The reaction was initiated by the addition of NahE (5 µL) to a final 
concentration of 3.2 nM (0.12 µg/mL). Final substrate concentrations in the reactions 
ranged from 1.51-114 µM. Reaction solutions were mixed by inversion. Reactions were 
monitored at 296 nm for 150 s using a 10 s cycle for concentrations 114-3.79 µM, 75 s 
with a 5 s cycle for 2.84 and 1.94 µM concentrations, and 45 s with a 3 s cycle for the 
1.51 µM concentration. The difference in ε296 for HBP (11,000 M
-1
cm
-1
)
 
and 
salicylaldehyde (1300 M
-1
cm
-1
) was 9700 M
-1
cm
-1
.
 
This value was used to convert initial 
rates from AU/s to M/s, which were then converted to kobs for fitting to the following 
equation that accounts for substrate (HBP) inhibition: 
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𝑘   =
𝑘   [HBP]
𝐾 + [HBP] (1 +
[HBP]
𝐾 
   )  
 
(1) 
 
All measurements were carried out at room temperature. 
 NahE Activity with HBP in the Presence of Salicylaldehyde. An aliquot of HBP 
(10 µL, 15, 9.0, 5.4, 3.0, 1.8, 1.1 mM) was added to initiate 1.0 mL reactions containing 
50 mM sodium phosphate (pH 7.0), NahE (18 nM), and various concentrations of 
salicylaldehyde (10 µL 10.1, 5.07, 2.53, 1.26, 0.633, and 0.317 mM dissolved in ethanol 
were added to give final concentrations of 101, 50.7, 25.3, 12.6, 6.33, and 3.17 µM 
HBP). The final concentration range of HBP was 11-150 µM. Initial rates were measured 
by A296 decrease over 25 seconds with spectra recorded every 2.5 seconds. All 
measurements were carried out at room temperature.  
 Steady-State Kinetics of NahE with BP and CBP. Stock solutions of BP (1.3-11 
mM) were prepared in ethanol. Stock solutions of CBP (0.525-52.5 mM) were prepared 
in 50 mM sodium phosphate (pH 7.0). Reactions were initiated by the addition of NahE 
(final concentrations of 1.5–3.4 µM). Reactions were monitored by the decrease in 
absorbance decrease at 300 nm. Reactions were monitored after initiation for 30-120 s 
with a 2.5-6 s cycle time depending on the reaction rate. The ε300 for substrates BP and 
CBP were 21000 M
-1
cm
-1
 and 10200 M
-1
cm
-1
, respectively. The ε300 for the products 
benzaldehyde and CBA were 540 M
-1
cm
-1
 and 1450 M
-1
cm
-1
, respectively. The 
difference in ε300 for substrates and products were used to calculate kobs which were 
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plotted vs. substrate concentration and fit to the Michaelis-Menten equation. All 
measurements were carried out at room temperature. 
 Relative Activity of K183A NahE. K183A NahE was made 110 nM to initiate a 
1.00 mL reaction with HBP (84 µM) in 50 mM sodium phosphate (pH 7.0). The same 
reaction was performed using wild-type NahE (110 nM). The intitial decrease of A296 was 
measured. All measurements were carried out at room temperature. 
 NahE Activity with Salicylaldehyde and Pyruvate. Stock solutions of pyruvate (20 
µL) and salicylaldehyde dissolved in ethanol (5 µL, diluted from a 2 M stock) was added 
to 50 mM sodium phosphate (pH 7.5, 965 µL) to reach final concentration ranging from 
25 µM to 1.0 mM and 0.4 to 40 mM, respectively. NahE (10 µL of a 0.13 mg/mL 
solution) was added and mixed in the solution to a final concentration of 35 nM to initiate 
reactions. Spectra were recorded every 3 s over 30 min. Initial rates were calculated using 
increase of A296 and were fit to the following equation for a ping-pong mechanism: 
 
 𝑘   =
𝑘   [pyr][ald]
𝐾   [ald] + [pyr][ald] + 𝐾   [pyr] 
 (2) 
 
where ald is salicylaldehyde, and pyr is pyruvate. All measurements were carried out at 
room temperature. 
 PhdJ Activity with CBP. CBP (2.0 mg, disodium salt) was added to 50 mM 
sodium phosphate buffer (pH 7.0, 500 µL) to make a 16 mM solution (pH ~8 by pH 
paper). The stock solution was diluted to make various concentrations (8.1 mM, 4.1 mM, 
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2.4 mM, 1.6 mM, 1.1 mM, and 0.81 mM) in the same sodium phosphate buffer. 
Subsequently, aliquots (10 µL) of the diluted substrate stock solutions were added to 50 
mM sodium phosphate buffer (985 µL, pH 7.0).  PhdJ (5 µL of a 0.51 mg/mL solution) 
was added and mixed, to a final concentration of 71 nM, with CBP (81, 41, 24, 16, 11, 
and 8.1 µM) to initiate reactions. Initial rates were measured by following the decrease of 
absorbance at 300 nm. The initial rates were converted to molar units using the difference 
between extinction coefficients for CBP (10500 M
-1
cm
-1
) and CBA (1450 M
-1 
cm
-1
). The 
activities for the S278N and D282E mutants of PhdJ were determined by adding CBP (7 
µL, 0.489-2.75 mg/mL) to 50 mM sodium phosphate (pH 7.0, 986 µL). Reactions were 
initiated by adding S278N and D282E mutants of PhdJ (10 µL made 33.7 µM and 100 
µL made 15.5 µM, respectively, in sodium phosphate, pH 7.0). The kcat/KM values for 
these reactions were determined by a linear fit of kobs plotted vs. CBP concentration with 
the y-intercept set to 0 (kobs is 0 without substrate). All measurements were carried out at 
room temperature. 
 PhdJ, S278N PhdJ, and D282E PhdJ Activity with HBP. The substrate (2.7 mg) 
was dissolved in ethanol (1.0 mL) and further diluted (1.8, 1.4, 0.90, 0.54, and 0.36 
mg/mL) in ethanol. Aliquots (6 L) of the diluted substrate stocks were added to 50 mM 
sodium phosphate buffer (942 L, pH 7.0) so that the final concentrations of HBP were 
85, 56, 42, 28, 17, and 11 µM. The reaction was initiated by adding 50 µL aliquots of a 
PhdJ solution (0.51 mg/mL) to make a final concentration of 0.71 µM. Initial rates were 
measured by following the decrease of absorbance at 296 nm. Spectra were recorded 
every 5 s for 60 s. Initial rates were calculated using the differences in the ε296 for HBP 
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(10700 M
-1
cm
-1
) and salicylaldehyde (1260 M
-1
cm
-1
). Activities for the S278N and 
D282E PhdJ mutant were determined by adding HBP (7 µL, 0.293-2.20 mg/mL in 
ethanol) to 50 mM sodium phosphate (pH 7.0, 986 µL). Reactions were initiated by 
adding S278N and D282E PhdJ mutant (7 µL made 33.7 µM and 20 µL made 15.5 µM, 
respectively, in sodium phosphate, pH 7.0) was added. The kcat/KM values for these 
reactions were determined by a linear fit of kobs plotted with HBP concentration setting 
the y-intercept to 0. All measurements were carried out at room temperature. 
 PhdJ, S278N PhdJ, and D282E PhdJ Activity with BP. BP (5.4 mg) was dissolved 
in ethanol (1 mL) and further diluted to 1.1, 0.72, 0.54, 0.36, 0.27, 0.18, and 0.12 mg/mL 
in ethanol. Aliquots (7 µL) of the diluted stock solution were added to 50 mM sodium 
phosphate buffer (pH 7.0, 943 µL) so that final concentrations of BP were 48, 32, 24, 16, 
12, 7.9, and 5.3 µM. The reactions were initiated by adding PhdJ (10 µL, 0.51 mg/mL) to 
a final concentration of 1.4 µM. Spectra were recorded every 20 s for 10 min. Initial rates 
were determined by following the decrease of absorbance at 300 nm. The ε300 for BP and 
benzaldehyde was determined to be 21,000 ± 1,000 and 540 ± 20 M
-1
 cm
-1
, respectively. 
The activity for S278N and D282E PhdJ mutants were measured by adding BP (7 µL, 
0.128-1.01 mg/mL in ethanol) to 50 mM sodium phosphate (pH 7.0, 973 µL). The 
reactions were intitiated by the addition of S278N and D282E PhdJ mutants (20 µL, 33.7 
µM and 15.5 µM, respectively). All measurements were carried out at room temperature. 
 PhdG Activity with trans-Cinnamaldehyde and Pyruvate. trans-Cinnamaldehyde 
(17.7 mg) was dissolved in ethanol (981 µL) to make a 17.7 mg/mL stock. This stock 
solution was diluted to make solutions ranging from 0.443 mg/mL to 17.7 mg/mL. 
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Sodium pyruvate (17.5 mg) was dissolved in 50 mM sodium phosphate (pH 7.0, 318 µL), 
and was diluted to make 7.0, 1.75, and 0.70 mg/mL of pyruvate stocks. Using these 
solutions, trans-cinnamaldeyde (5 µL) and pyruvate (5 µL) were added to 50 mM sodium 
phosphate buffer (pH 7.0, 985 µL). PhdG (5 µL, 0.17 mg/mL) was added to initiate 
reactions. Initial rates were measured by following the decrease of absorbance at 340 nm 
measured every 3 s for 60 s. The ε340 for cinnamaldehyde and the product were 
determined to be 570 M
-1
s
-1
 and 14400 M
-1
s
-1
. Rates were plotted vs. pyruvate and 
cinnamaldehyde concentration and fit to eq. 2. All measurements were carried out at 
room temperature. 
 Steady State Kinetics for PhdG using BP. BP (12.1 mg) was dissolved in ethanol 
(1.0 mL) and diluted into stock solutions ranging from 0.128-1.01 mg/mL. An aliquot (7 
µL) was added to 50 mM sodium phosphate buffer pH 7.0 (986 µL). To initiate reactions, 
PhdG (7 µL, 1.7 mg/mL) was added. Spectra were recorded every 3 s for 60 s. Initial 
rates were determined by following the decrease of absorbance at 300 nm. All 
measurements were carried out at room temperature. 
 
2.2.4 
1
H NMR Spectrometric Time Course for Reactions Catalyzed by NahE, NahD, 
PhdJ, and PhdG 
 
 
 1
H NMR Time Course of Reactions Catalyzed by NahE and NahD. HBP or HCCA 
(4.0 mg, 30 mM) dissolved in DMSO-d6  (30µL) was added to 50 mM sodium phosphate 
(600 µL, pH 7.5) to monitor the production of aldehyde and pyruvate. Reactions with 
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benzaldehyde and salicyaldehyde were prepared in a like manner, but pyruvate (1 eq) 
dissolved in the sodium phosphate buffer was added first to the NMR tube. Reactions 
were initiated by adding NahE (100 µL, 4.1 mg/mL) and/or NahD (100 µL, ~1 mg/mL). 
Spectra were recorded every 3 min for 33 min. The NMR spectra were recorded on a 
Varian INOVA-500 spectrometer (Palo Alto, CA), using selective presaturation of the 
water signal with a 2 s presaturation interval. The lock signal is DMSO-d6. Chemical 
shifts are standardized to the DMSO-d6 signal at 2.49 ppm. Reactions prepared for the 
measurement of NahE activity were: HBP only, HCCA only, NahD and HBP, 
benzaldehyde and pyruvate, and salicylaldehyde and pyruvate. Control samples were 
prepared in a like manner, but buffer (100 µL) was added instead of enzyme. 
Approximate amounts of product were determined by integration. 
 1
H NMR Identification of the Products in the PhdJ-catalyzed Reaction. To NMR 
tubes containing 100 mM sodium phosphate buffer (600 µL, pH 7.5) was added a 
quantity of CBP or CBA (4.5 mg in 30 µL DMSO-d6). For the reaction containing CBA, 
pyruvate (1 eq) was dissolved in the same buffer that was initially added to the NMR 
tube. The reaction was initiated by adding PhdJ (100 µL of a 0.51 mg/mL solution) to a 
final concentration of 1.9 µM. The final pH of the reaction mixtures were 7.5. DMSO-d6 
was used as the lock signal and for the standardization of the chemical shifts (at 2.49 
ppm). A non-enzymatic control was prepared identically except that PhdJ was not 
included in the reaction. NahE spectra were recorded every 3 min over the course of 33 
min.  
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1
H NMR Identification of the Products in the PhdG-catalyzed Reactions. To an 
NMR tube containing 100 mM sodium phosphate buffer (600 µL, pH 7.5) was added a 
quantity of BP or cinnamaldehyde (4.5 mg in 30 µL DMSO-d6). For the reaction 
containing cinnamaldehyde, pyruvate (1 eq) was initially dissolved in the NMR tube 
using the same buffer. Reactions were initated by adding PhdG (25 µL, 8.3 mg/mL). 
 
2.2.5 UV/Vis Absorbance and Mass Spectrometry of Modified Hydratase-Aldolases 
 
 
 UV/Vis spectra of NahE and PhdJ with benzaldehyde, salicylaldehyde and CBA.  
Each aldehyde (5 µL, 3.46 mM) was added separately to solutions containing NahE or 
PhdJ (95 µL, 91 µM) to make final concentrations of 173 µM aldehyde and 86.5 µM 
NahE or PhdJ (2:1 ratio). The spectrophotometer was blanked immediately after mixing. 
UV/Vis spectra were monitored over the course of several hours. 
 NahE and K183A NahE Modification with HBP, salicylaldehyde, pyruvate, 2-oxo-
3-Pentynoate (2-OP), and 4-phenyl-2-oxo-3-Butynoate (POB). All modification 
experiments were performed at room temperature. NaCNBH3 was added to all solutions 
except the sample containing POB. Stock solutions of NaCNBH3 were made to 0.75 M 
by dissolving NaCNBH3 in 100 mM dibasic Na2HPO4. HBP, salicylaldehyde, pyruvate, 
2-OP, and POB (final concentrations of 1.8, 0.29, 8.0, 0.21, and 0.088 mM, respectively) 
were added to 50 mM sodium phosphate (pH 7.0) containing enzyme (8.9-140 µM) and 
NaCNBH3 (15 mM). The compounds and additional NaCNBH3 (15-250 mM, final) were 
added incrementally over the course of several hours until enzyme activity using HBP 
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had decreased more than 50% relative to the control with NaCNBH3 treatment only (with 
the exception of pyruvate, where the activity decreased ~30%). 
 Covalent Modification of PhdJ by CBP, CBA, or Pyruvate in the Presence of 
NaCNBH3. Three reaction mixtures containing CBP (260 µM), CBA (550 µM), or 
pyruvate (20 mM) were made up in 50 mM sodium phosphate (pH 7.0) containing 
NaCNBH3 (~15 mg/mL in 100 mM Na2HPO4) and PhdJ (0.5 mg/mL). CBP, CBA, and 
pyruvate were added to the samples (1-15 µL increments) until enzyme activity had 
decreased more than 50% (2-4 h). Inactivation using pyruvate was slow compared to the 
samples with CBP and CBA, and activity only dropped ~30% over 4 h. 
 Treatment of PhdG with CBP, 2-OP, or POB in the Presence of NaCNBH3. Three 
reaction mixtures containing CBP (460 µM), 2-OP (460 µM), POB (460 µM), and 
pyruvate (460 µM) were made in 50 mM sodium phosphate (pH 7.0, 120-160 µL) 
containing NaCNBH3 (~15 mg/mL in 100 mM Na2HPO4) and PhdJ (6 mg/mL).  
 Preparation of Inactivated NahE and PhdJ for ESI-MS. NahE and PhdJ were 
exchanged into 10 mM ammonium carbonate (pH 8.2) using PD-10 columns. Samples 
were concentrated with Amicon Ultra 0.5 mL Centrifugal Filters (3 kD cutoff). 
Membranes were rinsed first by filling and decanting the cells five times with filtered 
water, then spinning the cell filled with water at 10,000 rpm for 5 min. The rinsing 
procedure was performed five times before ESI-MS. The samples were made ~0.1 
mg/mL and submitted for ESI-MS.  
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2.2.6 Dynamic Light Scattering Analysis of NahE, PhdJ, and PhdG 
 
  
 Dynamic Light Scattering. A DAWN HELEOS-II Multi-Angle Static Light 
Scattering (MALS) instrument (664 nm beam) connected to an Shimadzu LC-20AD 
HPLC System equipped with a size-exclusion column Model WTC-030S5 (7.8  300 
mm, pore size 300 Å, Wyatt Technologies) was used to collect data. Molar mass 
moments in g/mole were determined with 100 µL samples of NahE, PhdJ, and PhdG (25 
µM each). The HPLC solvent was 50 mM sodium phosphate buffer (pH 7.0), and the 
flow rate was 0.4 mL/min.   
2.2.7 Crystallization, Soaking, and Structure Determination of NahE  
 
 Crystallization and Crystal Soaking. The diffraction-quality crystals of SeMet 
NahE (NahE-SeM) were obtained in 0.1 M MES (pH 6.5-8.0) and 21-26% PEG 2000 
monomethyl ether (MME). The crystals were set up in sitting drop and incubated at 
~20°C before harvesting for data collection. Crystals were cryoprotected by 25% glycerol 
prior to vitrification in liquid nitrogen. 
  To obtain the NahE structure with (R)-4-hydroxy-4-(2-hydroxyphenyl)-2-
iminobutanoate bound (NahE-HN), an apo crystal of NahE was soaked in the mother 
liquor containing HBP (5 mM) for ~30 min. For obtaining the structure of NahE in 
complex with salicylaldehyde and pyruvate (NahE-SP), an apo crystal was soaked for 19 
min in HBP. For the solution of NahE in complex with BP (NahE-BP), an apo crystal of 
NahE was soaked with 10 mM BP in mother liquor overnight (~20 h). To obtain the 
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crystal structure of NahE modified by salicylaldehyde at Lys-183 (NahE-Sal), a crystal 
was soaked in 10 mM salicylaldehyde in mother liquor for 1 h. All crystals were 
cryoprotected by 20-25% glycerol in mother liquor prior to vitrification in liquid 
nitrogen.  
 Data Collection and Structure Determination. X-ray diffraction data for the 
NahE-SeM were collected at Advanced Light Source beamline 8.2.1 (ALS, Berkeley, 
CA) where diffractions in multiple wavelengths were captured. Datasets used for the 
solution of NahE-HN and NahE-SP were collected using ALS beamlines 5.0.3 and 5.0.1. 
Data for NahE-Sal and NahE-BP structures were collected at ALS beamline 5.0.2. 
Statistics for data collection is summarized in Table 2-9 and Table 2-10. 
 Data were indexed, integrated, and scaled using HKL-2000 (Otwinowski & 
Minor, 1997). Phases for Nah-SeM were calculated using Autosol from the Phenix suite 
of programs (Adams et al., 2004) using multiwavelength anomalous dispersion (MAD). 
The final model is refined to 2.0 Å resolution and used as the search model for the other 
complex structures in molecular replacement using Phaser (McCoy, 2007) and Autobuild 
(Terwilliger et al., 2008). Structures were refined using Phenix Refine (Afonine et al., 
2012). Manual model building was done using COOT (Emsley et al., 2010). Model 
structures were evaluated during and after refinement using Molprobity (Chen et al., 
2010). 
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2.2.8 Crystallization, Soaking, and Structure Determination of PhdJ 
 
  Crystallization and Crystal Soaking. The two crystallization conditions that gave 
diffraction-quality crystals of PhdJ were 0.1 M MES (pH 7.0-7.5) with 22-25% PEG 
3350 and 0.1 M MES (pH 6.5-7.5) with 20-21% PEG 6000. The former condition was 
used for structures of native PhdJ (PhdJ) and PhdJ in complex with substrate CBP (in 
two active sites) and products CBA and pyruvate (in the other two active sites, PhdJ-
CBP), and the latter condition was used in structure of PhdJ in complex with the (R)-2-
(3-carboxy-1-hydroxy-3-oxopropyl)benzoate intermediate (PhdJ-CN) and the PhdJ 
structure bound to product o-carboxybenzaldehyde (PhdJ-CBA). Crystals were grown 
using sitting drop vapor-diffusion method at ~20°C.  
  For soaking of crystals for the determination of PhdJ-CBP, CBP (1.2 mg) was 
dissolved in 45 µL dibasic sodium phosphate buffer (100 mM at pH 8-9) and diluted to 
10 mM in mother liquor. An apo PhdJ crystal was soaked for 4 min in this solution. The 
crystal used to obtain the structure of PhdJ-CN was soaked for 30 s in the same CBP 
stock (10 mM) in 0.1 M MES (pH 7.5) made 21% in PEG 6000. The crystal used to 
obtain PhdJ-CBA was soaked with 10 mM CBA in mother liquor for 60 min. The 
crystals were cryoprotected by 20-25% glycerol in mother liquor. 
 Data Collection and Structure Determination. X-ray diffraction data were 
collected at ALS beamline 5.0.3. Data were indexed, integrated, and scaled using HKL-
2000 (Otwinowski & Minor, 1997). The native structure of PhdJ was determined by 
molecular replacement using NahE-SeM as a search model. Complex crystal structures 
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were solved using the native PhdJ structure as a model. Molecular replacement was 
performed using Phaser (McCoy, 2007) and Autobuild (Terwilliger et al., 2008). 
Structures were refined using Phenix Refine (Afonine et al., 2012). Manual model 
building was done using COOT (Emsley et al., 2010). Model structures were evaluated 
during and after refinement using Molprobity (Chen et al., 2010). The statisitics for data 
collection and refinement is summarized in Table 2-11. 
2.2.9 Crystallization, Soaking, and Structure Determination of PhdG  
 
  Crystallization and Crystal Soaking. The diffraction-quality crystals of PhdG 
were obtained in 0.1 M MES (pH 7.0) and 19% PEG 6000. Crystals formed using sitting 
drop at 20°C. The structure of PhdG bound with pyruvate carbinolamine (PhdG-Pyr) 
was soaked in 50 mM sodium phosphate buffer (pH 7.0) made 50 mM sodium pyruvate 
prior to cryo-protection by 20-25% glycerol in mother liquor for 30 min.  
 Data Collection and Structure Determination. X-ray data for PhdG were collected 
at Advanced Light Source beamline 5.0.3 (ALS, Berkeley, CA). Data were indexed, 
integrated, and scaled using HKL-2000 (Otwinowski & Minor, 1997). The native PhdG 
structure was determined by molecular replacement using an apo NahE as a search 
model, and the refined PhdG structure was used as a search model for for PhdG-Pyr.The 
apo structure of PhdG determined was used as a search model in the solution PhdG-Pyr. 
Molecular replacement was performed using Phaser (McCoy, 2007) and Autobuild 
(Terwilliger et al., 2008). Structures were refined using Phenix Refine (Afonine et al., 
2012). Manual model building was done using COOT (Emsley et al., 2010). Model 
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structures were evaluated during and after refinement using Molprobity (Chen et al., 
2010).  The statisitics for data collection and refinement is summarized in Table 2-12. 
 
2.3 RESULTS 
 
2.3.1 Purification and Enzyme Activity of NahE, PhdJ, PhdG 
 
NahE, SeMet NahE, K183A NahE, PhdJ, S278N PhdJ, D282E PhdJ, and PhdG 
were purified to homogeneity, as determined by SDS-PAGE (NahE shown in Figure 2-
1A) and ESI-MS (Section 2.3.5). Peaks observed by ESI-MS were consistent with 
expected monomeric mass values. NahE, PhdJ, and PhdG converted HBP to 
salicylaldehyde and pyruvate, as indicated in the UV-absorbance spectra, where the 
decrease at 296 nm (HBP peak) accompanies an increase at 255 nm (salicylaldehyde 
peak). All reactions in this section were performed in 50 mM sodium phosphate buffer 
(pH 7.0) unless otherwise indicated. 
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Figure 2-1 Purified NahE and absorbance spectra of HBP in the presence of NahE, PhdJ, 
and PhdG. 
A) SDS PAGE of purified NahE. Lane 1: PageRuler Plus Protein Marker, MW from top 
(kDa): 250, 130, 100, 70, 55, 35, 15. Lane 2: 8 µg NahE. Lane 3: 4 µg NahE. Lane 4: 2 
µg NahE. Lane 5: 1 µg NahE. B) HBP (120 µM) with NahE (112 nM) over 60 min. C) E. 
coli crude lysate with expressed PhdJ and HBP (50 µM) at 0 min (red), 58 min (green), 
and purple (20 h). D) HBP (160 µM) and PhdG (1.1 µM) at 0 (blue), 14 (red), and 23 min 
(green). 
 
Non-enzymatic Isomerization of HBP and HCCA. HBP (75 µM) was converted to 
HCCA (Figure 2-2A) at a rate of 2.2 ± 0.6 nM/s, giving a rate constant of 2.9 x 10
-5
 s
-1
. 
HCCA (75 µM) was converted to HBP at a rate of 3.4 ± 0.2 nM/sec giving a rate constant 
2.4 ± 0.3 x 10
-5
 s
-1
.  
Absorbance of HBP basic pH. An absorbance peak is observed near 400 nm under 
alkaline conditions indicating deprotonation of the o-hydroxyl substituent (Figure 2-2B). 
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Figure 2-2 Isomerization of HBP over time and at basic pH.  
A) HBP absorbance when dissolved in 50 mM sodium phosphate buffer (pH 7.0) (blue, 
solid) and after 20 h (red, dashed) B) Absorbance of HBP dissolved in 50 mM sodium 
phosphate buffer at pH 7.0 (blue, solid) and at pH 12.5 (red, dashed). 
 
 NahE was inhibited by salicylaldehyde (Figure 2-3A) with an IC50 near 20 µM. 
Kinetic data at various HBP and salicyaldehyde concentrations show the inhibition is not 
competitive (Figure 2-3B). Increasing HBP concentrations do not overcome inhibition 
by salicyaldehyde, suggesting salicylaldehyde inhibits the enzyme at a potential allosteric 
site, as data for the Pseudomonas vesicularis DSM 6383 homologue suggests (Kuhm, et 
al., 1993). 
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Figure 2-3 A) Initial rates of NahE using HBP (98 µM) with salicyaldehyde in 50 mM 
sodium phosphate buffer (pH 7.0). B) Rates obtained with variable HBP and 
salicylaldehyde (procedure is in Section 2.2.3). 
 
When K183A NahE (11 µM) was added to 50 mM sodium phosphate buffer (pH 
7.0) containing HBP (~100 µM), the observed rate was 2.2% that of the HBP reaction 
with 110 nM wild-type NahE. Additionally, the K183A mutant was not modified by HBP 
or 2-OP in the presence of NaCNBH3 (Table 2-5), whereas wild-type NahE was 
modified. Taken together, these data confirm the importance of Lys-183 in covalent 
catalysis by NahE. CBP was converted to CBA and pyruvate by both NahE and PhdJ, but 
not PhdG (Figure 2-4), whereas BP and trans-cinnamaldehyde (with pyruvate) were 
converted to 2-oxo-6-phenyl-3,5-hexadienoate by all three enzymes (conversion by PhdJ 
and NahE has not been confirmed by NMR, Figure 2-5 and 2-6). trans-4-
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Nitrocinnamaldehyde (with pyruvate) was converted by PhdG to 2-oxo-6-phenyl[4-
nitro]-3,5-hexadienoate (Figure 2-6D). 
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Figure 2-4 Spectra showing the reaction of CBP in the presence of NahE, PhdJ, and 
PhdG. 
 A) Incubation of CBA (50 µM) and pyruvate (2.5 mM) with supernatant of E. coli lysate 
containing expressed NahE after 0 h (solid, blue), 2.5 h (red, dashed), and 25 h (green, 
dotted). B) CBP (128 µM) and 6.5 µg/mL PhdJ (180 nM) after 0 min (blue), 1 min (red), 
2 min (green), and 11 min (purple). C) CBP (87 µM, blue) alone and with PhdG (1.1 
µM) after 0 min (red), 1 min (green), 364 min (purple). 
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Figure 2-5 BP production/consumption by NahE, PhdJ, and PhdG 
A) NahE (39 nM) with benzaldehyde (152 µM) and pyruvate (79 µM) in 100 mM dibasic 
sodium phosphate buffer (pH ~8) after 0 min (blue), 3 min (red), 7 min (green), 21 min 
(blue, dashed), 100 min (green, dashed) B) BP (30 µM) and PhdJ (90 nM) after 0 min 
(blue), 5 min (green), and 122 min (purple). C) BP (blue) and PhdG (1.1 µM) after 0 min 
(red), 3 min (green), and 14 min (purple).  
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Figure 2-6 Absorbance spectra during conversion of trans-cinnamaldehyde and pyruvate 
to 2-oxo-6-phenyl-3,5-hexadienoate by NahE, PhdJ, and PhdG. 
A) trans-cinnamaldehyde (76 µM) and pyruvate (5.9 mM, blue) with NahE (3.5 µM) 
after 0 min (red), 3 min (green), 11 min (purple), 30 min (light blue). B) Same as A, 
except PhdJ (0.69 µM) replaces NahE C) trans-cinnamaldehyde (100 µM) and pyruvate 
(1 mM) (red) with PhdG (1.1 µM) after 0 min (blue), 1 min (orange), 17 min (pink). D) 
trans-4-nitrocinnamaldehyde (~100 µM) and pyruvate (1 mM, blue) with PhdG (1.1 µM) 
after 0 min (purple and light blue), 1 min (orange), and 9 min (pink). 
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NahE, PhdJ, and PhdG did not process trans-cinnamaldehyde, 2-OP, or 4-phenyl-
2-oxo-3-butynoate (POB). NahE did not convert HCCA. Additionally, none of the 
enzymes processed 1-hydroxy-2-naphthaldehye or 2-hydroxy-1-naphthaldehyde in the 
presence of pyruvate.  
 
2.3.2 Steady-State Kinetic Parameters for NahE, PhdJ, PhdJ Mutants, and PhdG 
 
Steady State Kinetic Parameters for NahE Using HBP. The KM value for the 
NahE-catalyzed conversion of HBP to salicylaldehyde and pyruvate is low (1.2 µM), and 
was difficult to measure because of the low absorbance near 1 µM. Coupled assays using 
lactate dehydrogenase and salicyaldehyde dehydrogenase failed to give consistent rates at 
low concentrations. Eventually, an uncoupled assay protocol at low NahE concentration 
(3.2 nM) and at extended time courses allowed rate determination near 1 µM HBP. The 
NahE-catalyzed reaction was also affected by substrate inhibition (Figure 2-7) as HBP 
inhibited NahE with a KI value of 61 ± 9 µM. It is unclear whether the inhibition is 
competitive, where HBP binds distal from the active site (as determined for 
salicylaldehyde) and allosterically decreases activity, or if inhibition is uncompetitive, 
where HBP binds to the pyruvate Schiff base complex, for example, and prevents 
regeneration of the active site. It is possible NahE could be affected by mixed inhibition, 
where both types of inhibition occur simultaneously. 
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Figure 2-7 Initial rates for NahE with HBP reveal the enzyme is inhibited by substrate 
and possesses a low KM value (20-fold less than KI). 
 
Steady state kinetic parameters for these reactions are shown in Table 2-1. These 
values show NahE prefers HBP as a substrate (vs. CBP or BP). The high kcat/KM value for 
NahE using HBP (1  107 M-1s-1) is partly due to the low KM value that is ~100-fold less 
than for CBP and BP (in their conversion to CBA and benzaldehyde, respectively, and 
pyruvate). The kcat/KM value for NahE using HBP is ~10
4
-fold higher than that using CBP 
or BP. The kcat value for NahE using HBP is 45-fold higher than NahE using CBP and 
120-fold higher than NahE using BP. The kcat/KM for PhdJ with CBP is 26-fold higher 
than PhdJ using HBP, mostly due to the higher kcat, and 1000-fold greater than PhdJ using 
BP. 
The kcat/KM value using HBP is 3200-fold higher for NahE than that for PhdJ. The 
difference is due to both kcat and KM, as the kcat for NahE is 42-fold higher than for PhdJ, 
HBP (µM) 
kobs (s
-1
) 
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and the KM value for NahE is 75-fold lower than for PhdJ. The kcat/KM value for PhdJ 
using CBP is 68-fold higher than the kcat/KM for NahE using CBP, due to both kcat and 
KM. The kcat for NahE is decreased 25-fold relative to PhdJ, and the KM increased by 2.6-
fold. The kcat/KM for NahE using BP is 7.6-fold greater than for PhdJ.  
 
Table 2-1 Steady-state parameters of NahE and PhdJ with HBP, CBP and BP.  
 
  NahE PhdJ 
  kcat (s
-1
) KM (μM) kcat/KM (M
-1
s
-1
) kcat (s
-1
) KM (μM) kcat/KM (M
-1
s
-1
) 
HBP 11.7 ± 0.6 1.2 ± 0.2 (1.0 ± 0.2)  107 0.28 ± 0.04 90 ± 20  (3.1 ± 0.8)  103 
CBP 0.26 ± 0.06 210 ± 60 (1.2 ± 0.5)  103 6.5 ± 0.4 79 ± 7 (8.2 ± 0.9)  104 
BP 0.10 ± 0.01 160 ± 20 600 ± 100 Did Not Saturate 79 ± 1 
 
 
Comparison of the S278N and D282E PhdJ Mutants Using HBP. Steady state 
kinetic parameters for the S278N and D282E PhdJ mutants are shown in Table 2-2. The 
KM values for S278N and D282E mutants with HBP are 2-fold lower than for wild-type, 
and the kcat values are reduced 54- and 35-fold, respectively. The S278N and D282E 
mutants were designed to the mimic residues of NahE interacting with the o-hydroxyl 
group of HBP. The parameters consistent with the residues being more significant in the 
binding of HBP than turnover. The kcat/KM value for the S278N and D282E PhdJ mutants 
using HBP is 24-fold and 16-fold less than wild-type. The kcat/KM value for NahE is ~10
4
-
fold greater than the values for S278N PhdJ and D282E PhdJ. 
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Comparison of the S278N and D282E PhdJ Mutants Using CBP. The kcat/KM 
value of the S278N and D282E PhdJ mutants for conversion of CBP to CBA and 
pyruvate are reduced 23-fold and 1500-fold, respectively, compared to wild-type. These 
values demonstrate the importance of Asp-282 in the PhdJ conversion of CBP (to CBA 
and pyruvate) relative to HBP or BP. The kcat/KM value for S278N PhdJ using CBP is 3-
fold greater than that for NahE, but the kcat/KM  for the D282E mutant using CBP is 23-
fold less than that for NahE.  
Comparison of the S278N and D282E PhdJ Mutant Using BP.  The kcat/KM values 
for the S278N and D282E PhdJ mutants in their conversion of BP to benzaldehyde and 
pyruvate were 2.2-fold and 34-fold greater than that for wild-type PhdJ. These increases 
in kcat/KM values when arranging the PhdJ active site to be more NahE-like make the 
values using BP closer to those determined for wild-type NahE. The kcat/KM for S278N 
PhdJ is 3.5-fold less than that for NahE, and the value for D282E PhdJ is 4.5-fold greater 
than for NahE. 
 
Table 2-2 Kinetic parameters of the S278N and D282E PhdJ mutant using HBP, CBP, 
and BP. 
 
  PhdJ S278N PhdJ D282E 
  kcat (s
-1
) KM (μM) kcat/KM (M
-1
s
-1
) kcat (s
-1
) KM (μM) kcat/KM (M
-1
s
-1
) 
HBP (5.2 ± 0.4)  10-3 39 ± 6 130 ± 40 (8 ± 1)  10-3 40 ± 10  200 ± 60 
CBP Not Detectable (3.6 ± 0.3)  103 Not Detectable 53 ± 7 
BP Not Detectable 170 ± 2 Not Detectable (2.7 ± 0.1)  103 
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 Comparison of Wild-type Enzymes Using BP. The kcat value for the PhdG 
conversion of BP to benzaldehyde and pyruvate is ~4.5-fold greater than for NahE, where 
the KM is about three-fold lower, giving a kcat/KM that is 15-fold higher. The kcat/KM value 
for PhdG using BP is 110-fold greater than with PhdJ.  
Table 2-3 Steady-state parameters of PhdG using BP. 
 
kcat (s
-1
) Km (μM) kcat/Km (M
-1
s
-1
) 
BP 0.44 ± 0.08 50 ± 10 (9 ± 2)  103 
 
 
2.3.3 Steady-State Kinetic Parameters of NahE and PhdG Using Pyruvate and an 
Aldehyde 
 
 
 Initial rates for NahE- and PhdG-catalyzed conversion of salicyaldehyde and 
cinnamaldehyde, respectively, with pyruvate to form HBP and 2-oxo-6-phenyl-3,5-
hexadienoate, respectively, were plotted with respect to both substrates (Figure 2-8A,B), 
and fit to eq. 2 (Section 2.2.3), used for ping-pong mechanisms. The kinetic parameters 
for NahE and PhdJ using salicylaldehyde and cinnamaldehyde, and pyruvate, are 
summarized in Table 2-4. 
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Figure 2-8 3-D plot of kobs vs. conc. and fits to bisubstrate reactions.  
A) NahE using salicyaldehyde (sal) and pyruvate (pyr) and B) PhdG using 
cinnamaldehyde (cin) and pyruvate. 
 
 
 Comparison of NahE- and PhdJ-catalyzed Aldol Condensation Reactions. The 
affinity of hydratase-aldolases and pyruvate varies in the low mM range. KM,pyr for PhdG 
[sal] (µM) 
[pyr] (mM) 
kobs (s
-1
) 
[pyr] (µM) 
[cin] (µM) 
kobs (s
-1
) 
A 
B 
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is 22-fold less than that for NahE. For NahE, the KM,pyr value is 750-fold greater than 
KM,ald. For PhdG, the KM,pyr value is 2.3-fold greater than that for KM, ald. 
 
Table 2-4 NahE and PhdG kinetic constants with aldehyde (ald, specifically 
salicylaldehyde and cinnnamaldehyde, respectively) and pyruvate.  
Enzyme kcat (s
-1
) KM, ald. (μM) KM, pyr. (μM) kcat/KM, ald (M
-1
s
-1
) kcat/KM, pyr (M
-1
s
-1
) 
NahE 18.7 ± 0.5  8 ± 1 (6.0 ± 0.4)  103 (2.3 ± 0.3)  106 (3.1 ± 0.2)  103 
PhdG 20 ± 2 120 ± 20 270 ± 50 (1.7 ± 0.3)  105 (7 ± 2)  104 
 
 
2.3.4 
1
H NMR Spectrometric Analysis of Reactions Catalyzed by NahE, NahD, 
PhdJ, and PhdG  
 
  
1
H NMR Analysis of NahE-catalyzed Reactions. 
1
H NMR peak integrations for 
pyruvate (product) formation in three reactions were compared to the integrations of 
substrate peaks after 33 min. HCCA was converted to salicylaldehyde and pyruvate and 
was 9.7 % complete after 33 min (Figure 2-9A) in the presence of NahE. HBP was 
converted to salicylaldehyde and pyruvate and 16% complete at 33 min (Figure 2-9B) in 
the presence of NahE. A mixture of HCCA/HBP was converted fastest to salicylaldehyde 
and pyruvate (26% complete after 33 min, Figure 2-9C) in the presence of isomerase 
NahD and NaheE. An aldehyde peak is barely visible in a spectrum of the nonenzymatic 
control which was recorded after an overnight incubation, showing that the non-
enzymatic rate is slow compared to reactions with NahE. NMR was used to confirm 
catalysis in the reverse direction, and for NahE conversion of benzaldehyde and pyruvate 
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to BP.  
1
H NMR chemical shifts for HBP and HCCA are reported in Section 2.2.2. 
salicylaldehyde: 
1
H NMR (H2O, 600 MHz)  6.794 (1H, d, J = 9.0), 6.862 (1H, t, J = 
7.47 Hz), 7.411 (1H, t, J = 7.77 Hz), 7.539 (1H, d, J = 7.74 Hz), 9.770 (1H, s) pyruvate: 
1
H NMR (H2O, 600 MHz)  2.168 (3H, s); benzaldehyde: 
1
H NMR (H2O, 600 MHz)  
9.749 (1H, s), 7.778 (2H, d, J = 7.44 Hz), 7.577 (1H, t, J = 7.39 Hz), 7.443 (2H, t, J = 
7.43) 
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Figure 2-9 
1
H NMR spectra of NahE and NahD using HBP and HCCA.  
A) NahE (16 µM) and HCCA (30 mM) B) NahE (16 µM) and HBP (30 mM) C) 
HCCA/HBP equilibrium (30 mM), NahE (16 µM) and NahD (~5 µM). 
 
A 
B 
C 
HBP 
HBP HCCA 
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1
H NMR Analysis of PhdJ-catalyzed Reactions. 
1
H NMR spectra following CBP 
with PhdJ indicated that CBP was consumed and CBA and pyruvate were produced over 
the course of 33 min. NMR was used to confirm catalysis in the reverse direction. 
1
H 
NMR chemical shifts for CBP are reported in Section 2.2.2. CBA: 
1
H NMR (H2O, 600 
MHz)  9.99 (1H, s), 7.68 (1H, d, J = 7.694 Hz), 7.5196 (1H, t, J = 8.002 Hz), 7.3862 
(1H, d, J = 7.694 Hz);  
  
1
H NMR Analysis of PhdG-catalyzed Reactions. 
1
H NMR spectra indicated BP 
was processed by PhdG to form benzaldehyde and pyruvate (chemical shifts for 
benzaldehyde and BP are reported above and in Section 2.2.2, respectively) over the 
course of 33 min. trans-Cinnamaldehyde and pyruvate conversion by PhdG to 2-oxo-6-
phenyl-3,5-hexadienoate was monitored by 
1
H NMR over the course of 33 min.
 
2-oxo-6-
phenyl-3,5-hexadienoate:
 1
H NMR (H2O, 600 MHz)  6.20 (1H, d, J = 15.58 Hz), 6.92-
7.03 (2H, m), 7.20-7.35 (4H, m), 7.196 (1H, td, J = 7.77 Hz, 1.65 Hz), 7.469 (1H, dd, J = 
7.86 Hz, 1.62 Hz), 7.425 (1H, s), 7.438 (1H, s).  
2.3.5 Modification of NahE, PhdJ, and PhdG by Various Aldehydes and α-Keto 
Acids 
 
 UV/Vis Spectra of NahE in the Presence of Salicylaldehyde, Benzaldehyde, and 
CBA. When salicylaldehyde (173 µM) was incubated with NahE (86.5 µM), the initial 
peak near 325 nm decreased and a peak emerged near 400 nm over the course of 90 min 
(Figure 9-10A). This indicates Schiff base formation between salicylaldehyde and NahE, 
similar to the absorbance spectra observed during Schiff base formation in PLP-
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dependent enzymes (Osterman et al., 1999). Similar absorbance changes were not 
observed when benzaldehyde or CBA (173 µM) were incubated with NahE (86.5 µM) for 
the same length of time (Figures 9-10B,C). 
 
 
Figure 2-10 UV/Vis spectra of NahE and aldehyde substrates/products.  
NahE (85.6 µM) in the presence of A) salicylaldehyde (173 µM); B) benzaldehyde (173 
µM) at 0 min (blue), 15 min (red), 30 min (green), 60 min (light blue), and 120 min 
(orange); C) and CBA at 0 min (blue), 15 min (red), 30 min (green), and 44 min (light 
blue). 
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 UV/Vis Spectra of PhdJ in the Presence of Salicylaldehyde, Benzaldehyde, and 
CBA. When salicylaldehyde (173 µM) was incubated with PhdJ (86.5 µM), the initial 
peak at 325 nM decreased and a new peak emerged near 400 nm over the course of 30 
min, indicating a Schiff base had formed with salicylaldehyde and the enzyme (Figure 9-
11A). Since the spectra at 15 min and 30 min are almost identical, equilibrium was 
reached in the first 15 min. The rate of Schiff base formation with salicyaldehyde was 
faster for PhdJ than that for NahE using the same concentration of salicylaldehyde and 
enzyme. Schiff base formation with benzaldehyde and CBA did not occur for PhdJ with 
the same amounts of enzyme and aldehyde during a similar time period (1-2 h) (Figures 
9-11B,C). 
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Figure 2-11 UV/Vis spectra of PhdJ and aldehyde substrates/products. 
PhdJ (86.5 µM) with A) salicylaldehyde (173 µM), at 0 min (blue), 15 min (red), 30 min 
(green); B) benzaldehyde (173 µM) after 0 min (blue), 15 min (red), 30 min (green); C) 
CBA (173 µM) after 0 min (blue), 30 min (green), and 884 min (light blue). 
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 Modification of NahE in the Presence of NaCNBH3. NahE was incubated with 
HBP, salicylaldehyde, pyruvate, 2-OP, and POB in the presence of NaCNBH3 and the 
residual activity was significantly decreased compared to the control sample with only 
NaCNBH3 treatment (no other added compound). Mass increases in samples correspond 
to each added compound (except NaCNBH3) minus one oxygen atom (within 5 Da), 
NahE had been modified by each compound with the loss of water (Table 2-5). 
Incubation of NahE with HBP resulted in mass increases corresponding to imine adducts 
with both HBP and pyruvate, showing HBP was occasionally processed before reduction 
of the Schiff base. Incubation of pyruvate with the enzyme resulted in mass increases 
indicative of labeling at one and two sites. Labeling with POB resulted in labeling at up 
to four sites. The observed mass of singly-labeled NahE indicated loss of an oxygen 
atom, whereas all other modifications occurred without this loss, suggesting Lys-183 
forms a Schiff base with POB, followed Micheal addition to the acetylene compound by 
other nucleophilic amino acids of NahE. 
 
Table 2-5 ESI-MS signal peak values with modification of NahE using NaCNBH3.  
Modification of NahE in the presence of NaCNBH3 
modifier calculated mass
a
  
observed mass 
(unmodified) 
observed mass 
(modified) 
difference 
None 36636.9 36641.0 not observed - 
HBP
b
 36813.1 36641.0 36818.0 177.0 
sal 36743.0 36641 36744 103.0 
pyr
c 
36709.0 not observed 36710 69.0 
2-OP 36733.0 36641.0 36735.0 94.0 
POB
d
 36809.1 not observed 36807.0 166.0 
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Table 2-6 ESI-MS signal peak values with modification of K183A NahE using 
NaCNBH3.  
 
Modification of NahE K183A in the presence of NaCNBH3 
modifier calculated mass  
observed mass 
(unmodified) 
observed mass 
(modified) 
difference 
No Treatment 36579.8 36585.0 not observed - 
HBP
e
 36756.0 36580.0 not observed - 
2-OP 36675.9 36585.0 not observed - 
a
The calculated mass is without the N-terminal Met and accounts for the loss of an oxygen atom. 
b
A peak was observed at 36716 consistent with modification by pyruvate. 
 cA second modification by pyruvate was observed at 36783. 
  dModification occurred with the loss of oxygen on first of four modifications. NaCNBH3 was not used. 
e
The peak at 36614.0 (+34) is likely TFA contamination. 
 
 
  ESI MS/MS analysis found Lys-183 was labeled with pyruvate 10-fold more 
frequently than other lysine residues (Figure 2-12). Further evidence of Schiff Base 
formation occurs with Lys-183 comes from the observation that HBP and 2-OP did not 
label K183A NahE in the presence of NaCNBH3 (Table 2-6). 
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Figure 2-12 ESI-MS/MS spectrum of fragments from modified NahE incubated with 
pyruvate and NaCNBH3. 
 
 PhdJ was incubated with CBP, CBA, and pyruvate in the presence of NaCNBH3, 
and residual activity significantly decreased when compared to a control without added 
substrate or product with NaCNBH3. Observed monomeric mass values (Table 2-7) 
indicated the labeling of these compounds occurred with oxygen loss, presumably 
through Schiff base formation with Lys-180.  
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Table 2-7 ESI-MS signal peak values with modification of PhdJ using CBP, CBA, and 
pyruvate in the presence of NaCNBH3.  
Modification of PhdJ in the presence of NaCNBH3 
modifier calculated massa  
observed mass 
(unmodified) 
observed mass 
(modified) 
difference 
No treatment 35966.8 35967 - - 
CBP
b
 36168.0 35967 36173 206.0 
CBA
c
 36109.9 not observed 36102 
 
Pyruvate
d
 36037.9 35967 36039 72.0 
a
The calculated mass is without the N-terminal Met and accounts for the loss of an oxygen atom. 
b
Peaks observed at 36099 and 36233. 
   cPeaks observed at 36140, 36235, 36274, 36268, 36406, 36502, and 38640. 
 dA second modification by pyruvate was observed at 36112. 
   
  
 PhdG was incubated with 2-OP, POB, and pyruvate in the presence of NaCNBH3 
and residual activity significantly decreased compared to the control with NaCNBH3 
treatment only (no modifier). Observed monomeric mass values from ESI-MS data 
indicated these compounds modified PhdG with the loss of oxygen, likely via Schiff base 
formation with Lys-180 (Table 2-8). PhdG was not modified when incubated with CBP 
with NaCNBH3. 
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Table 2-8 ESI-MS signal peak values with modification of PhdG                                  
using various compounds in the presence of NaCNBH3.  
Modification of PhdG in the presence of NaCNBH3 
modifier 
calculated 
massa  
observed mass 
(unmodified) 
observed mass 
(modified) 
difference 
No treatment 37454 37455 - - 
2-OP 37546 37454 37548 94 
POB
b
 37628 37455 37623 168 
Pyruvate 37627 37456 37528 72 
a
The calculated mass is without the N-terminal Met and accounts for the loss of an oxygen atom. 
b
Peaks observed at 37492 and 37651 may be a result of TFA contamination. 
    
2.3.6 Dynamic Light Scattering 
 
 Two peaks were observed in the LC chromatograph (19.9 min and 22.4 min) for 
NahE. The first peak (97.5% mass fraction) had a molar mass moment of 145700 Da. 
This species is likely the tetrameric form of NahE (predicted MW: 146548 Da). The 
second peak (2.5% mass fraction) had a molar mass of 36660 Da and this species is 
presumed to be monomeric NahE, as its predicted monomeric mass is 36637. For PhdJ, 
four absorbance peaks in the LC chromatogram were observed (15.7, 16.9, 19.2, and 20.5 
min). The second peak was the largest (88.0% mass fraction) with a molar mass moment 
of 138,300 Da. This molecular weight corresponds to the tetrameric state of PhdJ 
(predicted MW: 143995 Da). The fourth peak (4.8% mass fraction) had a molar mass 
moment of 421,500 Da and is consistent with trimerization of tetramers (predicted MW: 
431956). The other two peaks that contained 7.2% of the mass of the sample are likely 
𝑘𝑜𝑏𝑠
=
𝑘𝑐𝑎𝑡[𝑝𝑦𝑟][𝑠𝑎𝑙]
𝐾𝑝𝑦𝑟[𝑠𝑎𝑙] + [𝑝𝑦𝑟][𝑠𝑎𝑙] + [𝑝𝑦𝑟][𝐾𝑠] 
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due to impurities from the protein preparation. A single peak in the LC chromatogram for 
PhdG had a molar mass moment of 146700 Da, which corresponds to the tetrameric form 
of PhdG (predicted MW: 147160 Da). 
2.3.7 Crystal Structures of NahE 
 
 The structure of NahE was solved to identify primary active site residues (those 
binding the pyruvate moiety) and secondary active site residues (not conserved within the 
NAL subgroup) and to determine their roles in substrate binding and turnover. The SeMet 
derivative was solved at 1.9 Å resolution by Multiwavelength Anomolous Dispersion 
(MAD), with two monomers per asymmetric unit. The structure is a tetramer (Figure 2-
13A) composed of (α/β)8 barrels containing 3 C-terminal helices (Figure 2-13B). Crystal 
structures of NahE in complex with intermediates of the HBP- and BP-catalyzed 
reactions were obtained through soaking experiments and solved by molecular 
replacement using a Native NahE structure. 
 NahE and SeMet NahE formed rhombohedral crystals within a few days. The 
SeMet structure (NahE-SeM) was solved in the P3221 space group (as were all NahE 
structure presented here) using MAD. NahE-SeM is structurally homologous to NAL and 
DHDPS (Section 1.4), as the monomeric RMSD value is 2.18 Å for NAL (PDB entry 
1NAL) and 1.68 Å for DHDPS (PDB entry 1DHP). Significant deviations for NahE-SeM 
are seen in the loops and helices near the N-terminus of the β-barrel (Figure 2-13C). The 
active site of NahE-SeM shows Lys-183, Tyr-155, and Thr-65 and Phe-66 in the GXXGE 
motif, cores residues conserved in NAL subgroup members (Figure 2-13D). The active 
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site also contains secondary residues that are not conserved in the NAL family including 
Trp-128ʹ, Asn-157, Asn-281, Trp-224, Glu-285, and Arg-288. 
 
 
Figure 2-13 The 1.9 Å resolution crystal structure of NahE-SeM.  
A) The NahE-SeM tetramer. B) NahE-SeM monomer with Tyr-155 and Lys-183 shown 
as sticks. C) Alignment of NahE-SeM (forest), NAL (marine, PDB entry 1NAL), and 
DHDPS (yellow orange, PDB entry 1DHP) D) Active site of NahE-SeM. 
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  A crystal structure of NahE in complex with (R)-4-hydroxy-4-(2-hydroxyphenyl)-
2-iminobutanoate (HN, for o-hydroxyl intermediate), the intermediate in the reaction 
with HBP was solved at 2.1 Å resolution by crystal soaking experiments with HBP. The 
ligand HN is bound to the enzyme via an imino linkage with Lys-183 (Figure 2-14A,B). 
The hydroxyl group at C-4 is in the (R) configuration and forms hydrogen bonds with the 
side chain hydroxyl group of Tyr-155 and the side chain amide nitrogen of Asn-157. 
Interactions between Trp-128ʹ, Tyr-155, the GXXGE motif, and the C-1 carboxylate 
group are like those observed for NAL, DHDPS, and D-2-keto-3-deoxygluconate aldolase 
(KDGA) (Figure 2-14A,B). The side chain amide nitrogens Asn-157 N and Asn-281 
donate a hydrogen bond to a water molecule near the C-4 hydroxyl group of the 
intermediate. The o-hydroxyl group on the aromatic ring of the intermediate forms 
hydrogen bonds with one side chain carboxylate of Glu-285. This carboxylate is 
stabilized by the side chains of Ser-226 and Arg-288 (N). An α-helix extends over the 
C-terminus of the β-barrel bringing Phe-269, Phe274, and Phe277 near Lys-183, 
potentially increasing the hydrophobicity of the active site (Figure 2-14C). The distance 
of the o-hydroxyl group and C-3 of the intermediate is 3.1 Å, which makes the group a 
possible proton donor to C-3 during the addition of water. Another candidate for the 
proton donor is the hydroxyl group of Tyr-155, which is 3.9 Å from C-3. 
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Figure 2-14 Active site of the 2.1 Å resolution NahE-HN crystal structure. 
A) Continuous 2Fo-Fc electron density around Lys-183 and HN, contoured at 1.0 . B) 
Diagram of interactions near HN in the active site of NahE-HN. Distances are in Å. C) 
Phenylalanine residues near HN. 
 
  Another crystal structure of NahE (2.3 Å resolution) obtained in soaking 
experiments using HBP showed HN in one active site and a pyruvoyl adduct and 
salicyaldehyde in another active site (NahE-SP). A comparison of this structure, NahE-
SP, to NahE-HN, shows similar interactions with the pyruvoyl moiety (Figure 2-15A,B). 
Additionally, the hydrogen bond formed between the o-hydroxyl group of intermediate 
HN and the side chain carboxylate of Glu-285 in NahE-HN is likely the one formed for 
the hydroxyl group of salicyaldehyde NahE-Sal. The side chain amide nitrogen of Asn-
157 is 3.4 Å from the side chain hydroxyl group of Tyr-155, similar to the 3.3 Å distance 
in NahE-HN, but there is no longer a water molecule bridging the side chain amide 
nitrogen of Asn-157 (N) and Asn-281 (N). Interactions in NahE-SP between the o-
hydroxyl group of salicylaldehyde, and side chains of Ser-226, Glu-285, and Arg-288 
(N) are resembles those seen in NahE-HN. 
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Figure 2-15 Active site of the 2.3 Å resolution crystal structure of NahE-SP. 
A) 2Fo-Fc electron density map, countered at 1.0 , surrounding Lys-183, the pyruvoyl 
adduct, and the product salicyaldehyde. B) Map of interactions in an active site of NahE-
SP containing salicylaldehyde and pyruvate imine. 
 
 
B 
A 
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Data Collection NahE-SeM NahE-HN NahE-SP 
space group P3221 P3221 P3221 
cell dimensions 
             a, b, c (Å) 85.31, 85.31, 133.31 88.00, 88.00, 141.60 84.97, 84.97, 132.72 
          α, β, γ (deg) 90.00, 90.00, 120.00 90.00, 90.00, 120.00 90.00, 90.00, 120.00 
resolution (Å) 1.94-40.00 2.10 - 50.00 2.30-50.00 
Rsym (%)  
(linear R factor) 0.150 (0.506) 0.129 (0.854) 0.128 (0.335) 
I/σ 15 (4.5) 21 (2.3) 21 (4.47) 
completeness (%) 100.0 (100.0) 100.0 (100.0) 97.7 (53.8) 
    Refinement       
resolution (Å) 38.09-1.94  44.01-2.10 49.30-2.32 
no. of reflections 42138 37513 24619 
Rwork/Rfree (%) 13.55/18.63 20.09/22.88 15.74/21.03 
no. of atoms 
             protein 5053 5496 5032 
          water 650 439 324 
Average B factor (Å
2
) 
             protein 14.1 33.1 23.4 
          water 26.6 35.9 28.7 
rmsd 
             bond lengths (Å) 0.010 0.005 0.006 
          bond angles (deg) 1.140 0.869 1.032 
Ramachandran plot (%) 
             favored regions 98.3 98.1 98.0 
          allowed regions 1.7 1.9 2.0 
          disallowed regions 0.0 0.0 0.0 
Data for the last resolution shell are given in parentheses. 
  
Table 2-9 Crystallographic data and refinement statistics for NahE-SeM, NahE-HN, and 
NahE-SP. 
 
  A crystal structure of NahE (2.9 Å resolution) covalently linked to salicyaldehyde 
via Lys-183 (NahE-Sal) was obtained by soaking experiments. The o-hydroxyl group of 
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the covalent adduct likely hydrogen bonds (3.1 Å) with the backbone amide proton of 
Thr-65 (Figure 2-16). Due to the low resolution of NahE-Sal, it is possible that the o-
hydroxyl is pointing in the opposite direction. 
 
Figure 2-16 Active site of the 2.9 Å resolution crystal structure of NahE-Sal. 
2Fo-Fc electron density map surrounds Lys-183 and salicyaldehyde, contoured at 1.5 .  
 
  A crystal structure of NahE was solved to 1.9 Å resolution with active site 
electron density corresponding to BP and the products benzaldehyde and pyruvate. The 
structure was obtained by soaking NahE crystals in BP. When the structure was modeled 
to include BP (NahE-BP, Figure 2-17A), C-4 is much further from the hydroxyl group 
of Tyr-155 than the distance in NahE-HN (Figure 2-25). The 2Fo-Fc electron density 
maps show decreased density between C-3 and C-4 of BP in NahE-BP, indicating that 
NahE has processed BP. The strcture was modeled to indlude the pyruvate-Lys-183 
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Schiff base moiety and benzaldehyde in a separate refinement (NahE-BPy). When the 
pyuvoyl adduct and benzaldehyde were included in modeling, the carbonyl oxygen of 
benzaldehyde is hydrogen bonded to the side chain oxygen atoms of Asn-281 and Glu-
285.  
 
 
Figure 2-17 The 1.9 Å resolution crystal structures of NahE-BP and NahE-BPy  
The same experimental data was used for modeling of A) BP adduct (NahE-BP) and B) 
pyrovoyl adduct and product benzaldehyde (NahE-BPy). 2Fo-Fc electron density 
surrounds the ligands, contoured at 1.0 . 
 
 
 
 
 
 
 
B A 
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Data Collection NahE-Sal NahE-BP NahE-BPy 
space group P3221 P3221 
cell dimensions 
             a, b, c (Å) 88.136, 88.136, 141.19 84.609, 84.609, 132.53 
          α, β, γ (deg) 90, 90, 120 90, 90, 120 
resolution (Å) 2.88-40.00 1.90-50.00 
Rsym (%) (linear R factor) 0.116 (0.435) 0.084 (0.549) 
I/σ 11 (2.9) 18 (3.1) 
completeness (%) 97.4 (96.5) 100.0 (100.0) 
    Refinement  NahE-SAL NahE-BP  NahE-BPy  
resolution (Å) 40.06-2.91 49.15-1.90 49.15-1.90 
no. of reflections 14261 43849 43849 
Rwork/Rfree (%) 19.31/24.96 16.35/19.98 15.75/19.35 
no. of atoms 
             protein 5020 5044 5030 
          water 22 358 383 
Average B factor (Å
2
) 
             protein 46.0 36.7 36.4 
          water 29.0 39.8 40.5 
rmsd 
             bond lengths (Å) 0.003 0.006 0.010 
          bond angles (deg.) 0.708 0.960 1.130 
Ramachandran plot (%) 
             favored regions 96.3 98.0 98.0 
          allowed regions 3.7 2.0 2.0 
          disallowed regions 0.0 0.0 0.0 
Data for the last resolution shell are given in 
parentheses. 
  
Table 2-10 Crystallographic data and refinement statistics for NahE-Sal, NahE-BP, and 
NahE-BPy. 
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2.3.8 Crystal Structures of PhdJ 
 
  The crystal structure of PhdJ was solved in order to determine a structural basis 
for the substrate preference (i.e. CBP vs. HBP) and to better understand its ability to 
activate water. Structures of native PhdJ and PhdJ in complex with CBP, the 4-hydroxy 
intermediate, CBA, and pyruvate were obtained by soaking experiments. Phases for all 
PhdJ structures were solved using molecular replacement. NahE was used as a search 
model for PhdJ, and all PhdJ complexes were solved using native PhdJ as a search model. 
All PhdJ crystals grew in the P21 space group with four monomers per asymmetric unit. 
Like NahE, the enzyme is a tetramer and shows the primary active site residues 
conserved in the NAL subgroup: Lys-180, Tyr-152, and the GXXGE motif, where the 
XX residues are Thr-65 and Phe-66 (Figure 2-18A,B,D). Trp-125ʹ, Asn-154, Ser-278, 
and Asp-282 are secondary residues, although Asn-154 is conserved in NahE. Although 
the monomeric structure deviates slightly from DHDPS, the triose phosphate isomerase 
barrel and C-terminal helices remain intact (RMSD for PhdJ and DHDPS is 4.3 Å and the 
RMSD for PhdJ and NAL is 1.7 Å, Figure 2-18C). 
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Figure 2-18 The 2.1 Å resolution crystal structure of PhdJ. 
A) The PhdJ tetramer (rainbow gradient from blue N-terminus to red C-terminus) with 
transparent surface shown. B) PhdJ monomer with Lys-180 and Tyr-152 shown in sticks. 
C) Alignment of PhdJ (slate), NAL (marine, PDB entry 1NAL), and DHDPS (yellow 
orange, PDB entry 1DHP) D) Active site of PhdJ. 
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 The structure of PhdJ in complex with CBP (PhdJ-CBP) was obtained by soaking 
experiments. The 2.0 Å structure has 4 monomers per asymmetric unit where two active 
sites show CBP and the two other active sites have pyruvate and CBA. The interaction of 
the C-1 carboxylate of CBP with active site residues of PhdJ is similar to those observed 
for NahE, DHDPS, NAL, and KDGA. A C-1 carboxylate oxygen hydrogen bonds with 
the backbone amide hydrogens of Thr-62 and Phe-63, as well as the side chain hydroxyl 
of Tyr-152 (Figure 2-19A,B).  
 A water molecule (W1) is 3.6 Å from the benzylic carbon, near the C-4 carbon 
where addition occurs. Its position is, however, in plane with the double bond, implying 
that a conformational change must occur before hydration, so that the water is added on 
the Re-face, as deduced by the configuration of the 4-hydroxy intermediate (Figure 4-
20). W1 is coordinated by W5, the side chain nitrogen of Asn-154, and the o-carboxylate 
oxygen of the substrate. If W1 is adds to C-4 of the CBP adduct, both W5 and the 
carboxylate group are capable of accepting a proton from W1. Protonation at C3 might be 
facilitated by the side chain of Tyr-152 (4.1 Å from C-4) or the o-carboxylate (3.4 Å from 
C-4) (Section 2.4.3). A small helix at the C-terminus of the β-barrel resembles the helix 
observed in the NahE structures, and might seclude the active site from solvent. The helix 
has four nonpolar residues (Tyr-266, Phe-271, Phe-274, and Leu-275) on the face of the 
helix near Lys-183, which might increase the hydrophobicity of the binding pocket 
(Figure 2-19C). 
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Figure 2-19 Active site of the 2.0 Å resolution PhdJ-CBP crystal structure.  
A) Continuous 2Fo – Fc electron density, contoured at 1.0 , surrounding Lys-183 and 
CBP. B) Diagram of interactions near CBP with hydrogen bonds represented as dashes, 
except for the red dash from W1 the the benzylic carbon of CBP. Distances are in Å. C) 
Hydrophobic residues of α-helix 10 in the active site. 
 
 The structure of PhdJ in complex with (R)-2-(3-carboxy-1-hydroxy-3-
oxopropyl)benzoate (CN, for o-carboxy intermediate) was solved to 2.0 Å resolution via 
after soaking crystals with CBP (PhdJ-CN, Figure 2-20B). The hydroxyl oxygen of the 
intermediate is hydrogen bonded to the side chain nitrogen of Asn-154 and side chain 
hydroxyl of Tyr-152 (Figure 2-20A,B). The o-carboxyl group of CN is positioned 
perpendicular the aromatic ring, and closer to the side chain of Asp-282 than is observed 
for the CBP adduct in PhdJ-CBP. 
 
L206 
C 
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Figure 2-20 Active site of the 2.0 Å resolution PhdJ-CN crystal structure. 
A) 2Fo-Fc electron density map (0.5 ) surrounding CN, Schiff base linkage with Lys-
180, and W1. B) Diagram of interactions with CN. Distances are in Å.  
A 
B 
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 Two monomers of PhdJ-CBP contain CBA and pyruvate (Figure 2-21A). The 
interactions of the o-carboxylate oxygen atoms of CBA with the side chain of Asp-282 
are similar to that observed in PhdJ-CN (Figure 2-21B).  
 
 
Figure 2-21 Active site of PhdJ-CBP with pyruvate and CBA. 
A) 2Fo-Fc continuous electron density surrounding Lys-183, the pyruvoyl adduct, and 
CBA. B) Diagram of interactions near products in active site with distances in Å.  
A 
B 
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 A crystal structure PhdJ attached to the benzylic carbon of CBA (PhdJ-CBA) 
was determined after soaking experiments using CBA. The 2.2 Å resolution crystal 
structure shows that Lys-180 forms Schiff base with CBA in the active site. The 
carboxylate group of the ligand is pointed outwards toward the active site opening and is 
coordinated to side chain amide nitrogen of Asn-154 and a water molecule. The 
hydrophobic ring is sandwiched between Thr-62 and Phe-63 in the GXXGE motif.  
 
 
Figure 2-22 Active site of the 2.2 Å resolution PhdJ-CBA crystal structure with 2Fo-Fc 
electron density map (0.5 ) of surrounding CBA and the Schiff base 
linkage to Lys-180. 
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Data Collection PhdJ PhdJ-CBP PhdJ-CN PhdJ-CBA 
space group P21 P21 P21 P21 
cell dimensions 
    
          a, b, c (Å) 52.4, 137.0, 88.3 52.5, 137.2, 88.3 52.5, 137.2, 88.4 52.3, 136.9, 88.2 
          α, β, γ (deg) 90.0, 99.1, 90.0 90.0, 98.9, 90.0 90.0, 98.9, 90.0 90.0, 99.0, 90.0 
resolution (Å) 40.00-2.05 50.00-2.00 40.00-2.00 2.06-50.00 
Rsym (%) (linear R factor) 0.104 (0.496) 0.087 (0.326) 0.082 (0.222) 0.116 (0.492) 
I/σI  11 (2.1) 14 (3.2) 14 (4.5) 11 (2.5) 
completeness (%) 94.3 (83.6) 93.5 (88.7) 99.9 (99.9) 100.0 (99.9) 
     Refinement 
       
resolution (Å) 39.90 - 2.05 45.30-2.00 39.32-2.00 39.85-2.21 
no. of unique reflections 72626 77202 82301 61343 
Rwork/Rfree (%) 17.95/22.39 15.21/18.93 17.03/19.96 16.84/20.58 
no. of atoms 
    
          protein 9893 9960 9997 9985 
          water 894 1116 1145 778 
Average B factor (Å2) 
    
          protein 32.9 21.8 19.1 23.8 
          water 39.1 32.9 31.9 31.2 
rmsd 
    
          bond lengths (Å) 0.002 0.007 0.0023 0.004 
          bond angles (deg) 0.644 1.023 0.6923 0.814 
Ramachandran plot (%) 
    
          favored regions 98.15 98.69 98.46 98.00 
          allowed regions 1.85 1.31 1.54 2.00 
          disallowed regions 0.00 0.00 0.00 0.00 
aData for the last resolution shell are given in parentheses. 
 
Table 2-11 Crystallographic data and refinement statistics for PhdJ, PhdJ-CBP, PhdJ-
CN, and PhdJ-CBA. 
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2.3.9 Crystal Structures of PhdG 
 
  The crystal structure of PhdG was determined to assist the identification of its 
biological function, as well as to determine the structural basis for its substrate preference 
and mechanism. The identification for HBP as a substrate (April 2017) as a substrate via 
UV/Vis spectrophotometry sheds light on structure function relationships when 
comparing hydratase-aldolases. Crystals grew in the P43212 space group with two 
monomers in the asymmetric unit. The 2.7 Å resolution PhdG crystal structure was 
solved by molecular replacement using an unpublished native NahE structure as a search 
model. Monomeric backbone deviation after superpositioning of PhdG to NAL and 
DHDPS was low (RMSD values of 1.82 and 1.44, respectively, Figure 2-23A,B).  
  Lys-180, Tyr-152, and the GXXGE motif are conserved in PhdG, like all other 
NAL subgroup members. The XX residues in the GXXGE motif are Ser-62 and Ala-63, 
which differ from Thr and Phe residues found in NahE and PhdJ (Figure 2-23C). The 
side chain hydroxyl of Tyr-125 makes the intersubunit interaction with the side chain of 
Ser-62, like the equivalent tyrosine residues do in NAL, DHDPS, and KDGA, but unlike 
NahE, PhdJ (both use Trp), and KDGDH (which doesn’t make an equivalent hydrogen 
bond). Asn-154 and Trp-221 in PhdG are conserved in NahE and PhdJ, but are not 
conserved in other NAL subgroup members. Thr-182 is not conserved with other NAL 
subgroup enzymes and the side chain oxygen hydrogen bonds with the side chains of 
Lys-180. Gln-269 and Gln-272 are also nonconserved residues that are proximal to Lys-
180. 
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Figure 2-23 The 2.7 Å resolution crystal structure of PhdG. 
A) PhdG monomer. B) Alignment of PhdG (limon), NAL (marine, PDB entry 1NAL), 
and DHDPS (yellow orange, PDB entry 1DHP). C) Active site of PhdG. 
 
  A 1.9 Å resolution crystal structure of PhdG in complex with a pyruvate 
carbinolamine (PhdG-Pyr) was determined after soaking experiments using pyruvate. The 
hydroxyl of the carbinolamine hydrogen bonds with the hydroxyl group of Tyr-152 
A B 
C 
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(Figure 2-24A) and is an intermediate in Schiff base formation. A water molecule 
bridges the side chains of Gln-269 (Nε) and Gln-272 (Oε) and contacts the carbinolamine 
hydroxyl group. PhdG has numerous nonpolar residues nearby including Leu-205, Trp-
221, Ile-223, Phe-258, Met-265, Phe-268, Trp-275, and Trp-276 (Figure 2-24B). 
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Figure 2-24 Active site of the 1.9 Å resolution PhdG-Pyr crystal structure. 
A) 2Fo-Fc map of continuous density surrounding Lys-180 and carbinolamine adduct, 
countoured at 1.0 . B) Hydrophobic residues near the active site of PhdG. 
A 
B 
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Data Collection PhdG PhdG-Pyr 
space group P43212 P43212 
cell dimensions 
            a, b, c (Å) 86.879, 86.879, 183.907 86.671, 86.671, 184.133 
          α, β, γ (deg) 90.000, 90.000, 90.000 90.000, 90.000, 90.000 
resolution (Å) 50.00 - 2.65 50.00 - 1.94 
Rsym (%) (linear R factor) 1.041 (0.247) 1.105 (0.168) 
I/σI  13 (3.0) 17.6 (2.1) 
completeness (%) 100.0 (100.0) 100.0 (100.0) 
   Refinement     
resolution (Å) 43.440 - 2.650 43.3461 - 1.9378 
no. of reflections 21207 52924 
Rwork/Rfree (%) 23.42/28.12 16.80/19.53 
no. of atoms 
            protein 4904 4908 
          water 159 789 
Average B factor (Å
2
) 
            protein 33.50 21.60 
          water 26.10 29.05 
rmsd 
            bond lengths (Å) 0.003 0.005 
          bond angles (deg) 0.738 0.983 
Ramachandran plot (%) 
            favored regions 98.43 98.58 
          allowed regions 1.57 1.42 
          disallowed regions 0.00 0.00 
Data for the last resolution shell are given in parentheses. 
 
Table 2-12 Crystallographic data and refinement statistics for PhdG and PhdG-Pyr. 
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2.4 DISCUSSION 
 
2.4.1 Hydratase-Aldolases in the NAL Subgroup 
 
  The hydratase-aldolases NahE, PhdJ, and PhdG were identified as members of the 
NAL subgroup of the Type I aldolase superfamily by sequence analysis. As such, they 
have structural traits from the NAL subgroup including the (α/β)8 barrel, C-terminal 
helices, the conserved Lys-183 and Tyr-155 residues (NahE numbering), and the 
GXXGE motif (LeVieux, et al. 2016). The crystal structures are highly homologus, as 
indicated by their Cα RMSD values, which range from 0.72 to 0.94 Å. DLS experiments 
show that all three enzymes are tetrameric, like other members of the NAL subgroup. 
ESI-MS, chemical mutagenesis, and crystallographic analysis indicate the enzymes form 
Schiff base adducts with their α-keto acid substrates through the conserved lysine. Crystal 
structures of each enzyme with bound ligand show the C-1 carboxylate of the substrates 
interacts with the backbone amide hydrogens of the XX residues in the GXXGE motif.  
NahE, PhdJ, and PhdG have several other residues that are not shared with other 
NAL subgroup members, which are referred to as secondary residues. These residues are 
likely responsible for the distinct chemistry of the hydratase-aldolases. The enzymes have 
Asn-157 (NahE numbering) separated by two amino acids from Tyr-155 (sequence 
alignment, Figure 2-25). In NahE and PhdJ, this residue is near the benzylic carbon of 
benzylidenepyruvate substrates bound in crystal structures, to which water is added. The 
asparagine residue interacts with a water molecule in both the NahE-HN and PhdJ-CBP 
structures (Figure 2-14, 2-19). In NahE-HN, the side chain amide nitrogen Asn-157 is 
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hydrogen bonds with a water molecule that interacts with the amide nitrogen of Asn-281 
above the 4-hydroxyl intermediate HN (Figure 2-14). In PhdJ-CBP, the side chain amide 
nitrogen of Asn-154 hydrogen bonds to a water molecule only 3.6 Å from the benzylic 
carbon where water is added. The same water molecule is in contact with one o-
carboxylate oxygen atom of CBP and another water molecule (Figure 2-19). The Asn 
might be involved in positioning the water molecule and stabilization of the transient 
hydroxide ion during addition in NahE and PhdJ, and sets precedence for the role of the 
conserved asparagine in PhdG and other hydratase-aldolases.  
Trp-224 (NahE numbering) is another secondary residue located on β-strand 8. 
The side chain is parallel to the side chain of Lys-183 in crystal structure of NahE, PhdJ, 
and PhdG. The residue may lower the pKa of the amine group of Lys-183 to increase 
nucleophilicity for Schiff base formation, or it may contribute to positioning of the 
substrate. Other important amino acids are specific to the individual hydratase-aldolases 
and are referred to as tertiary residues (Figure 2-25). 
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Figure 2-25 Sequence alignment of representative NAL subgroup members.  
Secondary structure for PhdJ is shown above the alignment. The dots beneath select 
residues indicate primary residues (blue) in the NAL subgroup, secondary residues (red) 
common in hydratase-aldolases, and tertiary residues (green) that are specific to 
individual hydratase-aldolases. The red line indicates an insertion in hydratase-aldolases 
that which codes for α10. 
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  When sequences of hydratase-aldolases are aligned and compared to other 
members of the NAL subgroup, the hydratase-aldolases contain an insertion near position 
270 (Figure 2-25). The 8-residue insertion in NahE, PhdJ, and PhdG allows for an α-
helix (designated α10) to form between two longer α-helices at the C-terminus. This α-
helix extends over the C-terminal opening of the β-barrel forming a deep cavity, a feature 
not seen in other NAL subgroup members (Figure 2-26A). Beneath the helical “shield” 
are hydrophobic side chains that could assist in the binding of the less polar moieties of 
substrates for these 3 enzymes (Figure 2-26B). A nonpolar environment in the active site 
would explain the high affinity of hydratase-aldolases for their substrates, as the KM 
values are in the mid to low µM range, whereas those for DHDPS and NAL are in the 
high µM to low mM range range (Aisaka et al., 1991, Laber et al., 1992). One 
hydrophobic residue Phe-277 is located on α10 and is conserved in NahE, PhdJ, and 
PhdG, and can be considered a secondary residue (Figure 2-26B). Other key residues 
identified in the crystal structures reported here vary among NahE, PhdJ, and PhdG 
(tertiary residues) and are discussed in the context of each enzyme in the following 
sections. 
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Figure 2-26 The helix α10 unique to hydratase-aldolases in the NAL subgroup. 
A) Alignment of PhdJ (slate), NAL (marine, PDB entry 1NAL), and DHDPS (yellow 
orange, PDB entry 1DHP). B) Close-up of α10 in NahE (forest), PhdJ (slate), and PhdG 
(light teal). Residues on the helix are shown in reference to the conserved lysine and 
tyrosine residues. 
A 
B 
α10 
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2.4.2 The Mechanism of NahE Using HBP 
 
  NahE exhibits a strong preference for HBP, with the kcat/KM value (1  10
7
 M
-1
s
-1
) 
10
4
-fold greater than that using BP or CBP, in part due to its low KM (1.2 µM), which is 
~100-fold less than the value measured for BP or CBP. Other reports have shown relative 
rates with BP and CBP that are close to 1% of that using HBP (Kuhm et al., 1993, Eaton, 
2000). In addition, the reported KM values are in the low µM concentration range (Kuhm 
et al., 1993), which is consistent with our results. 
 The kcat values for NahE catalysis in the reverse direction using salicylaldehyde 
and pyruvate (18.7 s
-1
) were similar to that using HBP (11.7 s
-1
). The KM value for 
pyruvate was high (6 mM), suggesting low affinity of NahE and pyruvate, despite the 
favorable interactions observed in the crystal structure in complex with pyruvate (Schiff 
base) and salicylaldehyde (NahE-SP, Figure 2-15). This structure shows Schiff base 
formation between C-2 of pyruvate and the side chain nitrogen of Lys-183 and hydrogen 
bonds between the C-1 carboxylate of pyruvate and backbone of the GXXGE motif. The 
KM value with respect to pyruvate is significantly lower for E. coli DHDPS (0.26 mM) 
(Dobson et al., 2004) and PhdG (0.27 mM).  
  Crystal structures were obtained for native NahE and NahE in complex with the 
4-hydroxy intermediate, saicylaldehyde and pyruvate, salicyaldehyde (Schiff base), and 
BP (or products benzaldehyde and pyruvate). The overall crystal structure of NahE did 
not change significantly when in complex with HN, BP, or salicylaldehyde and pyruvate 
(Cα RMSD < 0.3 Å, Figure 2-25A). In addition to overall homology of tertiary structure, 
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the active site residues remained in almost identical positions in the unliganded and 
liganded structures (Figure 2-25B,C). 
 
Figure 2-27 Superposition of NahE crystal structures. 
A) NahE (grey) alignment with NahE-HN (forest). B) Superposition of NahE-HN 
(forest), NahE-BP (lime), and NahE-SP (limon). C) Close-up of ligands shown in B. 
 
  Based on the crystal structures of NahE and mechanisms in the NAL subgroup, 
the following catalytic mechanism is proposed (Scheme 2-2). First, Schiff base formation 
between the side chain nitrogen of Lys-183 and C-2 of HBP occurs, mediated by the 
B 
C 
A 
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hydroxyl group of Tyr-155, as suggested for other type I aldolases (Choi et al., 2006), 
based on structure analysis and kinetic studies. Crystal structures of fructose-1,6-
bisphosphate aldolase (Lorentzen et al., 2005) and PhdG (Section 2.4.5) have covalently 
bound carbinolamine species (intermediates in Schiff base formation and decay) where 
the C-2 oxygen hydrogen bonds to the side chain hydroxyl group of Tyr-152 (PhdG 
numbering), suggesting the residue mediates proton transfer and hydration/dehydration 
during reactions in these enzymes. Subsequent to Schiff base formation, the side chain 
amide nitrogen of Asn-157 (and possibly the same nitrogen of Asn-281) position the 
water molecule, and Tyr-155 acts as a general base for the addition of water to the Re- 
face of HBP. Evidence for the step comes from the NahE-HN structure which shows the 
C-4 oxygen of the intermediate HN hydrogen bonds with the side chain amide nitrogen of 
Asn-157 and side chain oxygen of Tyr-155 (Figure 2-14). It is possible the side chain 
amide nitrogen Asn-281 is also involved, though the distance to the 4-hydroxyl group is 
3.8 Å, whereas the distance from Asn-157 is 3.3 Å. Asn-278 is the counterpart to Asn-
281 conserved in DHDPS (sequence alignment in Figure 2-25, Asn-281 on left side of 
gap). Electrons are pushed to the side chain nitrogen of Lys-183, forming an enamine, 
prior to protonation at C-3 by the side chain oxygen of Tyr-155 (syn- addition). A single 
general acid/base for syn- addition is proposed for Enoyl-CoA hydratase (Bahnson et al., 
2002), where the proposed E1cb mechanism features a carbanion/enolate intermediate. 
The reason a quinone methide mechanism is not operative (as suggested by rate 
comparison using HBP, and its o- and m- derivatives discussed in Section 1.2.3, Eaton, 
2000) may be due to the hydrogen bond donation by the o-hydroxyl group of HBP to the 
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carboxylate oxygen of Glu-285. Glu-285 is likely deprotonated as one carboxylate 
oxygen of Glu-285 interacts with the side chain of Arg-288 (N), probably in a charge-
charge interaction. Because the o-hydroxyl group is not deprotated to form a quinone 
methide, the functional group draws electron density by induction from the benzylic 
carbon, making the atom more electrophilic and susceptible to Micheal addition.   
  Deprotonation during water addition by the ortho phenoxide of HBP cannot be 
ruled out (2.8 Å in NahE-HN), but a dramatic change in conformation would need to 
occur after addition at the Re face of HBP, to produce the (R)-4-hydroxyl adduct 
observed in NahE-HN. Additionally, the interaction of Glu-285 and Arg-288, and the 
evidence against a quinone methide intermediate suggest the ortho-hydroxyl group of 
HBP is not deprotonated during the reaction. 
  Another reasonable scenario for water activation includes the C-1 carboxylate 
group of HBP. One oxygen of this group is only 3.1 Å (in NahE-HN) from the benzylic 
position of the intermediate HN, and also interacts with the side chain hydroxyl of Tyr-
155 (3.2 Å, NahE-HN). The distance is close enough to add water, but the C-1 carboxlate 
is in plane with the C-3/C-4 double bond of BP in (NahE-BP, Figure 4-17), where Tyr-
155 is on the Re face of the C-4, to which water is added. Water activation by carboxylate 
groups (glutamate side chains) for hydration of α,β-unsaturated substrates has been 
reported in Enoyl-CoA hydratase, hydroxycinnamoyl-CoA hydratase-lyase (Bahnson et 
al., 2002, Bennett et al., 2008), and tautomerase superfamily members such as cis-CaaD 
and MSAD (Poelarends et al., 2003, Huddleston et al., 2014). 
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  The side chain oxygen of Tyr-155 deprotonates the C-4 oxygen of the 
intermediate (atomic distance is 2.7 Å in NahE-HN) for cleavage of the C-3/C-4 bond of 
HN, as proposed for NAL, DHDPS and KDGA. The pyruvate enamine adduct on Lys-
183 tautomerizes and salicylaldehyde is released. Release of salicylaldhyde likely 
precedes pyruvate hydrolysis since salicylaldehyde sterically blocks the exit of pyruvate 
at the opening to the active site, as observed in NahE-SP (Figure 2-15) and is consistent 
with the sequential Uni-Bi mechanism suggested for NAL and DHDPS. 
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Scheme 2-2 Proposed mechanism for NahE using HBP. 
 
2.4.3 The Mechanism of PhdJ Using CBP 
 
 
 The kcat and Km values for PhdJ (6.5 ± 0.4 s
-1
 and 79 ± 7 µM) using CBP are 
similar to those published for the ortholog from Nocardioides strain KP7 (55% sequence 
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identity, 13 s
-1
 and 50 µM, Iwabuchi & Harayama, 1998). The enzyme exhibits a clear 
preference for CBP, as its kcat/KM value is 26-fold and 1000-fold greater than that using 
HBP and BP, respectively.  
  Crystal structures were obtained for PhdJ and PhdJ in complex with CBP (and 
products CBA and pyruvate bound in other sites of the same structure), the 4-hydroxy 
intermediate CN, and CBA (Schiff base). Native PhdJ and PhdJ complex crystal 
structures are superimposable with RMSD values less than 0.25 Å (Figure 2-26A,B). 
Like NahE, the positioning of side chains in the active site are similar, with the most 
significant differences being in the small helix that caps the β-barrel.  
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Figure 2-28 Superposition of PhdJ crystal stuctures. 
A) Alignment of PhdJ (grey) and PhdJ-CN (aqua marine). B) Alignment of PhdJ-CBP 
(light teal), PhdJ-CN (aqua marine), and PhdJ-SP (marine). C) Close-up of Schiff base 
adducts of substrate CBP (light teal), 4-hydroxy intermediate (CN, aqua marine), and 
products CBA and pyruvate (marine), shown in B. 
 
 
  Water deprotonation via the side chain oxygen of Tyr-152 may occur as was 
proposed for NahE (Scheme 2-2). The oxygen of Tyr-152 is 4.8 Å from W1 in the PhdJ-
CBP, and only 3.8 Å from the benzylic carbon, and is positioned on the Re face to which 
B 
C 
A 
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the water molecule adds. The likelihood of deprotonation of water by the side chain 
hydroxyl group of Tyr-152 and the C-1 carboxylate of CBP is increased with the 
understanding that CBP is in a nonproductive orientation, and that CBP likely undergoes 
rearrangement prior to water addition. 
  However, the o-carboxylate of CBP is 3.0 Å from W1 in PhdJ-CBP, as shown in 
Figure 2-29A, which indicates could be a general base for water addition. The substrate-
assisted catalysis implies PhdJ would use a different mechanism than that proposed for 
NahE. This seems unlikely given the conserved residues Tyr-152 and Asn-154 (PhdJ 
numbering) were proposed to activate water for NahE (Scheme 2-2) and the 45% identity 
between the enzymes. However, the possibility of water deprotonation by the ortho-
carboxylate group of CBP is worth considering due to the proximity of W1 to the ortho-
carboxlate in the PhdJ-CBP (3.0 Å). This mechanism for PhdJ using CBP (Scheme 2-3) 
begins with Schiff base formation between the side chain amino group Lys-183 and the 
C-2 of CBP mediated by the side chain of Tyr-152 as proposed for NahE and other NAL 
subgroup members. The o-carboxylate oxygen of CBP deprotonates water with the 
assistance of a water molecule and the side chain nitrogen of Asn-154. Water activation 
by another water molecule stabilized to the side chain hydroxyl group of Ser-278 cannot 
be ruled out. Another possibility, noted for NahE (Section 2.4.2) is the deprotonaton of 
water via the C-1 carboxylate, which is 5.2 Å from W1 in PhdJ (though only 3.3 Å from 
C-4 where water is added in PhdJ-CBP). After water is added, electron rearrangement 
then occurs to form an enamine intermediate. The protonated o-carboxylate then transfers 
the proton to C-3 (atomic distance of 3.4 Å in PhdJ-CN, Figure 2-29B) to complete anti- 
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addition. PhdJ-CN shows that the side chain hydroxyl of Tyr-152 and water molecule is 
4.1 and 4.0 Å from C-3 (Figure 2-27B), making these groups less likely proton donors to 
C-3 during hydration.  
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Figure 2-29 Candidates for water activation and proton donation during hydration of 
CBP by PhdJ. 
Distances (yellow dashes) are in Å. 2Fo-Fc electron density map (1.0 ) surrounds 
adducts and nearby water moledules. A) PhdJ-CBP active site with groups that 
potentially activate water and protonate C-3. B) PhdJ-CN active site with groups that may 
protonate C-3.  
B 
A 
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  Based on CBP and CN intermediates in PhdJ-CBP and PhdJ-CN crystal 
structures, hydration is likely accompanied by a 180 degree rotation of the o-carboxylate 
group around the oxygen that is hydrogen bonded to Asp-282. A 0.7 Å shift of the 
benzylic carbon is also observed when the PhdJ-CBP and Phd-CN structures are 
compared. These movements may allow access of activated water to C-2, since W1 is in 
plane with the double bond in PhdJ-CBP. In addition, these movements that go with 
hydration appear to bring one ortho-carboxylate oxygen close to C-3 (3.4 Å). Imine-
enamine tautomerization may occur via this oxygen as the 2Fo-Fc electron density (at 1.0 
) protrudes toward C-3 (Figure 2-29B).  
  Like NAL, DHDPS, and KDGA (Section 1.4), the retro aldol reaction proceeds 
by deprotonation of the C-4 oxygen by the side chain of Tyr-152 (distance in PhdJ-CN is 
2.9 Å), where the developing anion is stabilized by the side chain amide nitrogen of Asn-
154. The pyruvate enamine tautomerizes and CBA is released from the active site. 
Pyruvate can then be hydrolyzed and released, consistent with a sequential Uni-Bi 
reaction. 
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Scheme 2-3 Proposed mechanism of PhdJ using CBP. 
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2.4.4 The S278N and D282E PhdJ Mutants  
 
Steady state kinetic parameters were determined for the S278N and D282E PhdJ 
mutants, which were designed to mimic the active site of NahE (Figure 2-30). The KM 
values for S278N and D282E PhdJ mutants using HBP are both 2-fold lower than with 
wild-type, and the kcat values are reduced 54- and 35-fold, respectively. Although the 
mutation impeded turnover, the parameters are consistent improved binding of HBP. The 
kcat/KM values for S278N and D282E PhdJ mutants are close to 10
4
-fold less than that for 
NahE, thus these point mutations do not imitate NahE in its efficiency using HBP. 
Double mutant S278N D282E PhdJ may have kinetic parameters more similar to wild-
type NahE when using HBP, though similar enzyme efficiency may require Arg-288 
(NahE numbering), which participates in the proposed mechanism for NahE (Scheme 2-
2).  
The D282E mutation was more detrimental to PhdJ activity using CBP, as the 
kcat/KM decreased 1500-fold, whereas the S278N mutant merely decreased only 23-fold. 
Although the drop for the D282E mutant seems to indicate Asp-282 might activate water, 
especially with the presedence for carboxylate side chains to do so (Bahnson et al., 2002, 
Bennett et al., 2008, Poelarends et al., 2003, Huddleston et al., 2014), Glu-282 is 6.5 Å 
from W1 in PhdJ-CBP (6.2 Å from C-4, Figure 2-30), and its closest side chain oxygen 
to W1 interacts with an ortho-carboxylate oxygen in each liganded PhdJ structure. The 
extra methylene on the side chain in the D282E mutant might instead disrupt the 
interaction of the carboxylate oxygen of Glu-282 with the o-carboxylate of CBP. 
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Surprisingly, the S278N and D282E PhdJ mutants processed BP 2.2-fold and 34-
fold more efficiently (kcat/KM) than wild-type PhdJ. Replacing Asp-282 with glutamate 
may displace the carboxylate group away from the phenyl ring of bound BP, increasing 
the affinity of BP and PhdJ.  
 
Figure 2-30 Superposition of NahE-HN (green) and PhdJ-CN (slate) active sites. 
 
 
2.4.5 Structure and Function of PhdG 
 
  The proposed role of PhdG in the phenanthrene catabolic pathway could not be 
confirmed in our hands (Figure 1-8). However, PhdG is functionally linked to its paralog 
PhdJ by its ability to convert HBP to salicylaldehyde and pyruvate, a reaction in the 
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naphthalene degradation pathway in M. vanbaalenii PYR-1. The recently discovered 
PhdG activity using HBP was assessed by UV/Vis spectrophotometry (Section 2.3.1). 
Both enzymes have the secondary residues conserved in hydratase-aldolases (Asn-157 
and Trp-224 in NahE), but tertiary residues (which vary among hydratase-aldolases) Asn-
281 and Glu-285 that might be involved in NahE catalysis (Scheme 2-2) are replaced by 
Gln-272 and Trp-276 in PhdG (Figure 2-32).  
  Crystal structures were obtained of native PhdG and PhdG in complex with 
pyruvate carbinolamine. The carbinolamine adduct observed in the PhdG-Pyr is 
unexpected, as pyruvoyl adducts in NahE and PhdJ were involved in Schiff base. 
However, carbinolamine intermediates have been observed before in several type I 
aldolases (Heine et al., 2001, Lorentzen et al., 2005). The carbinolamine oxygen atom in 
archaeal fructose-1,6-bisphosphate aldolase hydrogen bonds with the side chain oxygen 
of Tyr-146 (conserved in PhdG) which was proposed to deprontonate the carbinolamine 
for Schiff base formation. The rabbit fructose-1,6-bisphosphate aldolase A has Glu-187 at 
the equivalent position which was suggested to be involved in deprotonation and 
dehydration of the carbinolamine, based on kinetic studies of Glu-187 mutants. The 
interaction of C-2 oxygen of the carbinolamine adduct and Tyr-152 in the crystal 
structure of PhdG-Pyr suggests proton transfer might occur between these groups 
providing further evidence that the side chain oxygen of Tyr-152 (PhdG numbering) 
mediates Schiff Base formation for hydratase-aldolases and NAL subgroup members. 
  Although the overall structures of PhdG and PhdG-Pyr are nearly superimposable 
(RMSD of 0.18), several differences are observed in the active site. First, the difference 
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in dihedral angle between Cα and Cβ of Gln-272 is ~180°. In PhdG-Pyr, the difference 
accompanies a hydrogen bond between the side chain amide nitrogen Gln-272 and a 
water that interacts with the carbinolamine oxygen of the adduct. Secondly, the side chain 
of Thr-182 hydrogen bonds with the side chain nitrogen Lys-180 in PhdG, but the side 
chain oxygen of Thr-182 points away from Lys-180 bound to the carbinolamine adduct in 
PhdG-Pyr. 
 
 
Figure 2-31 Superposition of PhdG and PhdG-Pyr. 
  
 The mechanism of PhdG using HBP and BP likely resembles that proposed for 
NahE using HBP, though Glu-269 and Glu-272 may be involved in water activation or 
the retro aldol reaction as they extend further towards the pyruvoyl adduct in PhdG-Pyr 
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than the equivalent residues in NahE (Ser-278 and Asn-281) and PhdJ (Leu-275 and Ser-
278) do (Figure 2-32). The lack of an equivalent to Asp-282 in PhdJ and presence of 
nearby Ile-223 likely prevents binding of the CBP, as the interaction between the o-
carboxylate and the protein in this region may be unfavorable sterically and/or 
electrostatically.  
 
 
Figure 2-32 Superposition of NahE (forest), PhdJ (slate), and PhdG (light teal). 
 
The kcat/KM value for PhdG using BP, which is not an intermediate in PAH 
metabolism in M. vanbaalenii PYR-1 is 15- and 110-fold greater than that for NahE or 
PhdJ. The increased efficiency of PhdG compared to NahE is due to both an increase in 
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kcat and a decrease in KM. The difference kcat/KM value may influenced by Trp-276 in 
PhdG which replaces Glu-285 in NahE and Asp-282 in PhdJ, Figure 2-32).  
  The KM value with respect to pyruvate for PhdG using cinnamaldehyde and 
pyruvate with 22-fold less than that for NahE. Additionally, the KM value for PhdG using 
BP is 3.2-fold less than that for NahE. The basis for the tighter binding in PhdG may be 
related to Tyr-125 which interacts with the adjacent monomer (replaces Trp-128 in 
NahE), and Gln-272 which hydrogen bonds to the carbinolamine oxygen via a water 
molecule and is replaced by Asn-281 in NahE (Figure 2-32). The formation of the 
carbinolamine might also be related to the higher affinity of PhdG for α-keto acids. 
2.4.6 Biological Roles for NahE, PhdJ, and PhdG 
 
  Kinetic and 
1
H spectrometric data indicate NahE converts HBP, an intermediate 
in naphthalene degradation (as was known previously, Section 1.2.3), and processes 
CBP, an analoguous metabolite in phenanthrene degradation via 3,4-
dihydroxyphenanthrene. The latter activity indicates NahE may be used in phenanthrene 
metabolism in Pseudomonas fluorescens containing an NAH7-like plasmid (Menn et al., 
1993), albeit at a ~10
4
-fold lower kcat/KM value than in naphthalene degradation. The low 
KM (1.2 µM) of NahE using HBP may allow for the prevention of buildup of HBP and 
HCCA in the pathway. NahE may control flux through the pathway due to its inhibition 
by salicylaldehyde, as well as its slow inactivation by salicyaldehyde.  
  PhdJ is relatively nonspecific compared to NahE, as the kcat/KM value using CBP, 
a phenanthrene catabolic intermediate, is only 26-fold greater than when using HBP. 
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Since PhdG also processes HBP (the kinetic parameters are not determined yet), both 
enzymes participate in naphthalene catabolism in M. vanbaalenii PYR-1, as the 
bacterium degrades naphthalene through salicylate as is established in Pseudomonas 
putida G7 (Kelley et al., 1990). The lack of activity of PhdG with 1-hydroxy-2-
naphthaldehyde and pyruvate (reverse reaction that is proposed to be PhdG-catalyzed, 
Stingley, et al., 2004) in our laboratory and the redundancy of PhdG in its ability to 
process HBP suggests it might act on other pathway intermediates in M. vanbaalenii 
PYR-1. 
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Chapter 3: The 4-Oxalocrotonate Tautomerase, cis-3-Chloroacrylic 
Acid Dehalogenase, and Malonate Semialdehyde Decarboxylase 
Subgroups of the Tautomerase Superfamily 
 
  Characterized members of the tautomerase superfamily (TSF) are distinct in that 
they have a catalytic N-terminal proline. In addition, they have a common fold. Some 
TSF members are composed of a single β-α-β unit (55-75 amino acids), while others are 
made up of two β-α-β units connected by a linker (105-150 residues, Figure 3-1). Thus 
far, over 15,000 predicted gene products have been annotated as TSF members, and 
characterized members are known to catalyze tautomerization, isomerization, 
dehalogenation, hydration, decarboxylation, and oxygenation reactions (Poelarends et al., 
2008, Zandvoort et al., 2012, Zandvoort et al., 2012, Baas et al., 2015). Studies of these 
enzymes uncover strategies used by nature to generate diversity, and it might be possible 
to mimic these principles to develop new proline-based enzymes (Poelarends et al., 
2008). The TSF consists of five subgroups designated by the first characterized member. 
They are the 4-oxalocrotonate tautomerase (4-OT), cis-3-chloroacrylic acid 
dehalogenase (cis-CaaD), macrophage migration inhibitory factor (MIF), malonate 
semialdehyde decarboxylase (MSAD), and 5-(carboxymethyl)-2-hydroxymuconate 
isomerase (CHMI) subgroups. Grouping of enzymes is based on sequence analysis and 
experimentally characterized functions. The work presented here focuses on the 
structures and functions of enzymes within the cis-CaaD, MSAD, and 4-OT subgroups. 
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Figure 3-1 Assemblies of long and short monomers in the TSF. 
A) Canonical 4-OT (limon) is a hexamer, made up of short monomers that have six Pro-1 
residues (violet purple, PDB entry 1OTF). The structure can be thought of as a trimer of 
dimers. B) cis-CaaD is made up of long monomers with three Pro-1 residues (yellow 
orange, PDB entry 3MF8). 
 
3.1 4-OXALOCROTONATE TAUTOMERASE 
 
 
 4-Oxalocrotonate tautomerase (4-OT) is a small enzyme in the catabolic meta-
fission pathway that converts monocyclic aromatic hydrocarbons to compounds that can 
be shuttled into the Krebs cycle. 4-OT is encoded by the xylH gene on the TOL plasmid 
WW0, which is similar to the NAH7 plasmid (Section 1.2) in Pseudomonas putida mt-1. 
The hexameric enzyme catalyzes the tautomerization of 2-hydroxymuconate (2-HM) to 
2-keto-3-hexenedioate shown in Scheme 3-1 (Whitman et al., 1991). Each chain has 62 
A B 
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amino acids and folds into a single β-α-β motif with a C-terminal β-hairpin (Figure 3-
2A). The latter feature is important in forming the hexamer (Whitman, 2002). 
 
 
 
Scheme 3-1 Role of 4-OT in the meta-fission pathway. 
 
 Pro-1, Arg-11, Arg-39, and Phe-50 are crucial in the tautomerization reaction, and 
their roles have been studied for over 25 years by NMR, crystallography, mutagenesis, 
kinetic, and inhibition studies (Figure 3-2B). Pro-1 has a pKa of about 6.4, which is 
lowered more than 3 units from the model compound proline amide, due in part to the 
nearby hydrophobic Phe-50ʹ (Czerwinski et al., 2001). The prime symbol indicates that a 
residue comes from the other monomer in the dimer and the double prime indicates that a 
residue comes from an adjacent dimer. The hexameric structure is a trimer of dimers 
(Figure 3-1A), and residues from three adjacent subunits participate in catalysis. For one 
active site containing Pro-1, the proximal Arg-11ʹ and Phe-50ʹ are from the other subunit 
in same dimer, and Arg-39ʹʹ is from a neighboring dimer. 
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Figure 3-2 Crystal structure of 4-OT (1.9 Å resolution, PDB entry 1OTF). 
A) 4-OT monomer with Pro-1 shown as a sphere. B) Key active site residues shown in 
hexameric assembly.  
 
 The low pKa value allows Pro-1 to function as a general base catalyst for 
deprotonation of the 2-hydroxyl group of 2-HM and rearrangement to form an enediolate 
at C-5 and C-6 (Scheme 3-2). Arg39ʹʹ is involved in catalysis as the side chain stabilizes 
the developing anion at the 2-hydroxyl group during deprotonation. Arg-11ʹ forms a salt 
bridge with the C-6 carboxylate and is thought to polarize 2-HM so that electrons are 
pulled towards C-6 for protonation at the C-5 position (Czerwinski et al., 1999, Harris et 
al., 1999). Delivery of a proton to C-5 of the enediolate intermediate completes the 
tautomerization (Stivers et al., 1996, Czerwinski et al., 1997, Poelarends et al., 2008). 
The protonation is stereoselective and the 5(S)-isomer is generated when the reaction is 
performed in D2O (Whitman et al., 1992). 
A B 
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Scheme 3-2 Mechanism of 2-HM tautomerization by 4-OT. 
 
 2-Oxo-3-pentynoate (2-OP) is an acetylene compound initially discovered to be 
an irreversible inhibitor of 4-OT, initiated by attack of the prolyl nitrogen (Pro-1) at C-4. 
Inactivation as a function of 2-OP concentration suggested half-of-the-sites stoichiometry 
(Johnson et al., 1997), though the crystal strcture of 4-OT in complex with 2-OP revealed 
that each Pro-1 residue was modified (Taylor et al., 1998). The half-of-the-sites 
stoichiometry observed in solution was proposed to be a result of allostery, where 
inactivation of the first monomer precludes the inactivation in the second monomer of 
one dimer. Inactivation may proceed through initial Micheal addition to form an allene 
adduct (top intermediate, Scheme 3-3), followed by protonation at C-3. Alternatively, 4-
OT may catalyze allylic rearrangement of 2-OP by proton abstraction at C-5 to form an 
allene (bottom intermediate, Scheme 3-3), which is poised for attack by Pro-1 at C-4 and 
protonation at C-5. In the first mechanism, 2-OP is an active site-directed irreversible 
inhibitor. In the second mechanism, where rearrangement occurs first, 2-OP is a 
mechanism-based inhibitor. The interactions observed in the crystal structure of the 
inactivated enzyme suggested that Arg-39ʹʹ and an ordered water polarize of the 2-oxo 
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group of 2-OP to assist Micheal addition of Pro-1 (Johnson et al., 1997, Taylor et al., 
1998). Additionally, Arg-61ʹ, the C-terminal residue of 4-OT, was coordinated to the C-5 
carboxylate in the inactivated structure. These interactions may parallel those that occur 
in the tautomerization reaction with 2-HM except for the interaction with Arg-61ʹ, which 
was subsequently shown by mutagenesis not to be inolved in the tautomerization 
reaction. 
 
Scheme 3-3 Inactivation of 4-OT by 2-OP. 
 
3.2 1,3-DICHLOROPROPENE CATABOLIC PATHWAY 
 
 The synthetic compound 1,3-dichloropropene was introduced into the 
environment in the 1940s and is used as a nematocide (Poelarends et al., 1998). The 
compound is rapidly degraded in the soil in part due to the 1,3-dichloropropene catabolic 
pathway. This pathway converts racemic 1,3-dichloropropene to acetaldehyde and CO2 
(Scheme 3-4) and involves three steps to form cis- and trans-3-chloroacrylate 
(Poelarends & Whitman, 2004). The cis- and trans- isomers are processed by isomer-
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specific cis-CaaD (Poelarends et al., 2003) and CaaD (Poelarends et al., 2001), 
respectively, to produce malonate semialdehyde. Malonate semialdehyde decarboxylase 
(MSAD), the final enzyme in the pathway, is a TSF member that catalyzes the 
decarboxylation of malonate semialdehyde (Section 3.5). Subsequently, the product 
acetaldehyde is likely channeled to the Krebs cycle. The dehalogenation reactions 
involving CaaD and cis-CaaD, and the decarboxylation reaction catalyzed by MSAD are 
cofactor-independent.  
 
 
 
Scheme 3-4 Degradation of racemic 1,3-dichloropropene. 
 
3.3 TRANS-3-CHLOROACRYLIC ACID DEHALOGENASE 
 
 1,3-Dichloropropene is converted by three enzymes to form a mixture of cis- and 
trans-3-chloroacrylate. The trans isomer is converted to malonate semialdehyde by trans-
3-chloroacrylic acid dehalogenase (CaaD), through hydrolytic cleavage of the β-vinylic 
carbon-chlorine bond (Scheme 3-5). CaaD is a heterohexameric protein composed of 3 α-
subunits and 3 β-subunits, where each monomer is composed of a single β-α-β motif with 
Pro-1 at the N-terminus (Poelarends et al., 2001). The mechanism for CaaD involves 
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αGlu-52, αArg-8 and αArg-11, where αGlu-52 activates water for addition at C-3. The 
two arginine residues αArg-8 and αArg-11 stabilize the C-1 carboxylate and increase 
electrophilicity at C-3. The arginine residues might stabilize a enediolate species which 
forms after hydration. Protonation  could occur at C-2 (Scheme 3-5, upper pathway) 
which is followed by aldehyde formation and expulsion of chloride. In an alternate 
mechanism, electrons are pushed back to C-3 (Scheme 3-5, lower pathway) concomitant 
with chloride release. Protonation can subsequently occur at C-2 during tautomerization 
of the enolate in the formation of malonate semialdehyde.  
 
 
Scheme 3-5 Mechanism for CaaD using trans-3-chloroacrylate. 
 
 CaaD was the first TSF member identified that uses Pro-1 as an general acid. In 
addition to dehalogenation of trans-3-chloroacrylate, CaaD catalyzes the hydration of 2-
OP to form acetopyruvate (Scheme 3-7) and is inactivated by 3-halopropiolates (Wang et 
al., 2003). These reactions are discussed in more detail in the next section. 
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3.4 CIS-3-CHLOROACRYLIC ACID DEHALOGENASE 
 
  
 cis-3-Chloroacrylic acid dehalogenase (cis-CaaD) is the most thoroughly studied 
enzyme within the cis-CaaD subgroup of the TSF. cis-CaaD was isolated from 
Coryneform bacterium strain FG41, which is capable of using 1,3-dichloropropene as its 
sole carbon source (van Hylckama Vlieg & Janssen, 1991). cis-CaaD is a trimer where 
each member has 149 amino acids that codes two β-α-β units (Figure 3-3A). There are 
three active sites where each has a Pro-1. Sequence analysis and mutagenesis showed that 
Pro-1, Arg-70, Arg-73, and Glu-114 are important residues for cis-CaaD catalysis 
(Figure 3-3B) (Poelarends et al., 2004). These residues are conserved in trans-3-
chloroacrylic acid dehalogenase (CaaD), and dehalogenation of cis-3-chloroacrylate by 
cis-CaaD was initially assumed to proceed by a similar mechanism. 
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Figure 3-3 Crystal structure of Native cis-CaaD (2.0 Å resolution, PDB entry 3MF8) 
A) cis-CaaD monomer with Pro-1 shown as a sphere. B) Active site of trimeric cis-CaaD. 
 
 pH rate profiles suggest that the pKa of Pro-1 in cis-CaaD is ~9.3 (Poelarends et  
al., 2008), which indicates that Pro-1 is a general acid in the dehalogenation of cis-3-
chloroacrylic acid (Scheme 3-6). A crystal structure of cis-CaaD inactivated by the 
substrate analogue (R)-oxirane-2-carboxylate indicates that Arg-70 and Arg-73 polarize 
cis-3-chloroacrylate prior to hydration (Poelarends et al., 2004, de Jong et al., 2007). 
Glu-114 was the obvious candidate for water activation since the equivalent residue for 
CaaD was required for activity; the αE52Q CaaD variant is completely inactive (de Jong 
et al., 2007). The process for water activation is different for cis-CaaD, though, as the 
kcat/KM value for the E114Q mutant decreased only 10-fold (Poelarends et al., 2003). 
 The cis-CaaD crystal structure modified by (R)-oxirane-2-carboxylate implicated 
Tyr-103ʹ as a residue that assists Glu-114 in water activation (de Jong et al., 2007). 
A B 
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Although the kcat/KM value decreased slightly for the Y103F variant, the kcat dropped 
more than tenfold, and the activity of the Y103F/E114Q variant was severely 
compromised when the reaction was followed by 
1
H NMR spectroscopy (de Jong et al., 
2007). Tyr-103ʹ might position the water molecule for activation or it might position Glu-
114 for water activation, or the mechanism might involve some combination of the two 
functions. Tyr-103ʹ also provides specificity as it contributes to the formation of a U-
shaped active site, which differs from the CaaD active site cavity. Tyr-103ʹ could block 
the chloro group of trans-3-chloroacrylate and prevent binding. The cis-CaaD structure 
inactivated by (R)-oxirane-2-carboxylate implicated His-28 as another important residue 
for catalysis. His-28 might accompany Arg-70/Arg-73 in their interaction with the C-1 
carboxylate. In addition, the crystal strcture suggested Thr-34, Leu-38, and Leu-119 
“cradle” cis-3-chloroacrylate in the binding pocket (Poelarends et al., 2008).  
 
 
Scheme 3-6 Mechanism for cis-CaaD using cis-3-chloroacrylate. 
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 Consistent with the higher pKa of Pro-1, cis-CaaD (like CaaD) catalyzes the 
hydration of 2-oxo-3-pentynoate (2-OP) shown in Scheme 3-7 (Poelarends et al., 2003). 
cis-CaaD was inactivated at high 2-OP concentrations (60 mM), and the hydration 
activity with cis-CaaD is 500-fold less efficient than that of CaaD. The hydration likely 
involves Micheal addition and formation of an allene which then ketonizes. Hydration of 
2-OP by TSF members could indicate they exhibit a hydratase activity in their native 
organism. 
 
 
Scheme 3-7 Hydration mechanism for 2-OP. 
 
 The phenypyruvate tautomerase (PPT) activity (Scheme 3-8) of cis-CaaD links 
the enzyme to 4-OT and provides insight into cis-3-chloroacrylate dehalogenation. 
Although the physiological significance of phenylenolpyruvate tautomerization is not 
known, comparable PPT activity of 4-OT and cis-CaaD (in addition so sequence identity) 
suggests a functional relationship between the two proteins (Poelarends et al., 2007, 
Poelarends et al., 2008, Burks et al., 2010). Heterohexameric 4-OT from Chloroflexus 
aurantiacus J-10-fl is composed of α and β subunits where each form a dimer (like CaaD) 
in a trimer of dimers. Studies of PPT activity in this homologue suggest that Pro-1 is the 
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catalytic base and αArg-12 (equivalent to Arg73 of cis-CaaD) interacts with the 
carboxylate of phenylenolpyruvate to increase the efficiency of ketonization. αTrp-51 
(equivalent to Met-112 in cis-CaaD) might be important in binding the phenyl ring 
(Burks et al., 2010). The PPT activity suggests that cis-CaaD (as well as 4-OT) is capable 
of ketonizing enol compounds. This tautomerization ability of cis-CaaD supports the α,β-
elimination mechanism with cis-3-chloroacrylic acid (lower pathway in Scheme 3-6) and 
formation of the enol intermediate (Poelarends et al., 2007).  
 
 
Scheme 3-8 Ketonization of phenylenolpyruvate.  
 
 Fragmentation analysis of cis-CaaD inactivated after being incubated with 3-
bromopropiolate using MALDI-MS showed a malonyl adduct covalently bound to Pro-1 
(Poelarends et al., 2003). 3-Bromopropiolate is considered a mechansim-based inhibitor 
where hydration of 3-bromopropiolate likely occurs (using Glu-114) prior to inactivation. 
In a possible mechanism proposed for cis-CaaD, water addition to 3-bromoproiolate 
forms an unstable enol species (Scheme 3-9). Tautomerization forms an acyl bromide, or 
bromide is expeled to form a ketene species. Hydration of 3-bromopriololate 
deprotonates Pro-1, making the residue nucleophilic and poised for attack of the acyl 
bromide or ketene, producing a malonate adduct (de Jong et al., 2004). Decarboxylation 
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of the adduct then occurs to form an acetyl modification at Pro-1. The decarboxylation 
might result from the conditions of MALDI-MS analysis. 
 
 
Scheme 3-9 Covalent labeling of Pro-1 (prolyl nitrogen) after incubation with 3-
bromopropiolate. 
 
3.5 MALONATE SEMIALDEHYDE DECARBOXYLASE 
 
  
 Following dehalogenation reactions in the 1,3-dichloropropene pathway, 
malonate semialdehyde decarboxylase (MSAD) catalyzes the decarboxylation of 
malonate semialdehyde. MSAD from Pseudomonas pavonaceae 170 is a trimer where 
each long monomer (129 amino acids) encodes two β-α-β units (Figure 3-4A).  
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Figure 3-4 Crystal structure of MSAD (1.9 Å resolution, PDB entry 2AAG). 
A) MSAD monomer with Pro-1 shown as spheres. B) Key active site residues in trimeric 
MSAD. 
 
 Key active site residues include Pro-1, Asp-37, Arg-73, and Arg-75 (Figure 3-
4B). Pro-1 and Arg-75 are believed to be catalytic because the kcat values for R73A and 
R75A mutants are reduced more than 100-fold (Poelarends et al., 2004). Pro-1 of MSAD 
has a high pKa value of ~9.2, as determined by 
15
N NMR spectroscopy (Poelarends et al., 
2004, Poelarends et al., 2008). Arg-75 is proposed to orient the C-1 carboxylate of 
malonate semialdhyde favorably for decarboxylation (Scheme 3-10) (Poelarends et al., 
2005). Arg-73 and Asp-37 are also shown to be important, as the R73A and D37A 
variants had 1.8% and 0.5% specific activity relative to wild-type (Almrud et al., 2005). 
A crystal structure of MSAD indicated that a water molecule positioned by Pro-1 and 
A B 
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Asp-37 might polarize the aldehyde oxygen and promote decarboxylation. The active site 
also contains hydrophobic residues Trp-114, Phe-116, Phe-123, and Leu-128, which 
could facilitate decarboxylation. 
 
 
Scheme 3-10 Mechanism for decarboxylation of malonate semialdehyde by MSAD. 
 
 
 The NMR-derived pKa value of 9.2 for MSAD (Poelarends et al., 2005) is 
consistent with the observed 2-OP hydration activity (Scheme 3-7), a physical property 
that links the enzyme to CaaD and cis-CaaD. Hydration was shown to take place in the 
same active site as decarboxylation since the P1A, D37A, R73A, and R75A mutants all 
eliminated activity (Huddleston et al., 2014). Mutagensis and crystallography suggest a 
mechanism involving polarization of 2-OP by Arg-73 and Arg-75 through interaction 
with the C-1 carboxylate to increase electophilicity at C-4 and allow hydration. Water is 
activated by Asp-37 for Micheal addition at C-4. Pro-1 subsequently provides a proton to 
complete the addition.  
 Kinetic, mass spectrometric, and crystallographic data indicate MSAD is 
inactivated by 3-bromo- and 3-chloropropiolates and provides insight into the MSAD-
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catalyzed decarboxylation (Almrud et al., 2005, Poelarends et al., 2005). Inactivation 
proceeds via a acyl halide or ketene prior to labeling at Pro-1 (Scheme 3-9). The 
positioning of the resulting 3-oxopropanoate adduct in the crystal structure suggests that 
Asp-37 and Arg-75 are involved in both decarboxylation and hydration activities, 
consistent with the mutagenesis results (Almrud et al., 2005).  
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Chapter 4: Enzymes Linking 4-Oxalocrotonate Tautomerase and cis-3-
Chloroacrylic Acid Dehalogenase Subgroups 
 
4.1 INTRODUCTION 
 
 Members of the 4-oxalocrotonate tautomerase (4-OT) subgroup within the 
tautomerase superfamily (TSF) are composed of short monomers (55-75 amino acids) 
with a single β-α-β fold that typically oligomerize into a functional hexamer. The 
oligomeric state of members of the cis-3-chloroacrylic acid dehalogenase (cis-CaaD) 
subgroup is different. They are trimers composed of long monomers (105-150 amino 
acids) with two β-α-β motifs. Members of the 4-OT subgroup catalyze the 
tautomerization of 2-hydroxymuconate (2-HM), a reaction in the meta-fission pathway 
for xylenes. Though cis-CaaD (Section 3.4) catalyzes a dehalogenation reaction in the 
1,3-dichloropropene pathway that may have evolved in the last century (Section 3.2), 
other members of the subgroup have low level cis-CaaD activity (Poelarends et al., 2008, 
Baas et al., 2011). cis-CaaD subgroup members are believed to have originated through a 
gene duplication and gene fusion event of an ancestral 4-OT-like enzyme. Closer 
inspection of the cis-CaaD and 4-OT subgroups led to the discovery of three long 
monomers having sequence homology with both 4-OT and cis-CaaD, which may be 
functional intermediates between the two subgroups. 
 These “linkers” were identified in the genomes of Pseudomonas sp. UW4 (protein 
designated Ps01740, Uniprot code KNIA5), Pusillimonas sp. (strain T7-7) (protein 
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designated Pt0534, Uniprot code F4GMX9), and Burkholderia lata (strain ATCC 17760) 
(protein designated Fused 4-OT, Uniprot code Q392K7) using a sequence-similarity 
network technology developed in collaboration with Dr. Patricia Babbitt at The 
University of California, San Francisco (Davidson et al., In Preparation). Of all the 
~15,000 proteins that comprise the contemporary TSF, these three linker proteins afford 
the best scoring connection based on sequence identity between the 4-OT and cis-CaaD 
subgroups (Table 4-1). Based on sequence analysis, Ps01740 is closely related to the cis-
CaaD subgroup, and both Pt0534 and Fused 4-OT are members of the 4-OT subgroup. 
Crystal structures of these enzymes were determined in order to understand relationships 
between sequence and structure of enzymes that bridge the two subgroups within the 
TSF. 
  
Table 4-1 Sequence identity of 4-OT and cis-CaaD with Ps01740, Pt0534, and Fused 4-
OT.  
 
  
cis-CaaD 
4-OT and first 
β-α-β unita 
4-OT and second 
β-α-β unita 
Ps01740 24.2 25.4 16.1 
Pt0534 18.9 37.1 37.7 
Fused 4-OT 16.9 34.9 41.9 
 
a
The single β-α-β unit of 4-OT is aligned to each β-α-β unit of the linkers. 
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4.2 EXPERIMENTAL PROCEDURES 
 
  Crystallization of Ps01740 and Soaking Procedure The expression and 
purification of Ps01740, Pt0534, and Fused 4-OT are described previously (LeVieux, et 
al., In Preparation). Crystallization and soaking of crystals were carried out at 
~20°C.The crystal used to obtain diffraction data for native Ps01740 (Ps01740) and 
Ps01740 in complex with 2-OP (Ps01740-2OP) were obtained in 0.1 M CHES buffer 
(pH 9.0) and 16-18% PEG 8000. The crystal was soaked for 4 min in a solution of 2-OP 
(6 mM made in mother liquor) before cryoprotection by 20% glycerol in mother liquor 
prior to vitrification in liquid nitrogen. 
 Crystallization of Pt0534 and Soaking with 2-OP. The crystals used to determine 
Pt0534 in complex with 2-OP (Pt0534-2OP) were obtained in 0.2 M ammonium acetate, 
0.1 M trisodium citrate (pH 5.6) 24% PEG 4000. The crystals used in the diffraction 
experiment were grown overnight at 20° C and soaked in 2-OP (6 mM) for 5 min was 
prior to cryoprotection by 20% glycerol in mother liquor and then vitrified in liquid 
nitrogen. 
 Crystallization and Soaking of Fused 4-OT with 2-Hydroxymuconate (2-HM), 2-
OP, and Phenylpyruvate. The diffraction-quality crystals for native Fused 4-OT (F4OT), 
and Fused 4-OT in complex with 2-HM, 2-OP, and phenylpyruvate (F4OT-2HM, 
F4OT-2OP, and F4OT-PP) were obtained in 0.1 M HEPES (pH 8.0) and 28% PEG 
8000, whereas the native structure and F4OT-PP were obtained in 0.1 M HEPES (pH 7.5) 
and 33% PEG 8000. Crystal soaking for F4OT-2HM was performed in mother liquor 
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with 6 mM 2-HM for 5 min. F4OT-PP structure was determined using crystals soaked 
with 5 mM phenylpyruvate in mother liquor for 30 min. F4OT-2OP structure was 
obtained using crystals soaked with 6 mM 2-OP in mother liquor for 11 min. Crystals of 
all Ps01740, Pt0534, and Fused 4-OT were cryoprotected by 20-25% glycerol in mother 
liquor. 
 Data Collection and Structure Determination. X-ray diffraction data for Ps01740, 
Ps01740-2OP, Pt0534-2OP, F4OT-2HM, and F4OT-2OP were collected at Advanced 
Light Source (ALS) beamline 5.0.3 (Lawrence Berkeley National Laboratory, Berkeley, 
CA). Data for F4OT and F4OT-PP structures were collected at ALS beamline 5.0.1. 
Statistics for data collection are summarized in Table 4-2, 4-3, 4-4, and 4-5. Data were 
indexed, integrated, and scaled using HKL-2000 (Otwinowski & Minor, 1997). All 
structures were solved via molecular replacement using Phaser (McCoy, 2007) and 
Autobuild (Terwilliger et al., 2008) from the PHENIX suite (Adams et al., 2004).  
 The Cg10062 monomer crystal structure (31.3% sequence identity, PDB code 
3N4G) was used as a search model for Ps01740. The solution of Ps01740-2OP was found 
via molecular replacement using a monomer of Ps01740 as a search model. The structure 
of Pt0534-2OP was solved via molecular replacement using a 1.2 Å resolution structure 
of Pt0534 which lacked a C-terminal β-hairpin. The high resolution Pt0534 structure was 
solved via molecular replacment using a single monomer of Cg10062 (29.0% sequence 
identity, PDB code 3N4G). All Fused 4-OT structures were solved using a 1.78 Å 
resolution native structure of Fused 4-OT as a search model.  
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 Refinement of all Ps01740, Pt0534, and Fused 4-OT structures was performed 
using Phenix Refine (Afonine et al., 2012) Manual model building was done using 
COOT (Emsley et al., 2010). Model structures were evaluated during and after 
refinement using Molprobity (Chen et al., 2010).  
 
4.3 RESULTS 
 
4.3.1 Crystal Structure of Ps01740 and Ps01740-2OP 
 
 Ps01740 crystallized in the C2 space group with 3 monomers per asymmetric 
unit.  The crystal structure of native Ps01740 (Ps01740) was determined at a resolution of 
2.6 Å via molecular replacement using Cg10062 as a search model. Of the 127 amino 
acids in Ps01740, the N-terminal 112 residues of each chain were resolved. Each 
Ps01740 monomer assumes two β-α-β units, the signature fold for members of the TSF. 
The monomer is comprised of two β-α-β units, a linker connecting the two units, and a C-
terminus (Figure 4-1A). The β-α-β units form a pair of parallel β strands which interact 
in an antiparallel manner to make a β-sheet.  
 The Ps01740 trimer contains a three-fold axis of symmetry (Figure 4-1B). The 
inner core of the Ps01740 trimer is composed of β-strands and is surrounded by an outer 
wall of alpha helices. The β-hairpins in the linkers and short segments of the C-terminus 
(residues 109-112) form short anti-parallel β-sheets with the neighboring monomer. 
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Figure 4-1 The 2.6 Å resolution crystal structure of Ps01740.  
A) The Ps01740 monomer with Pro-1 atoms shown as spheres. B) The Ps01740 hexamer.   
  
 The active site of Ps01740 contains Pro-1, His-28, Arg-68, Arg-71, and Glu-112, 
which mirror active site residues in cis-CaaD (Figure 4-2A). However, one catalytic 
residue in cis-CaaD, Tyr-103ʹ (cis-CaaD numbering) is missing in Ps01740, and is 
substituted with Ala-101ʹ. Glu-112 is the C-terminal residue in the structure of Ps01740 
(128 amino acids), and its side chain forms a salt bridge with Arg-68. The prime indicates 
that the residue comes from an adjacent monomer.  
 The crystal structure of Ps01740 inactivated by 2-OP (Ps01740-2OP) was 
determined at a resolution of 2.6 Å via molecular replacement using a monomeric 
Ps01740 as a search model. Two of the three monomers are covalently modified at Pro-1. 
In both modified sites, the C-1 carboxylate group of the 2-oxo-3-pentenoate adduct 
A B 
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extends towards the center of the trimer. The overall structures of Ps01740 and Ps01740-
2OP are highly homologous, as the RMSD value for the structures is 0.42 Å. However, 
the conformation of Arg-68 differs in the modified active site of Ps01740-2OP, as the 
side chain (N) does not contact either carboxylate oxygen of Glu-112 as observed in 
Ps01740. Instead, one carboxylate oxygen of Glu-112 hydrogen bonds with the C-2 
oxygen atom (2.9 Å) of the 2-oxo-3-pentenoate adduct on Pro-1 (Figure 4-2B). One 
carboxylate oxygen atom of 2-OP is 3.6 Å from the backbone carbonyl oxygen of Gln-
66, but is otherwise free of ordered interactions in the interior of the trimer. On the 
opposite side of Pro-1, the side chain of His-28 (Nε) is stabilized by the hydroxyl group 
of Thr-32. The side chain of His-28 (Nε) and Arg-71 (N) interact with a water molecule 
which is 4.5 Å from C-4, opening up the possibility that these these residues might 
substitute for Glu-112 in water activation for addition to 2-OP. 
 
 
 
 
 168 
 
Figure 4-2 Active sites of Ps01740 (2.6 Å resolution) and Ps01740-2OP (2.5 Å 
resolution).  
Distances (yellow dashes) are in Å. A) Active site of Ps01740. B) 2Fo-Fc electron density 
map of 2-OP adduct at Pro-1 and nearby ordered water, contoured at 0.8 .  
A 
B 
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Data Collection Ps01740 Ps01740-2OP 
PDB entry 5UIF 5UMA 
space group C2 C2 
cell dimensions 
            a, b, c (Å) 80.7, 58.9, 84.8 81.1, 59.6, 85.1 
          α, β, γ (deg) 90.0, 110.4, 90.0 90.0, 110.4, 90.0 
resolution (Å) 50.00 - 2.58 50.00-2.46 
Rsym (%) (linear R factor) 0.524 (0.118) 0.484 (0.090) 
I/σI  7.9 (1.5) 8.2 (1.6) 
completeness (%) 96.0 (76.3) 72.9 (65.3) 
   Refinement     
resolution (Å) 46.481 - 2.574 40.178-2.458 
no. of reflections 11402 10226 
Rwork/Rfree (%) 21.92/27.16 19.17/24.12 
no. of atoms 
            protein 2520 2567 
          water 57 36 
Average B factor (Å
2
) 
            protein 52.3 47.7 
          water 44.7 46.8 
rmsd 
            bond lengths (Å) 0.002 0.002 
          bond angles (deg) 0.464 0.575 
Ramachandran plot (%) 
            residues in most favored regions 99.09 98.79 
          residues in additional allowed regions 0.91 1.21 
          residues in disallowed regions 0.00 0.00 
Data for the last resolution shell are given in parentheses. 
  
Table 4-2 Crystallographic data and refinement statistics for Ps01740 and Ps01740-2OP. 
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4.3.2 Crystal Structure of Pt0534-2OP 
 
  
 Pt0534 crystallized in the P1 space group and contained 6 monomers per 
asymmetric unit. The structure of Pt0534 inactivated by 2-OP (Pt0534-2OP) was 
obtained at a resolution of 2.0 Å via soaking experiments. Molecular replacement was 
performed using a 1.2 Å resolution Pt0534 structure that lack a resolved C-terminal 
hairpin. This incomplete structure was determined using a model for Cg10062. In four of 
the six monomers of Pt0534-2OP, each of the 123 residues of the protein was resolved 
(the other two monomers have 122 resolved residues). In Pt0534-2OP, only one of the six 
monomers is modified.  
 The tertiary structure of the Pt0534-2OP monomers is identical to that of 
Ps01740, except a β-hairpin is resolved at the C-terminus, after the second β-α-β unit 
(Figure 4-3A). Additionally, a short α-helix follows the hairpin. The trimer of Pt0534-
2OP is homologous to Ps01740 and has a three-fold rotational axis of symmetry (Figure 
4-3B).  The conformation of the active site residues does not differ considerably in the 
unmodified active sites. 
 All interactions between the 2-oxo-3-pentenoate adduct and Pt0534 are mediated 
by water (Figure 4-3C). The C-2 carbonyl oxygen interacts with a water molecule 
stabilized by the backbone carbonyl of Gly-111 and side chain oxygen of Tyr-2. One of 
the carboxylate oxygen atoms of the 2-oxo-3-pentenoate adducts interacts with two water 
molecules, where one donates a hydrogen bond to the backbone carbonyl of Ala-113, and 
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the other is in contact with the side chain of Arg-99ʹ (N). The ε nitrogen of the side 
chain of Arg-123 is positioned 4.0 Å from the 2-oxo-3-pentenoate carboxylate oxygen. 
 
Figure 4-3 The 2.0 Å resolution crystal structure of Pt0534-2OP.  
A) Unmodified Pt0534-2OP monomer with Pro-1 atoms shown as spheres. B) Pt0534-
2OP trimer. Atoms of Pro-1 and 2-OP adduct shown as spheres. C) Modified active site. 
2Fo-Fc electron density map surrounding modified Pro-1 and nearby water molecules, 
contoured at 0.8 . 
A B 
C 
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 Data Collection Pt0534-2OP 
PDB entry 5UNQ 
space group P1 
cell dimensions 
           a, b, c (Å) 54.214, 57.586, 63.528 
          α, β, γ (deg) 106.693, 104.539, 94.028 
resolution (Å) 50.00 - 1.98 
Rsym (%) (linear R factor)  0.088 (0.437) 
I/σI  6.6 (1.6) 
completeness (%) 96.0 (85.9) 
  Refinement   
resolution (Å) 40.830 - 1.976 
no. of reflections 47016 
Rwork/Rfree (%) 20.34/25.18 
no. of atoms 
           protein 5492 
          water 645 
Average B factor (Å
2
) 
           protein 30.97 
          water 37.18 
rmsd 
           bond lengths (Å) 0.003 
          bond angles (deg) 0.563 
Ramachandran plot (%) 
           residues in most favored regions 98.89 
          residues in additional allowed regions 1.11 
          residues in disallowed regions 0.00 
Data for the last resolution shell are given in parentheses. 
Table 4-3 Crystallographic data and refinement statistics for Pt0534-2OP. 
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4.3.3 Crystal Structure of Fused 4-OT  
 
Fused 4-OT crystallizes in the P212121 space group, and contains 3 monomers per 
asymmetric unit. The native crystal structure of Fused 4-OT (F4OT) was determined at 
1.5 Å resolution by molecular replacement using a 1.8 Å resolution Fused 4-OT structure 
(solved via molecular replacement using Cg10062). Each monomer is composed of two 
β-α-β motifs, a linker that connects the two units, and a C-terminal motif (Figure 4-4). 
As with Ps01740 and Pt0534, a β-hairpin follows each β-α-β unit in the linker and at the 
C-terminus, which interacts with neighboring subunits. A 310 helix is positioned between 
each β-hairpin and the preceding β-α-β unit. All 127 residues in each monomer of Fused 
4-OT structure are resolved. 
 
 
Figure 4-4 Monomer of the 1.5 Å resolution Fused 4-OT (F4OT) crystal structure. 
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The trimeric structure of Fused 4-OT is unsusual because it does not have three-
fold rotational symmetry present in all other known trimeric structures within the TSF. 
One monomer (Chain A) is “flipped” or inverted relative to the other two monomers in 
the trimer (Figure 4-5A). In this configuration of monomers, each interface in the trimer 
is unique. One interface  has two Pro-1 residues and two Arg-39 residues and is 
designated Interface A (Figure 4-5B). The two-fold symmetry in this interface arises 
from the inversion of one Fused 4-OT monomer. Another interface is asymmetrical and is 
designated Interface B, where Pro-1 is near Arg-104ʹ of the adjacent monomer (Figure 
4-5C), replacing Arg-39ʹ in active sites of Interface A. This interface can be described as 
“intact,” as it would exist between each monomer if inversion did not occur, as is true for 
other trimeric TSF members. A third interface has two-fold rotational symmetry with no 
Pro-1 residues, and is designated Interface C (Figure 4-5D). Again, the prime indicates 
that the residue comes from an adjacent monomer.  
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Figure 4-5 The 1.5 Å resolution F4OT crystal structure.  
Pro-1 is shown as spheres. A) Face view of the F4OT hexamer and identification of the 
inverted monomer. B) Side view of Interface A. Arg-39 is shown as sticks. C) Side view 
Interface B with indicated linker. Arg-104 (sticks) replaces Arg-39 of Interface A. D) 
Side view of Interface C with indicated linkers.  
 
  
 The asymmetry observed in the trimer prompted a closer examination of 
monomers for a better understanding of the causes or consequences of the inverted 
A B 
C D 
Inverted 
Interface A 
Interface C Interface B 
Linker 
Linkers 
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configuration. Superposition of the F4OT monomers (Figure 4-6A) reveals that Chain C 
deviates significantly from Chain A (inverted monomer) and Chain B near the β-hairpin 
region of the linker. The structural deviation observed in the Fused 4-OT monomers is 
greatest near the beginning of the second β-α-β unit, where a difference in peptide 
configuration is observed (Figure 4-6B). The Leu-65/Pro-66 peptide bond is in the cis 
configuration for both Chain A (lime) and Chain B (wheat), but is trans for Chain C 
(light teal). The difference is accompanied by a 3 Å backbone displacement N-terminal to 
Pro-66 of the second β-α-β unit and a 180° difference in side chain orientation of Leu-65. 
Unlike Leu-65 of Chain A or B, the side chain of Leu-65 in Chain C extends towards 
Ala-98 and Pro-99, where the backbone is displaced up to 2 Å relative to the Chain A and 
B. 
 The alternate conformations of the Leu-65/Pro-66 peptide bond may be related to 
the asymmetrical arrangement of subunits in Fused 4-OT. The linker regions of Chains A 
and B are near an interface with two-fold rotational symetry (Interface C, Figure 4-5D), 
and their environments are identical, consistent with their common peptide bond 
configuration at Leu-65/Pro-66 (cis). The linker region of Chain C is near Interface B in a 
different environment than the other linkers (Figure 4-5C), consistent with the difference 
in peptide bond configuration at Leu-65/Pro-66 (trans).  
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Figure 4-6 Comparison of F4OT monomers. 
The structures depicted are the 1.8 Å resolution Fused 4-OT structure solved prior to the 
1.5 Å resolution F4OT structure (RMSD 0.19). The Leu-65/Pro-66 peptide bond 
configurations are the same for each chain in the two structures A) Superposition of 
F4OT monomers. RMSD for Chain A (lime) and Chain B (wheat) is 0.38 Å, the RMSD 
value for Chain A and Chain C (light teal) is 0.71 Å. B) Close-up of superposition with 
Pro-66 in cis-configuration (Chains A and B, lime and wheat, respectfully) and trans-
configuration (Chain C, light teal). 
 
 The conformation of the arginine side chains in each active site of Fused 4-OT are 
different (Figure 4-7A), including Arg-104 and Arg-39, which differ in identity in 
Interface A when compared to Interface B (Figure 4-7B). In Interface A (Figure 4-5B), 
the side chain of Arg-39ʹ (N) hydrogen bonds to the side chain hydroxyl group of Thr-2ʹ 
and the backbone carbonyl oxygen of Ser-37 (Figure 4-7C).  
A B 
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 In the Interface B (Figure 4-5C), Val-67ʹ replaces Thr-2ʹ present in the Interface 
A, and a hydrogen bond cannot be made with the side chain of Arg-39 (N) (Figure 4-
3D). Furthermore, the backbone carbonyl oxygens of Ala-102ʹ and Ser-64ʹ of the linker 
region form a hydrogen bond with the side chain of Arg-39 (Nε and N, respectively). 
Arg-104ʹ does not interact with Thr-2 as observed for Arg-39ʹ in Interface B (Figure 4-
3B). Instead, the side chain of Arg-104ʹ (N) interacts with backbone carbonyl groups of 
Gln-101ʹ and Thr-103ʹ. 
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Figure 4-7 Comparison of active sites in F4OT.  
Images in A and B depict a 1.8 Å resolution Fused 4-OT structure determined prior to the 
solution of the 1.5 Å resolution F4OT structure (RMSD 0.19). Hydrogen bonding 
interactions in A and B are the same for both structures.  A) Superposition of active sites 
of Interface A (lime and wheat) and Interface B (deep teal). B) Close-up of superposition 
showing Arg-39 and Arg-104 conformations with surrounding residues. C) 2Fo-Fc 
electron density map (1.5 Å resolution F4OT structure) surrounding Arg-39 residues in 
Interface A, contoured at 2.0 . D) 2Fo-Fc electron density map of Arg-39 and Arg-104ʹ, 
contoured at 2.0  in the Interface B. Side chains of Thr-103ʹ, Gln-101ʹ, and Ala-102ʹ are 
oriented away from Arg-39 and Arg-104ʹ and are not shown.  
A B 
C D 
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Data Collection F4-OT 
PDB code 5UN4 
space group P212121 
cell dimensions 
           a, b, c (Å) 47.8, 67.2, 94.8 
          α, β, γ (deg) 90.0, 90.0, 90.0 
resolution (Å) 50.00 - 1.49 
Rsym (%) (linear R factor) 0.083 (0.698) 
I/σI  25.5 (1.8) 
completeness (%) 99.7 (99.7) 
  Refinement   
resolution (Å) 42.695 - 1.488 
no. of reflections 50550 
Rwork/Rfree (%) 19.531/21.01 
no. of atoms 
      protein 2751 
     water 329 
Average B factor (Å
2
) 
      protein 25.9 
     water 37.04 
rmsd 
      bond lengths (Å) 0.007 
     bond angles (deg) 1.113 
Ramachandran plot (%) 
      residues in most favored regions 99.47 
     residues in additional allowed regions 0.53 
     residues in disallowed regions 0.00 
Data for the last resolution shell are given in parentheses. 
Table 4-4 Crystallographic data and refinement statistics for F4OT. 
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4.3.4 Crystal Structures of F4OT-2HM, F4OT-2OP, and F4OT-PP 
 
  
 A crystal structure of Fused 4-OT in complex with 2-HM was solved to 1.9 Å 
resolution (F4OT-2HM). This is the first crystal structure of any TSF member bound to 
2-HM. The ligands bound may be the products 2-keto-3-hexenedioate or 2-keto-4-
hexenedioate, or a mixture of substrate and products, but these compounds are tautomers, 
and their identity cannot be determined based on electron density maps. The ligand is 
bound with partial occupancy in near one Pro-1 in Interface A (Figure 4-8B,C) and the 
Pro-1 in interface B (Figure 4-8D,E) and in the linker region of Chain A (Figure 4-8F).  
 In both active sites bound with 2-HM, the C-1 carboxylate of 2-HM hydrogen 
bonds with the side chain of Arg-76 (N) as well as the backbone amide of Ile-73 
(Figure 4-5C,E). In both sites, C-2 oxygen hydrogen bonds with Pro-1 and a water 
molecule stabilized by the side chain of Thr-2. Side chains of Ile-73, Phe-115, and Ile-
117 are near hydrophobic atoms C-3, C-4, and C-5.  
 In Interface A, the side chain of Arg-39ʹ (N1) contacts the 2-HM C-6 
carboxylate, and Arg-39ʹ (N2) is in contact with the side chain of Thr-2 (Figure 4-5B). 
In Interface B, the side chains of Arg-104ʹ (N) and Arg-39 (N) hydrogen bond with the 
C-6 carboxylate, and neither residue interacts with the side chain hydroxyl group of Thr-2 
(Figure 4-5D,E).  
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Figure 4-8 The 1.9 Å resolution structure of F4OT-2HM shown with 2F0-Fc map 
contoured at 0.5 .  
A B 
C D 
E F 
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Figure 4-8 (continued) Distances (yellow) in Å. A) Face view of F4OT-2HM. Pro-1 is 
(yellow) spheres in each monomer. B,C) 2-HM (cyan) bound at Interface A. D,E) 2-HM 
bound at Interface B. F) 2-HM bound near linker region of Chain A. 
 
 
 Crystals of Fused 4-OT were modified by 2-OP via soaking experiments for the 
solution of F4OT-2OP. The structure was solved at 2.3 Å resolution by molecular 
replacement using a 1.8 Å native Fused 4-OT structure solved prior to F4OT. All three 
active sites were modified (Figure 4-9A), and the binding modes of the 2-oxo-3-
pentenoate adduct were different in each case.  
 In the Interface B, the carboxylate oxygen atoms of the adduct are interacting with 
the side chain of Arg-104ʹ (N and Nε) and a water molecule stabilized by Arg-39 (N) 
(Figure 4-9B). The C-2 oxygen interacts with the side chain of Arg-127 (N).  
 In the Interface A, the C-2 oxygen atoms of both 2-oxo-3-pentenoate adducts 
interact with Arg-39ʹ (N and Nε, Figure 4-9C). The C-1 carboxylate is oriented 
differently in the two active sites — the side chain of Arg-127 (N) in Chain C interacts 
with the C-1 carboxylate of the 2-oxo-3-pentenoate adduct whereas the side chain of Arg-
76 (N) in Chain A interacts with the C-1 carboxylate via a water molecule (Figure 4-
9C).  
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Figure 4-9 The 2.3 Å resolution F4OT-2OP crystal structure.  
Continuous 2Fo-Fc electron density map surrounds the 2-oxo-3-pentenoate and Pro-1, 
contoured at 1.0 . A) Face view of F4OT-2OP. B) Modified active site in Interface B. 
C) Interface A with two modified Pro-1 residues.  
 
 
A B 
C 
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 Differences in conformation of ligands and arginine residues are observed when 
active sites of F4OT-2OP and F4OT-2HM are superimposed. In the superposition of 
F4OT-2HM active sites, Arg-76 of Chain B in Interface B does not extend towards Pro-1 
like the other chains, nor is 2-HM bound in this active site (Figure 4-10A). The 
differences in binding of the C-6 carboxylate of 2-HM are discussed above. In the 
alignment of F4OT-2OP active sites, the alternative positioning of Arg-39ʹ and Arg-39 in 
Interface A relative to Arg-104ʹ and Arg-39 in Interface B is accompanied by an alternate 
orientation of the 2-oxo-3-pentenoate (Figure 4-10B) where the carboxylate adduct 
(yellow orange) hydrogen bonds with the side chain of Arg-104ʹ (teal). 
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Figure 4-10 Superposition of A) F4OT-2HM and B) F4OT-2OP active sites. 
A) The alternate conformation of Arg-76 in Chain B (orange) in Interface A is 
concomminant with the lack of bound 2-HM. B) The alternate conformations of Arg-39 
and Arg-104ʹ side chains in Interface B (yellow orange, and teal, respectively) relative to 
the Arg-39 and Arg-39ʹ side chains in Interface A (green and teal) is accompanied by 
alternate conformations of the 2-oxo-3-pentenoate adduct (yellow orange at Interface B, 
and green/teal at Interface A). 
A 
B 
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  The Fused 4-OT structure in complex with phenylpyruvate (F4OT-PP) was 
solved to 2.7 Å resolution using phenylpyuvate-soaked crystals. The 2Fo-Fc electron 
density map near Pro-1 in Chain A (at Interface A) indicated phenylpyruvate binds in two 
positions. Two phenylpyruvate ligands were modeled in the structure with partial 
occupancy (Figure 4-11). The pyruvoyl moiety of one phenylpyruvate ligand is oriented 
away from Pro-1 and its C-2 carbonyl interacts with a water molecule stabilized by the 
side chain of Arg-39ʹ (Nε and N1). The pyruvoyl moiety of the other phenylpyruvate 
ligand is oriented towards Pro-1, where the C-1 carboxylate of interacts with the side 
chain of Arg-39ʹ (N2), the prolyl nitrogen of Pro-1, and the backbone carbonyl of Ile-73. 
The C-2 oxygen atom is interacting with the backbone amide of Ile-73 and the side chain 
of Arg-76 (N). The presence of these interactions and the fact that the prolyl nitrogen of 
Pro-1 is 3.2 Å from C-3 of phenylpyruvate indicates that the orientation might resemble 
the catalytic conformation. 
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Figure 4-11 Active site of the 2.7 Å resolution F4OT-PP crystal structure. 
A, B) Two views of the active site in two conformations in Interface A with 2Fo-Fc 
electron density surrounding phenylpyruvate (slate) and a nearby ordered water molecule, 
contoured at 0.5 .  
 
 
 
A 
B 
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Data Collection F4OT-2HM F4OT-2OP F4OT-PP 
PDB code N/A N/A N/A 
space group P212121 P212121 P212121 
cell dimensions 
             a, b, c (Å) 48.1, 68.6, 96.4 48.1, 69.4, 96.4 48.2, 69.5, 96.1 
          α, β, γ (deg) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
resolution (Å) 50.00 - 1.88 50.00 - 2.30 50.00 - 2.69 
Rsym (%) (linear R factor) 0.092 (0.123) 0.271 (0.949) 0.236 (0.738) 
I/σI  12 (1.6) 6.6 (1.5) 3.153 (1.579) 
completeness (%) 95.9 (85.4) 99.9 (100.0) 93.4 (95.7) 
    Refinement       
resolution (Å) 43.026 - 1.872 36.567 - 2.319 48.067 - 2.663 
no. of reflections 25795 14540 8887 
Rwork/Rfree (%) 17.63/21.82 19.33/23.25 22.22/27.71 
no. of atoms 
        protein 2783 2780 2751 
     water 308 190 53 
Average B factor (Å
2
) 
        protein 32.8 28.9 42.5 
     water 40.4 32.5 39.2 
rmsd 
        bond lengths (Å) 0.004 0.003 0.003 
     bond angles (deg) 0.771 0.765 0.715 
Ramachandran plot (%) 
        residues in most favored 
regions 99.20 98.93 99.20 
     residues in additional allowed 
regions 0.80 1.07 0.80 
     residues in disallowed regions 0.00 0.00 0.00 
Data for the last resolution shell are given in parentheses. 
   
Table 4-5 Crystallographic data and refinement statistics for F4OT-2HM, F4OT-2OP, 
and F4OT-PP. 
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4.4 DISCUSSION 
 
 Ps01740, Pt0534 and Fused 4-OT are linked by sequence identity to the title 
enzyme in the 4-OT and cis-CaaD subgroups. The long monomers of cis-CaaD and these 
linker enzymes may have arisen as a result of duplication and fusion of an ancestral 4-
OT-like gene sequence. Crystal structures of the linker enzymes show divergence in 
active site composition from their better understood homologues 4-OT and cis-CaaD, as 
was expected from sequence analysis (Figure 4-12). Arginine residues that bind 
dicarboxylate substrates such as 2-HM are on opposite sides of Pro-1 in 4-OT (Arg-11ʹ 
and Arg-39ʹʹ), and are substituted for two arginine residues on one side of Pro-1 (Arg-70 
and Arg-73) in cis-CaaD. His-28, Glu-114, and Tyr-103ʹ are other key catalytic residues 
in cis-CaaD. The structure-function analysis of the contemporary linkers with 
intermediate functional properties of both cis-CaaD and 4-OT might reveal insight the 
changes in architecture and active site composition during the proposed evolution from 
the 4-OT-like enzymes that act on diacid substrates to cis-CaaD-like enzymes which 
process monoacid compounds.  
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Figure 4-12 Sequence alignment of enzymes of the 4-OT and cis-CaaD subgroups. 
Active site residues for 4-OT are boxed in blue and active site residues for cis-CaaD are 
boxed in red, adapted from (Davidson et al., In Preparation). 
 
  
4.4.1 Ps01740 Structure and Function 
 
 Ps01740 has no activity with cis-3-chloroacrylate (LeVieux, et al., In 
Preparation), despite its close sequence similarity with cis-CaaD. The key residues in 
cis-CaaD (Pro-1, Arg-70, Arg-73, Glu-114, and His-28) are conserved in Ps01740 
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(equivalent residues are Pro-1, Arg-68, Arg-71, Glu-112, and His-28, Figure 4-13B), and 
the monomeric RMSD for cis-CaaD and Ps01740 is 1.11 Å (Figure 4-13A). However, 
Tyr-103ʹ in cis-CaaD is not conserved in Ps01740, which may explain its lack of cis-
CaaD activity as the residue is believed to assist Glu-114 (cis-CaaD numbering) in the 
activation of water (Poelarends et al., 2003). The importance of Tyr-103ʹ is further 
substantiated by studies of Cg10062, an enzyme that has all 6 cataytic residues found in 
cis-CaaD (34% sequence identity), including Tyr-103ʹ. Cg10062 exhibits cis-CaaD 
activity (kcat/KM of 184 M
-1
s
-1
), albeit two orders of magnitute less than kcat/KM for cis-
CaaD (Poelarends et al., 2008).  
 Ps01740 does not process 2-hydroxymuconate (2-HM), likely because it lacks 
Arg-39 (4-OT numbering) to stabilize the second carboxylate of the diacid. However, the 
enzyme catalyzes the tautomerization of phenylpyruvate at a rate of 3.5  105 M-1s-1 
(Table 4-6). Ps01740 has Pro-1 and Arg-71, which are equivalent to catalytic residues 
Pro-1 and Arg-11ʹ in 4-OT (Figure 4-13C), and the RMSD for the 4-OT dimer and 
Ps01740 is 1.23 Å (Figure 4-13A). The active site residues Arg-39ʹʹ and Phe-50ʹ in 4-OT 
are not conserved in Ps01740, and are replaced by Val-99ʹ and Ala-101ʹ.  
 Ps01740 does not have a proline residue at the N-terminus of the second β-α-β 
unit which should align with Pro-1 of 4-OT (Figure 4-13C), as observed for Fused 4-OT 
(Figure 4-17C). However, Pro-60 of Ps01740 is located in the linker region two residues 
N-terminal to this position. 
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Figure 4-13 Superposition of Ps01740, cis-CaaD, and 4-OT. 
A) Structural alignment of cis-CaaD (dark salmon, PDB entry 3MF8) monomer and the 
4-OT dimer (limon, PDB entry 1OTF) to Ps01740 monomer (yellow orange). B) Active 
site comparison of Ps01740 (yellow orange) and cis-CaaD (dark salmon). C) Active site 
comparison of Ps01740 (yellow orange) and 4-OT (limon). 
A B 
C 
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 Covalent modification of the prolyl nitrogen of Pro-1 in Ps01740 by 2-OP was 
confirmed by MS (LeVieux, et al., In Preparation) and by the solution of a crystal 
structure of Ps01740-2OP. Comparison of Ps01740-2OP and structures of cis-CaaD and 
Cg10062 modified by 2-oxirane-2-carboxylate (Figure 4-14A) reveal an alternative 
positioning for the 2-oxo-3-pentenoate adduct in the active site of Ps01740 relative to 2-
hydroxypropanoate adducts of cis-CaaD and Cg10062, where the carboxylate is buried 
near the center of the trimer. The “in” conformation of the 2-oxo-3-pentenoate may 
related to the absence of Tyr-103 which gives space to accommodate the 2-oxo-3-
pentenoate adduct.  
 Ps01740 is a member of the cis-CaaD subgroup, where the studied members have 
higher pKa values (~9.2 for cis-CaaD) for Pro-1, and can hydrate 2-OP. Since both 
hydration and inactivation occur for Ps01740, Pro-1 might have an intermediate pKa 
value (~7-8) as was postulated for the cis-CaaD homologue known as MsCCH2 (Baas, et 
al., 2011). The altered binding mode of the 2-oxo-3-pentenoate in Ps01740, as observed 
in the Ps01740-2OP structure, might be related to the low hydratase activity. Arg-71 and 
His-28 interact with a water molecule near the modified Pro-1 (Figure 4-2B), and are 
alternate candidates to Glu-112 for water activation. The 2-oxo-3-pentenoate adduct 
formed at Pro-1 in the crystal structures of Ps01740-2OP and BP4401-2OP (Section 5.3), 
both enzymes which hydrate 2-OP (and are modified by the compound), opens the 
possibility for covalent catalysis in these enzymes (Scheme 4-1B).  
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Scheme 4-1 A) Direct and B) covalent hydration mechanism of Ps01740 using 2-OP. 
  
 In the 4-OT co-crystal structure covalently modified by 2-OP, the side chain Arg-
39ʹ (Nε and N) hydrogen bond to C-2 oxygen and carboxylate oxygen, respectively 
(Figure 4-14B). Ps01740 does not have an equivalent arginine residue to stabilize the 
carboxylate of the 2-oxo-3-pentenoate adduct in Ps01740-2OP. The lack of the arginine 
and presence of Tyr-38 nearby forces the 2-oxopentenoate adduct to the “in” 
conformation where the adduct extends towards the center of the trimer in a water-filled 
pocket that exists in the absence of a Tyr-103ʹ (cis-CaaD numbering).  
 196 
 
Figure 4-14 Superposition of Ps01740-2OP and inactivated homologues.  
A) Overlay of Ps01740-2OP (yellow orange), cis-CaaD-2-hydroxypropanate (dark 
salmon, PDB entry 3MF7) and Cg10062-2-hydroxypropanate (forest, PDB entry 3N4H) 
active sites. B) Active site superposition of Ps01740-2OP (yellow orange) and 4-OT 
inactivated by 2-OP (limon, PDB entry 1BJP).  
 
4.4.2 Pt0534 Structure and Function 
 
 Pt0534 is a member of the 4-OT subgroup, and has trace levels of cis-CaaD 
activity (monitored over several weeks). Unlike Ps01740, the identity of active site 
residues of cis-CaaD and Pt0534 is low, as only Pro-1 and Arg-71 in Pt0534 are 
conserved (equivalent to Pro-1 and Arg-73 in cis-CaaD, Figure 4-15B). In addition, the 
tertiary structure of Pt0534-2OP deviates more from cis-CaaD (monomer RMSD: 1.39 Å) 
than for 4-OT (Pt0534-2OP monomer and 4-OT dimer RMSD: 0.78 Å, Figure 4-15A). 
A B 
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Pt0534 is inactivated by 2-OP and has no hydration activity with the acetylene 
compound, consistent with other members of the 4-OT subgroup. 
Pt0534 is an efficient tautomerase, as the kcat/KM values for 2-HM and 
phenylenolpyruvate (3.5  107 and 1.3  106 M-1s-1, respectively, Baas et al., In 
Preparation) are comparable for that of 4-OT (5.5  107 M-1s-1 and 3.7  105 M-1s-1, 
respectively, Chen et al., 1992, Burks et al., 2010). The key residues conserved in Pt0534 
are Pro-1, Arg-71, and Arg-99ʹ, are equivalent to catalytic residues Pro-1, Arg-11ʹ, Arg-
39ʹʹ, respectively, in 4-OT (Figure 4-15C). The active site residue Met-110 in Pt0534 
replaces Phe-50ʹ, indicating the residue can be exchanged for another bulky amino acid, 
as evident in the 4-OT homologue TomN, where Phe-50ʹ is replaced by tryptophan 
(Burks, et al., 2011). Pro1ʹʹ in 4-OT is not conserved in Pt0534, but Pro-59 is only two 
residues N-terminal to the start of the second β-α-β unit. The equivalent residue for Arg-
61ʹ in 4-OT is present in Pt0534 (the C-terminal residue Arg-123), and is resolved in the 
native structure.  
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Figure 4-15 Superposition of Pt0534-2OP with 4-OT and cis-CaaD. 
A) Structural alignment of Pt0534-2OP monomer (unmodified, violet purple) to 4-OT 
dimer (limon, PDB entry 1OTF) and cisCaaD monomer (dark salmon, PDB entry 3MF8), 
with Pro-1 residues shown as spheres. B) Comparison of Pt0534-2OP (unmodified site) 
and cis-CaaD active sites. C) Comparison of Pt0534-2OP (unmodified site) and 4-OT 
active sites. 
A B 
C 
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 The 2-oxo-3-pentenoate adduct bound in the modified active site of Pt0534-2OP 
does not adopt the “in” conformation observed for Ps01740-2OP (Figure 4-16). Instead, 
the adduct is positioned similarly to the ligand in the structure of 4-OT structure 
inactivated by 2-OP, where the C-1 carboxylate group of the 2-oxo-3-pentenoate adduct 
extends towards the side chain of Arg-123 (Nε and N) (Figure 4-16). In 4-OT, the C-1 
carboxylate of the 2-oxo-3-pentenoate interacts with the side chain of Arg-61ʹ (Nε and 
N). The distance is greater in Pt0534-2OP, as the closest atomic distance between the 
two groups is 4.0 Å. The 2-oxo-3-pentenoate adduct makes direct contact to Arg-39ʹʹ in 
4-OT, whereas all interactions between the adduct and Pt0534 are mediated by water. 
Although the interaction of the C-1 carboxylate of the 2-oxo-3-pentenoate adduct and 
Arg-123 in Pt0534 is less direct, and 4-OT does not require the equivalent residue for 
activity (Harris, et al., 1999), this C-terminal residue may participate in 2-HM 
tautomerization in Pt0534, as was observed for TomN (R61A mutant showed a 5-fold 
decrease in kcat, Burks et al., 2011), and Fused 4-OT (100-fold decrease in kcat/KM, 
Section 4.4.4).  
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Figure 4-16 Alignment of Pt0534 (deep teal and violet purple) and 4-OT labeled with 2-
oxo-3-penteonate adduct (orange, PDB entry 1BJP). 
 
4.4.3 Fused 4-OT Structure and Function 
 
  
 The tertiary structure of the native Fused 4-OT (F4OT) monomer resembles the 
4-OT dimer more than it does the cis-CaaD monomer (RMSD of F4OT and 4-OT dimer 
is 0.65 Å and RMSD for F4OT and cis-CaaD is 5.2 Å, Figure 4-17A). One monomer of 
F4OT is inverted relative to the others, which could result from the different peptide bond 
configurations at Leu-65/Pro-66, creating two equivalent active sites in the Interface A 
(Figure 4-5B) and one active site in Interface B (Figure 4-5C) that is not equivalent to 
the other two. Though sequence identity of Fused 4-OT and cis-CaaD is lowest out of the 
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three enzymes studied, Fused 4-OT has trace cis-CaaD activity (monitored over several 
weeks, Levieux J, et al., In Preparation). The catalytic residues Pro-1 and Arg-76 in cis-
CaaD are conserved in Fused 4-OT (Pro-1 and Arg-73, respectively, Figure 4-17B).  
 
Figure 4-17 Superposition of F4OT with 4-OT and cis-CaaD. 
A) Structural alignment of dimeric 4-OT (limon, PDB entry 1OTF) and monomeric cis-
CaaD (dark salmon, PDB entry 3MF8) to monomeric F4OT (deep teal). B) Active site 
alignment of cis-CaaD and F4OT (normal interface). C) Active site alignment of 4-OT 
and F4OT (normal interface). 
A B 
C 
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 Fused 4-OT exhibits significant phenylenolpyruvate and 2-HM activity (1.9  105 
M
-1
s
-1
 and 2.8  106 M-1s-1, respectively, Baas et al., In Preparation, Table 4-6). The key 
active site residues Pro-1, Arg-11ʹ, Phe-50ʹ, and Arg-39ʹʹ of canonical 4-OT are 
conserved in Fused 4-OT (equivalent to Pro-1, Arg-76, Phe-115, and Arg-104ʹ in 
Interface B, Figure 4-17C). Arg-104ʹ is replaced by Arg-39ʹ at both sites in interface A. 
Pro-66ʹ of Fused 4-OT is equivalent to Pro-1ʹʹ of the canonical 4-OT, suggesting that the 
evolution of Fused 4-OT involved gene duplication and fusion of an ancient 4-OT-like 
gene.  
 In Interface B, the side chain of Arg-39 (N) interacts with the backbone of the 
linker between the β-α-β units and blocks the side chain of Arg-104ʹ from interacting 
with the side chain hydroxyl group of Thr-2 (Figure 4-7D). Although 4-OT does not 
have a linker, the positioning of these arginines resembles that of Arg-39ʹʹ and Arg-39 in 
4-OT (Figure 4-17C). The conformation differs with the Arg-39ʹ residues in Interface A 
of Fused 4-OT (Figure 4-7C), where the side chain of Arg-39ʹ (N) hydrogen bonds to 
the side chain hydroxyl group of Thr-2. In 4-OT, Thr-2 is replaced with Ile-2, so a similar 
interaction cannot be made with Arg-39ʹʹ. 
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Table 4-6 Steady-state parameters for Ps01740, Pt0534, Fused 4-OT (Baas BJ, In 
Preparation), cis-CaaD, and 4-OT. 
 
  
Enzyme kcat (s
-1
) KM (M) kcat/KM (M
-1
 s
-1
) kcat (s
-1
) KM (M) 
kcat/KM 
(M
-1
 s
-1
) 
cis-CaaD N.D. N.D. N.D. 0.20  0.03 110 ± 30 1.8  103 
Linker 1 N.D. N.D. N.D. 80  9 230  40 3.5  105 
Linker 2 2800  130 80  9 3.5  107 920  48 685  68 1.3  106 
Fused 4-OT 580  25 208  16 2.8  106 136  8 720  75 1.9  105 
4-OT 4000  182 62  8 6.5  107 73  6 199  23 3.7  105 
  N.D.: Not Detectable 
 
  
 The structure of Fused 4-OT in complex with phenylpyruvate (F4OT-PP) reveals 
that the ligand is bound at Interface A in two orientations (Figure 4-18A), one of which 
is similar to that observed in a modeling study with the heterohexameric 4-OT shown in 
Figure 4-18B (Burks et al., 2010). However, the hydrogen bonding interactions with the 
pyruvate moiety differ. In F4OT-PP, the carboxylate is hydrogen bonding to the prolyl 
nitrogen of Pro-1 and the backbone carbonyl oxygen of Ile-71 in (Figure 4-18A), 
whereas the carboxylate interacts with the side chain of αArg-12 (N) in 
heterohexameric 4-OT (Figure 4-18B). In F4OT-PP, the C-2 oxygen of phenylpyruvate 
interacts with the side chain of Arg-76 (N) (Figure 4-18A), which is equivalent to 
αArg-12 in heterohexameric 4-OT.  
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Figure 4-18 Comparison of phenylpyruvate bound to A) Fused 4-OT (F4OT-PP) and B) 
heterohexamer 4-OT (Burks et al., 2010). 
 
4.4.4 2-HM Tautomerization in Interface A and B of Fused 4-OT 
 
 In F4OT-2HM, the C-1 and C-6 carboxylate groups of 2-HM are bound to side 
chain of Arg-76 (N) and Arg-104ʹ/39ʹ (N), which is flipped 180° relative to the 
reported orientation of 2-HM in canonical 4-OT, where the C-1 and C-6 carboxylate 
groups are bound to the equivalent side chains of Arg-11ʹ (N) and Arg-39ʹʹ (N), 
respectively (Harris et al., 1999). To investigate the cause of the reverse orientation, the 
α-carbon atoms of Pro-1, Arg-104ʹ, and Arg-39 in Interface B were aligned to equivalent 
residues of 4-OT (Figure 4-19). In this superposition, Phe-115 (Cα) in Fused 4-OT is 
shifted 1.6 Å further from Pro-1 than Phe-50ʹ (Cα) in 4-OT, and Arg-76 (Cα) in Fused 4-
OT is shifted 2.8 Å closer to Pro-1 than Arg-11ʹ in 4-OT. This shift is present in each 
interface, as the backbone in each active site is superimposable (Figure 4-7). 
A B 
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Additionally, the C-2 oxygen of 2-HM in Interface A and B of F4OT-2HM is bonded to a 
water molecule stabilized by the side chain hydroxyl group of Thr-2 (Figure 4-8C,E). In 
4-OT, Thr-2 is substituted for Ile-2, and no hydrogen bond is made with the C-2 oxygen. 
The lack of Thr-2 and the increased distance of Arg-11ʹ from Pro-1 in 4-OT might cause 
the 2-HM orientation to be opposite to that observed in F4OT-2HM. 
 
 
Figure 4-19 Active site superposition of F4OT-2HM (orange and deep teal) and 4-OT 
(limon, PDB entry 1OTF). 
 
 The interaction of the Thr-2 side chain hydroxyl group and Arg-76 (N) with 2-
HM in Interface A matches interactions in Interface B, but interactions between arginine 
residues and the C-6 carboxylate groups differ (Figure 4-10A). The absence of 2-HM in 
 206 
one active site of Interface A is explained by the alternate orientation of Arg-76 in that 
active site which extends away from Pro-1.  
 Fused 4-OT mutants were prepared and characterized as described elsewhere 
(Baas BJ, et al. In Preparation). The steady state kinetic parameters are shown in Table 
4-7. The kcat/KM value for the P1A mutant decreases 200-fold, a drop less extreme than 
other mutants, of which the R76A mutant was the most impaired (kcat/KM decreases 770-
fold). The relative drop in activity was the same as the decrease for the equivalent 4-OT 
mutant (R11A, 770-fold) (Harris, et al., 1999). The kcat/KM value for R39A mutant of 
Fused 4-OT mutant dropped 330-fold relative to wild-type, which is similar to the 
decrease for the comparable 4-OT mutant (200-fold). The kcat value for the R104A 
mutant of Fused 4-OT dropped ~2-fold, and the KM value did not change. Arg-104 is only 
present in Interface B, so the data suggest it is required for catalysis in this interface. Arg-
104 must be accompanied by Arg-39, though, as the R39A mutant shows its role cannot 
be substituted in 2-HM tautomerization (330-fold decrease in kcat/KM). The notion is in 
agreement with the structure of 2-HM bound in the Interface B — both Arg-39 and Arg-
104ʹ contact the C-6 carboxylate (Figure 4-8D,E).  
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Table 4-7 Steady-state Kinetic Parameters of Fused 4-OT Mutants (Baas BJ, In 
Preparation). 
Enzyme kcat (s
-1
) rel. kcat Km (M) rel. Km 
kcat/Km 
(M
-1
 s
-1
) 
rel. 
kcat/Km 
WT 580  25 1.0 208  16 1.0 2.79  106 1.0 
P1A 3.4  0.1 5.9  10-3 221  11 1.06 1.54  104 5.5  10-3 
R39A N.D. N.D. N.D. N.D. 8.34  103 3.0  10-3 
R76A N.D. N.D. N.D. N.D. 3.74  103 1.3  10-3 
R104A 313  15 0.54 213  18 1.02 1.47  106 0.53 
R127A N.D. N.D. N.D. N.D. 2.84  104 1.0  10-2 
N.D.: Not Detectable 
 
 Surprisingly, the kcat/KM value for the R127A mutant was 100-fold less than that 
of wild-type. This result is contrary to the the result seen with 4-OT where the KM for the 
R61A mutant increased ~2-fold (Harris et al., 1998), but is more consistent with the 
study of TomN (Burks, et al., 2011). The decrease in activity for the R127A mutant of 
Fused 4-OT and distances of the side chain of Arg-127 (N) to the C-6 carboxylate (3.7 
Å in the Interface A and 4.2 Å in the Interface B) suggest that the C-6 carboxylate may 
be stabilized by Arg-127 in Fused 4-OT during enediolate formation and collapse. 
Conversely, intermediates in 2-HM tautomerization in 4-OT are stabilized by Arg-11ʹ, as 
this residue binds the C-6 carboxylate, and Arg-61 (equivalent to Arg-127) is not nearby 
to participate in catalysis by an interaction with the C-6 carboxylate.  
 Mechanisms for 2-HM tautomerization in Interfaces A and B are proposed 
(Scheme 4-2B,C, respectively). In both active sites, the prolyl nitrogen of Pro-1 removes 
the proton of the C-2 hydroxyl group, with the assistance of a water molecule that is 
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stabilized by the side chain group of Thr-2. Electron rearrangement occurs to form an 
enediolate species. In the Interface A (Scheme 4-2B), the side chain of Arg-39ʹ 
(respectively N1 and N2) is bound to the side chain hydroxyl group of Thr-2 and 
stabilizes one oxygen of the enediolate intermediate. The side chain of Arg-127 stabilizes 
the second oxygen of the enediolate, and protonation by the nitrogen of Pro-1 occurs at 
C-5. In the Interface B (Scheme 4-2C), one oxygen of the enediolate is stabilized by the 
side chains of Arg-39 (N) and Arg-104ʹ (N), while the other is stabilized by the side 
chain of Arg-127 (N).  
 
 
Scheme 4-2 Proposed mechanisms for A) 4-OT B) Fused 4-OT (Interface A) C) Fused 4-
OT (Interface B). 
A 
B 
C 
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4.4.5 Structure and Function Relationships of Linkers 
 
Our studies of Ps01740, Pt0534, and Fused 4-OT, contemporary enzymes that 
link 4-OT and cis-CaaD subgroups via sequence identity, have affirmed the consequence 
of arginine side chain positioning in the processing of monoacid and diacid substrates. 
Members of the 4-OT subgroup that bind dicarboxylate substrates such as 2-HM (from 
the meta-fission pathway) have a pair of arginine residues that are on opposite sides of 
Pro-1 (Arg-11ʹ and Arg-39ʹʹ, in 4-OT). Such is the case with Pt0534 and Fused 4-OT, 
which have efficient tautomerase activity using 2-HM. With Fused 4-OT, one monomer 
is inverted relative to the others, but each active site retains Arg76 and Arg-39ʹ/Arg-104ʹ 
(Arg-11ʹ and Arg-39ʹʹ in 4-OT) for binding 2-HM. This inversion of one subunit and the 
opposite 2-HM orientation to that proposed for 4-OT (Harris TK, et al. 1999) may be 
anomalies in the 4-OT subgroup, but further investigation is required to determine 
whether these traits are widespread. Fused 4-OT has a proline at position 65, which may 
be a relic of a catalytic Pro-1 of an ancestral 4-OT gene. Pt0534 is also a member of the 
4-OT subgroup and has Arg-71 and Arg-99ʹ conserved for binding 2-HM (equivalent to 
Arg-11ʹ and Arg-39ʹʹ in 4-OT). The 4-OT activity of Pt0534 suggests that Phe-50ʹ (4-OT 
numbering) can be replaced by other large hydrophobic residues (Met-110 in Pt0534), as 
seen before with heterohexamer 4-OT and TomN (Burks et al., 2010, Burks, et al., 2011). 
The structures of Pt0534-2OP and F4OT-2HM, in addition to low activity of the R127A 
mutant of Fused 4-OT (and R61A TomN, Burks EA, et al., 2011) indicate that Arg-127 
might be important in the 4-OT subgroup.  
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Members of the cis-CaaD subgroup retain Pro-1 and Arg-11ʹ, but lose Arg-39ʹʹ. 
The absence of this residue in Ps01740 is consistent its inability to process the 
dicarboxylate substrate 2-HM. Many other residues that are key for cis-CaaD activity 
have been acquired in Ps01740 (Arg-70, Glu-114, and His-28, cis-CaaD numbering) 
except for Tyr-103, which might explain the absence of cis-CaaD activity. The absence 
of Tyr-103ʹ allows for the “in” conformation of the 2-oxo-3-propenoate adduct in 
Ps01740-2OP (Figure 4-3), and may contribute to the low hydatase activity relative to 
other cis-CaaD homologues. Covalent modification by 2-OP at Pro-1 in Ps01740 and 
BP4401 (Figure 5-2), both of which catalyze 2-OP hydration, support a covalent 
mechanism for these enzymes, which might reflect their unknown biological activity. 
Phenylpyruvate tautomerase activity is exhibited in each linker and functionally connects 
the 4-OT and cis-CaaD subgroups. The anomolies discovered for the linker enzymes 
show the diversity of structure and behavior within an enzyme subgroup and could not be 
predicted by sequence alone. 
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Chapter 5: The Malonate Semialdehyde Decarboxylase Homologues 
BP4401 and YusQ 
 
5.1 INTRODUCTION 
 
 The enzymes designated BP4401 from Burkholderia phymatum strain STM815 
and YusQ from Bacillus substilis, respectively share 26 and 29% sequence identity with 
malonate semialdehyde decarboxylase (MSAD) from Pseudomonas pavonaceae 170. 
The latter enzyme participates in the 1,3-dichloropropene degradation pathway (Section 
3.5), whereas the homologues have unknown functions. These homologues are of interest 
because they possess the core catalytic residues of MSAD (Pro-1, Asp-37, and Arg-76), 
but do not have decarboxylase activity using malonate semialdehyde. Bp4401 shows 
increased hydratase activity using 2-oxo-3-pentynoate (2-OP, 3000 M
-1
s
-1
) relative to 
MSAD (600-1100 M
-1
s
-1
), while YusQ has moderate hydratase activity (440 M
-1
s
-1
) 
(Huddleston et al., 2014). BP4401 and YusQ are not encoded near genes for 1,3-
dichloropropene degradation, and biological roles for the enzymes might be related to 
their hydratase activity. In this chapter, crystallography is used to provide clues to 
establish the determinants of hydratase activity, to identify “missing” determinants of 
decaroxylase activity, and to assist identification of biological substrates.  
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5.2 EXPERIMENTAL PROCEDURES 
 
 
 Crystallization and Crystal Soaking of Bp4401. The diffraction-quality crystals of 
Bp4401 were obtained in PEG 3350 (22-26%) with ZnAc (0.2 M). To obtain the structure 
of BP4401 inactivated by 2-oxo-3-pentynoate (2-OP, BP4401-2OP) an apo crystal of 
Bp4401 was soaked in 5.9 mM 2-OP for ~5 min. To obtain the structure of BP4401 
inactivated by 3-bromopropiolate (BP4401-BrP), an apo crystal of Bp4401 was soaked 
in 10 µM 3-bromopropiolate for 75 min.  
 Crystallization and Crystal Soaking of YusQ. The diffraction-quality crystals of 
YusQ were obtained in 0.1 M MES (pH 6.5-7.0) and 26% PEG 3350. To obtain the the 
structure of YusQ inactivated by 3-bromopropiolate (YusQ-BrP), an apo crystal of YusQ 
was soaked in reservoir solution containing 3-bromopropiolate (10 µM) for 95 min. 
Crystals were cryoprotected by 25% glycerol in mother liquor prior to vitrification in 
liquid nitrogen. 
 Data Collection and Struture Determination. X-ray diffraction data for BP4401, 
BP4401-2OP, and YusQ were collected at Advanced Light Source beamline 5.0.3 (ALS, 
Berkeley, CA). Datasets used for the BP4401-BrP and YusQ-BrP was conducted at ALS 
beamline 5.0.1. The datasets were indexed, integrated, and scaled using HKL2000 
(Otwinowski & Minor, 1997). Statistics for data collection are summarized in Table 2-9 
and Table 5-1. All structures were determined by molecular replacement using Phaser 
(McCoy, 2007) and Autobuild (Terwilliger et al., 2008) from PHENIX (Adams et al., 
2004). The native structure of YusQ (YusQ) was determines by molecular replacement 
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using a crystal structure of MSAD FG41 (a homologue isolated from Cornyeform strain 
FG41) inactivated by 3-chloropropiolate (29.6% sequence identity, PDB entry 3N4G) as 
a search model. The YusQ structure was used as a search model for YusQ-BrP, BP4401, 
and BP4401-BrP. A monomer of BP4401 was used as a search model for the solution of 
BP4401-2OP. Molecular replacement was performed using Phaser (McCoy, 2007) and 
Autobuild (Terwilliger et al., 2008). Structures were refined using Phenix Refine 
(Afonine et al., 2012). Manual model building was done using COOT (Emsley et al., 
2010). Model structures were evaluated during and after refinement using Molprobity 
(Chen et al., 2010). The statisitics for data collection and refinement is summarized in 
Table 5-1. 
 
5.3 RESULTS 
 
 
BP4401 crystallized in the P1211 and P212121 space groups with six and three 
monomers per asymmetric unit, respectively. The native BP4401 crystal structure 
(BP4401) was solved to 2.2 Å via molecular replacement using YusQ as a search model. 
125 (of 126 amino acids in Bp4401) were resolved in 5 monomers, and all were resolved 
in the sixth monomer. 
YusQ crystallized in the P213 space group with one monomer per asymmetric 
unit. The 2.1 Å resolution crystal structure of native YusQ (YusQ) was determined by 
molecular replacement using inactivated FG41 MSAD as a search model. The N-terminal 
125 residues of the 127 amino acid protein were resolved. 
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BP4401 and YusQ fold into two β-α-β units, as expected for long TSF members. 
The monomers trimerize and possess three-fold rotational symmetry. Short beta strands 
in the linker and C-terminus interact with the neighboring monomer.  
 
Figure 5-1 The 2.2 Å resolution BP4401 crystal structure and the 2.1 Å resolution YusQ 
crystal structure.  
Pro-1 atoms are shown as spheres. A) BP4401 hexamer. B) YusQ hexamer generated by 
a symmetry operation. 
 
 The crystal structure of BP4401 inactivated by 2-OP (BP4401-2OP) was solved 
to 1.9 Å resolution using a soaking procedure. All 126 residues were resolved via 
molecular replacement using native BP4401 as a search model. Three monomers were 
present in each asymmetric unit. The 2Fo-Fc electron density map revealed 2-OP had 
modified the prolyl nitrogen at Pro-1 in two active sites and was converted to 
A B 
 215 
acetopyruvate in the third with no covalent modification of the prolyl nitrogen (Figure 5-
2). In each case, the C-1 carboxylate of the 2-oxo-3-pentenoate adduct was bound to the 
side chain of Arg-76 (N). The position of the C-2 oxygen atom varies in each active site 
near Thr-73. The side chain hydroxyl group of Tyr-124 hydrogen bonds to the side chain 
carboxylate group of Asp-37 in one active site (Figure 5-2B), but not in the others 
(Figure 5-2A,C). The C-4 oxygen of acetopyruvate forms a hydrogen bond with the side 
chain carboxylate oxygen of Asp-37 (Figure 5-2A). 
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Figure 5-2 Active sites of the 1.9 Å resolution structure of BP4401 inactivated by 2-OP. 
2Fo-Fc electron density of ligands and nearby waters are contoured at 0.5 . Active sites 
contain A) acetopyruvate and B, C) 2-oxo-3-pentenoate adducts.  
 
 Bp4401 and YusQ inactivated by 3-bromopropiolate (BP4401-BrP and YusQ-
BrP) using a soaking procedure and were solved to 1.8 and 2.8 Å resolution, 
respectively. Molecular replacement was used to solve BP4401-BrP and YusQ-BrP using 
the native YusQ as a search model. BP4401-BrP and YusQ-BrP contained six and one 
monomers per asymmetric unit, respectively.  
A B 
C 
 217 
 The initial 2Fo-Fc electron density map in the YusQ-BrP structure in complex 
inactivated by 3-bromopropiolate suggested a 2-oxopropanoate adduct at Pro-1 (Scheme 
5-1). The true ligand may be 3-oxopropanoate, since there is precedence for this adduct 
(Poelarends et al., 2005, Almrud et al., 2005) and the resolution of the YusQ-BrP 
structure is low (2.8 Å). 
 
 
Scheme 5-1 Possible BP4401 and YusQ modifications at Pro-1 (prolyl nitrogen) using 3-
bromopropiolate. 
Hydration at C-3 produces the 3-Oxopropanoate (top) adduct and water addition at C-2 
allows for the 2-oxopropaonate adduct (bottom).  
 
 The 2Fo-Fc electron density map of BP4401-BrP structure show density near Pro-
1 in all six monomers larger than the 3-oxo-propanoate adduct expected. Zinc was 
modeled in the active site (Figure 5-3A), given that a high concentration of zinc was 
present in the reservoir buffer (0.2 M). In addition, the bond lengths (1.9, 2.0, 2.3, and 2.6 
Å) are comparable with similar zinc compounds with Zn-O bond lengths of 2.1 Å (Chen 
& Powers, 1995). The C-1 carboxylate oxygen atoms of the 2-oxo-propanoate adduct in 
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BP4401-BrP and YusQ-BrP are bound to the side chain of Arg-76 (N). In YusQ, the 2-
oxopropanoate ligand was modelled in the structure instead of the 3-propanoate adduct 
due to the better fit in the 2Fo-Fc map. 
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Figure 5-3 Active sites of the 1.8 Å resolution BP4401-BrP structure and the 2.8 Å 
YusQ-BrP structure. 
A) 2Fo-Fc electron density map surrounding Pro-1 and the 2-oxopropanoate adduct, zinc 
(grey sphere), and water (red sphere) is contoured at 0.5 . B) 2Fo-Fc continuous density 
surrounding Pro-1 and 2-oxopropanoate adduct is contoured at 1.0 . 
A 
B 
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Data Collection BP4401 BP4401-2-OP BP4401-BrP YusQ YusQ-BrP 
space group P1211 P212121 P1211 P213 P213 
cell dimensions 
     
          a, b, c (Å) 
53.2, 136.6, 
55.4 
65.0, 67.9, 
100.5 
53.3, 136.4, 
55.6 
84.8, 84.8, 
84.8 
83.2, 83.2, 
83.2 
          α, β, γ (deg) 
90.0, 105.9, 
90.0 90.0, 90.0, 90.0 
90.0, 106.4, 
90.0 
90.0, 90.0, 
90.0 
90.0, 90.0, 
90.0 
resolution (Å) 50.00 - 2.18 50.00 - 1.88 50.00 - 1.80 50.00 - 2.14 50.00 - 2.81 
Rsym (%) (linear R 
factor) 0.097 (0.388) 0.096 (0.622) 0.256 (0.068) 0.400 (0.975) 0.127 (0.971) 
I/σI  15 (2.3) 21.8 (1.8) 20.4 (2.8) 21 (3.1) 16.9 (1.2) 
completeness (%) 99.9 (100.0) 99.1 (99.7) 100.0 (100.0) 100.0 (100.0) 99.9 (100.0) 
      
Refinement           
resolution (Å) 49.65 - 2.19 40.40 - 1.88 49.68 - 1.80 42.41 - 2.11 48.042 -2.80 
no. of reflections 39590 36524 70284 11477 4868 
Rwork/Rfree (%) 18.68/23.23 19.01/22.11 14.75/18.79 17.17/19.97 24.65/29.18 
no. of atoms 
     
          protein 6120 3111 6183 1052 1057 
          water 441 324 892 98 2 
Average B factor (Å2) 
     
          protein 35.6 38.6 21.9 29.5 63.1 
          water 39.3 43.6 35.5 38.0 23.1 
rmsd 
     
          bond lengths (Å) 0.015 0.005 1.748 0.008 0.007 
          bond angles (deg) 1.252 0.980 1.665 0.968 1.240 
Ramachandran plot (%) 
     
          favored regions 97.16 97.04 97.00 95.90 95.87 
          allowed regions 2.84 2.96 2.86 4.10 4.13 
          disallowed 
regions 0.00 0.00 0.14 0.00 3.30 
Data for the last resolution shell are given in parentheses. 
  
Table 5-1 Crystallographic Data and Refinement statistics for BP4401, BP4401-2OP, 
BP4401-BrP, YusQ, and YusQ-BrP. 
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5.4 DISCUSSION 
 
The tertiary structures of YusQ, BP4401, and MSAD are comparable (Figure 5-
4), as RMSD values of the proteins range between 0.55 and 0.72. MSAD deviates from 
YusQ and BP4401 at the loop in the β-hairpin in the linker region. Additionally, MSAD 
possesses an α-helix at its C-terminus, which is not present in YusQ or BP4401. 
 
 
Figure 5-4 Superposition of MSAD (deep salmon, PDB entry 2AAG), BP4401 (deep 
teal), and YusQ (forest) monomers.  
  
 Asp-37 has been proposed to activate water for addition to 2-OP in FG41 MSAD, 
(38% sequence ID with MSAD, referred to as FG41). Given the aspartate residue is 
conserved in MSAD, BP4401, and YusQ (in addition to Pro-1 and Arg-76, MSAD 
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numbering), it is not surprising that each of these enzymes has hydration activity with 2-
OP. The kcat/KM values for FG41, MSAD, YusQ, and BP4401 are 20, 600-1100, 440, and 
3000 M
-1
s
-1
, respectively (Huddleston et al., 2014). The crystal structure of BP4401-2OP 
is consistent with the role of Asp-37 in water activation as the C-4 oxygen of 
acetopyruvate ligand hydrogen bonds with the side chain carboxylate of Asp-37 (Figure 
5-2A). The 2-oxo-3-pentenoate adduct (Figure 5-2B,C) supports a covalent mechanism 
for hydration as noted for Ps01740, the cis-CaaD homologue with low level hydration 
activity, that was shown to be modified by 2-OP in the crystal structure (Section 4.4.1) 
 The carboxylate groups of the propanoate adducts (Figure 5-5) of the 3-
halopropiolate-inactivated structures of MSAD and YusQ are oriented towards the side 
chain of Arg-75 (N, MSAD numbering). Though the adducts are oriented similarly, 
differences in active site composition may prevent YusQ from exhibiting MSAD activity. 
An obvious difference in YusQ is Lys-73, which replaces Arg-73 in MSAD. 
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Figure 5-5 Superposition of MSAD with 3-oxopropanoate adduct (deep salmon, PDB 
entry 2AAL) and YusQ-BrP with 2-oxopropanoate adduct (lime green). 
  
 
 Though key residues Pro-1, Asp-37, and Arg-75 (Figure 5-6) in MSAD are 
conserved in BP4401 and YusQ, neither enzyme exhibits MSAD activity. BP4401 and 
YusQ lack an equivalent to Arg-73, which is replaced by Thr-73 and Lys-73, 
respectively. The lack of arginine at this position did not eliminate MSAD activity for 
FG41, though, when Arg-73 is replaced with Gln-73. The FG41-catalyzed 
decarboxylation is robust, as MSAD and FG41 have comparable kcat/KM values at 8700 
M
-1
s
-1 
and 7400 M
-1
s
-1
 (Huddleston et al., 2014). Mutagenesis and structural studies of 
FG41 suggest that Thr-72, Gln-73, and Tyr-123 likely replace Arg-73 and Arg-76 for 
MSAD activity (Guo et al., 2013). Thr-72 and Gln-73 are not conserved in BP4401 or 
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YusQ, but Tyr-123 is conserved in BP4401. Thr-72 and Gln-73 (FG41 numbering), or 
Arg-73 (MSAD numbering) may be required to introduce decarboxylase activity in 
BP4401. These residues in addition to Tyr-123 may be required for MSAD activity in 
YusQ. 
 
Figure 5-6 Sequence alignment of MSAD, FG41, BP4401, and YusQ. 
The residues discussed in the text are indicated with a red dot. Similar residues are in red 
type. Identical residues are indicated by filled red background. Secondary structure is 
based on MSAD (PDB entry 2AAG). 
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